DoubleClick personal page - To The Moon

DoubleClick

DoubleClick

No personal profile

20Follow

5Followers

0Topic

0Badge

2022-01-04

[Cool]

Some Vaccine Stocks Slid in Morning Trading

2022-01-01

[Shy] [Shy]

Wall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors

2022-01-03

✅

3 Biotech Stocks That Could Double in 2022

2022-01-02

[Cool]

If I Could Buy Only 1 Stock in 2022, This Would Be It

2022-01-11

[Cool]

Investing $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income

2022-01-14

[Cool]

Can Spotify Become the Next Google?

2022-01-01

[Cool]

Could Apple's Market Cap Hit $4 Trillion in 2022?

2022-01-13

[Cool] [Cool]

British lawmakers target Visa and Mastercard fee increases

2022-01-03

Ok

3 Dates for Disney Stock Investors to Circle in January

2021-12-29

[Cool]

Sorry, the original content has been removed

2022-01-20

[Cool]

Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report

2022-01-13

[Cool]

Delta Air Lines says company has no plans to invest in ITA Airways

2022-01-03

[Cool]

December jobs report, Federal Reserve meeting minutes, CES: What to know this week

2022-01-01

[Happy] [Sad]

U.S. Stocks End Lower on New Year’s Eve, but S&P 500, Dow, Nasdaq Score Big Gains for 2021

2021-12-29

[Cool]

3 No-Brainer Warren Buffett Stocks to Buy for 2022

2021-12-29

[Cool]

Toplines Before US Market Open on Wednesday

2021-12-25

[Cool] [Cool]

Electric boat developer Forza X1 files for a $29 million IPO

2021-06-20

Latest

A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens

2022-01-14

[Cool]

1 Growth Stock Down 89% That Could Soar, According to Wall Street

2022-01-13

[Cool]

Vir Biotechnology shares rose over 6% in premarket trading

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3574933488250733","uuid":"3574933488250733","gmtCreate":1611839465354,"gmtModify":1635779542349,"name":"DoubleClick","pinyin":"doubleclick","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":20,"tweetSize":42,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"60.35%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9094908298,"gmtCreate":1645032591723,"gmtModify":1676533989146,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"Words&nbsp;","listText":"Words&nbsp;","text":"Words","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094908298","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094908161,"gmtCreate":1645032572429,"gmtModify":1676533989122,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094908161","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004410452,"gmtCreate":1642655811900,"gmtModify":1676533732941,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004410452","repostId":"2204050273","repostType":4,"repost":{"id":"2204050273","pubTimestamp":1642632420,"share":"https://ttm.financial/m/news/2204050273?lang=&edition=fundamental","pubTime":"2022-01-20 06:47","market":"us","language":"en","title":"After-Hours Stock Movers: Casper Sleep, Silvergate Higher; United Airlines,Alcoa Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2204050273","media":"StreetInsider","summary":"After-Hours Stock MoversCasper Sleep Inc. (NYSE: CSPR) 11% HIGHER; announced that its stockholders v","content":"<html><head></head><body><p>After-Hours Stock Movers</p><p><a href=\"https://laohu8.com/S/CSPR\">Casper Sleep Inc.</a> (NYSE: CSPR) 11% HIGHER; announced that its stockholders voted today to adopt the Agreement and Plan of Merger, whereby Casper will be acquired by certain subsidiaries of Durational Consumer SPV IV, LP, an investment vehicle managed by Durational Capital Management, LP.</p><p>Matson, Inc. (NYSE: MATX) 7% HIGHER; expects fourth quarter operating income for Ocean Transportation of $445.0 to $455.0 million and Logistics operating income of $14.0 to $15.0 million. Also expect fourth quarter 2021 net income and diluted EPS to be $365.2 to $382.4 million and $8.70 to $9.10, respectively.</p><p><a href=\"https://laohu8.com/S/AMH\">American Homes 4 Rent</a> (NYSE: AMH) 4% LOWER; commenced an underwritten public offering of 20,000,000 of its Class A common shares of beneficial interest, $0.01 par value per share (&#34;Class A common shares&#34;), of which 10,000,000 shares will be offered directly by the Company, and 10,000,000 shares will be offered, at the request of the Company, by the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters have been granted a 30-day option to purchase an aggregate of up to an additional 3,000,000 Class A common shares.</p><p>Discover Financial Services (NYSE: DFS) 3.4% LOWER; reported Q4 EPS of $3.64, $0.12 better than the analyst estimate of $3.52. Revenue net interest expense for the quarter came in at $2.94 billion versus the consensus estimate of $2.99 billion.</p><p><a href=\"https://laohu8.com/S/SI\">Silvergate Capital</a> Corp. (NYSE: SI) 3% HIGHER; from Neutral to Buy with a price target of $166.00.</p><p>United Airlines (NASDAQ: UAL) 2% LOWER; reported Q4 EPS of ($1.60), $0.48 better than the analyst estimate of ($2.08). Revenue for the quarter came in at $8.19 billion versus the consensus estimate of $7.99 billion.</p><p>Alcoa (NYSE: AA) 1.5% HIGHER; reported Q4 EPS of $2.50, ex-items, $0.73 better than the analyst estimate of $1.77. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.3 billion.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Casper Sleep, Silvergate Higher; United Airlines,Alcoa Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Casper Sleep, Silvergate Higher; United Airlines,Alcoa Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 06:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19479123><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock MoversCasper Sleep Inc. (NYSE: CSPR) 11% HIGHER; announced that its stockholders voted today to adopt the Agreement and Plan of Merger, whereby Casper will be acquired by certain ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19479123\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4021":"海运","BK4095":"家庭装饰品","BK4211":"区域性银行","UAL":"联合大陆航空","BK4215":"住宅房地产投资信托","DFS":"发现金融","MATX":"Matson Inc","BK4008":"航空公司","BK4166":"消费信贷","AMH":"American Homes 4 Rent","BK4500":"航空公司"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19479123","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204050273","content_text":"After-Hours Stock MoversCasper Sleep Inc. (NYSE: CSPR) 11% HIGHER; announced that its stockholders voted today to adopt the Agreement and Plan of Merger, whereby Casper will be acquired by certain subsidiaries of Durational Consumer SPV IV, LP, an investment vehicle managed by Durational Capital Management, LP.Matson, Inc. (NYSE: MATX) 7% HIGHER; expects fourth quarter operating income for Ocean Transportation of $445.0 to $455.0 million and Logistics operating income of $14.0 to $15.0 million. Also expect fourth quarter 2021 net income and diluted EPS to be $365.2 to $382.4 million and $8.70 to $9.10, respectively.American Homes 4 Rent (NYSE: AMH) 4% LOWER; commenced an underwritten public offering of 20,000,000 of its Class A common shares of beneficial interest, $0.01 par value per share (\"Class A common shares\"), of which 10,000,000 shares will be offered directly by the Company, and 10,000,000 shares will be offered, at the request of the Company, by the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters have been granted a 30-day option to purchase an aggregate of up to an additional 3,000,000 Class A common shares.Discover Financial Services (NYSE: DFS) 3.4% LOWER; reported Q4 EPS of $3.64, $0.12 better than the analyst estimate of $3.52. Revenue net interest expense for the quarter came in at $2.94 billion versus the consensus estimate of $2.99 billion.Silvergate Capital Corp. (NYSE: SI) 3% HIGHER; from Neutral to Buy with a price target of $166.00.United Airlines (NASDAQ: UAL) 2% LOWER; reported Q4 EPS of ($1.60), $0.48 better than the analyst estimate of ($2.08). Revenue for the quarter came in at $8.19 billion versus the consensus estimate of $7.99 billion.Alcoa (NYSE: AA) 1.5% HIGHER; reported Q4 EPS of $2.50, ex-items, $0.73 better than the analyst estimate of $1.77. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.3 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004410217,"gmtCreate":1642655723433,"gmtModify":1676533732974,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cry]&nbsp;","listText":"[Cry]&nbsp;","text":"[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004410217","repostId":"1176584633","repostType":4,"repost":{"id":"1176584633","pubTimestamp":1642642008,"share":"https://ttm.financial/m/news/1176584633?lang=&edition=fundamental","pubTime":"2022-01-20 09:26","market":"us","language":"en","title":"Why the Microsoft-Activision Merger Is Bad News for GameStop","url":"https://stock-news.laohu8.com/highlight/detail?id=1176584633","media":"Barron's","summary":"GameStop got another piece of bad news when Microsoft announced plans to buy Activision Blizzard. Kr","content":"<html><head></head><body><p>GameStop got another piece of bad news when Microsoft announced plans to buy Activision Blizzard. Krisztian Bocsi/Bloomberg</p><p>On Tuesday, GameStop stock fell to its lowest level since February after Microsoft announced a deal to acquire videogame maker Activision Blizzard. It’s fast approaching a level that could mean more losses ahead.</p><p>GameStop stock (ticker: GME) fell 6.6% on Tuesday after Microsoft (MSFT) announced plans to purchase Activision Blizzard (ATVI), the maker of Call of Duty, among other videogame hits. It’s not hard to see why. As Jefferies analyst Stephanie Wissink notes, GameStop sells products by both companies, so would lose bargaining power with the combined company. Microsoft, meanwhile, could make Activision games available only for the Xbox, which would likely reduce the sales of games overall.</p><p>The biggest, problem, though, is that the acquisition would likely speed up the shift from physical games to digital ones, and that’s something GameStop doesn’t have a plan for just yet. “Microsoft intention to acquire Activision is a game changer in our view,” writes Wissink, who cut her price target on GameStop to $100 from $140.</p><p>Wissink is no GameStop bear. While she has a Hold rating on the stock, she has taken its rally seriously. Her target was as high as $190 in June, but she cut it to $145 earlier in January, and then $100. The other two analysts still covering the stock have targets at $45 and $23. But she also recognizes that GameStop doesn’t really seem to have a plan just yet. “We once again are forced to rethink our valuation assumptions, having cut recently due to lack of visibility into strategy, positioning and performance,” she writes.</p><p><img src=\"https://static.tigerbbs.com/536ff50d60daa8c4a2937b45006d3e81\" tg-width=\"1069\" tg-height=\"624\" width=\"100%\" height=\"auto\"/></p><p>That $100 should serve as a line in the sand for the stock. Tuesday’s decline took GameStop stock to $108.91, its lowest close since Feb. 26, when it closed at $101.74. A lot of trading occurs around round numbers, so it wouldn’t be surprising if the $100 level becomes a battleground for investors. With shares up 2.5% to $111.65 in premarket trading, that won’t happen today.</p><p>But it breaks, there’s nowhere to go but down.</p></body></html>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why the Microsoft-Activision Merger Is Bad News for GameStop</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy the Microsoft-Activision Merger Is Bad News for GameStop\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 09:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/gamestop-stock-activision-microsoft-51642601385?mod=hp_LEAD_4_B_1><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop got another piece of bad news when Microsoft announced plans to buy Activision Blizzard. Krisztian Bocsi/BloombergOn Tuesday, GameStop stock fell to its lowest level since February after ...</p>\n\n<a href=\"https://www.barrons.com/articles/gamestop-stock-activision-microsoft-51642601385?mod=hp_LEAD_4_B_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","ATVI":"动视暴雪","MSFT":"微软"},"source_url":"https://www.barrons.com/articles/gamestop-stock-activision-microsoft-51642601385?mod=hp_LEAD_4_B_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176584633","content_text":"GameStop got another piece of bad news when Microsoft announced plans to buy Activision Blizzard. Krisztian Bocsi/BloombergOn Tuesday, GameStop stock fell to its lowest level since February after Microsoft announced a deal to acquire videogame maker Activision Blizzard. It’s fast approaching a level that could mean more losses ahead.GameStop stock (ticker: GME) fell 6.6% on Tuesday after Microsoft (MSFT) announced plans to purchase Activision Blizzard (ATVI), the maker of Call of Duty, among other videogame hits. It’s not hard to see why. As Jefferies analyst Stephanie Wissink notes, GameStop sells products by both companies, so would lose bargaining power with the combined company. Microsoft, meanwhile, could make Activision games available only for the Xbox, which would likely reduce the sales of games overall.The biggest, problem, though, is that the acquisition would likely speed up the shift from physical games to digital ones, and that’s something GameStop doesn’t have a plan for just yet. “Microsoft intention to acquire Activision is a game changer in our view,” writes Wissink, who cut her price target on GameStop to $100 from $140.Wissink is no GameStop bear. While she has a Hold rating on the stock, she has taken its rally seriously. Her target was as high as $190 in June, but she cut it to $145 earlier in January, and then $100. The other two analysts still covering the stock have targets at $45 and $23. But she also recognizes that GameStop doesn’t really seem to have a plan just yet. “We once again are forced to rethink our valuation assumptions, having cut recently due to lack of visibility into strategy, positioning and performance,” she writes.That $100 should serve as a line in the sand for the stock. Tuesday’s decline took GameStop stock to $108.91, its lowest close since Feb. 26, when it closed at $101.74. A lot of trading occurs around round numbers, so it wouldn’t be surprising if the $100 level becomes a battleground for investors. With shares up 2.5% to $111.65 in premarket trading, that won’t happen today.But it breaks, there’s nowhere to go but down.","news_type":1},"isVote":1,"tweetType":1,"viewCount":474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004410985,"gmtCreate":1642655657908,"gmtModify":1676533732934,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004410985","repostId":"1178411704","repostType":4,"repost":{"id":"1178411704","pubTimestamp":1642649050,"share":"https://ttm.financial/m/news/1178411704?lang=&edition=fundamental","pubTime":"2022-01-20 11:24","market":"us","language":"en","title":"Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1178411704","media":"Benzinga","summary":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposur","content":"<html><head></head><body><p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.</p><p>Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.</p><p>Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.</p><p>The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration &amp; Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.</p><p>ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.</p><p>Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.</p><p>Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.</p><p>BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.</p><p>Here are a few other key Ark Invest trades on Wednesday:</p><p>Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 11:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKX":"ARK Space Exploration & Innovation ETF","ARKK":"ARK Innovation ETF","NFLX":"奈飞"},"source_url":"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178411704","content_text":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration & Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.Here are a few other key Ark Invest trades on Wednesday:Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005335514,"gmtCreate":1642170915758,"gmtModify":1676533688781,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005335514","repostId":"2203805712","repostType":4,"repost":{"id":"2203805712","pubTimestamp":1642168440,"share":"https://ttm.financial/m/news/2203805712?lang=&edition=fundamental","pubTime":"2022-01-14 21:54","market":"us","language":"en","title":"1 Growth Stock Down 89% That Could Soar, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2203805712","media":"Motley Fool","summary":"A stock that plunges nearly 90% is inherently risky, but Wall Street is rapidly warming up to this small-cap company.","content":"<html><head></head><body><p>It&#39;s no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are observing the collapse in price of many technology stocks right now after a strong 2021.</p><p>But for action camera leader <b><a href=\"https://laohu8.com/S/GPRO\">GoPro</a></b> (NASDAQ:GPRO), the journey from top-of-the-world to rock bottom happened more slowly. After listing on the stock exchange in 2014, its stock hit an all-time closing high of $93.85 before a painful eight-year decline of 89% to $10.58 as of this writing. GoPro has become a rare case, though, because it&#39;s successfully turning things around.</p><p>Its recent strategies have been so promising that at least three top Wall Street firms have upgraded the stock since last November. A building consensus like that might be enough to get some investors off the sidelines and into the action.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/884d755da3119dda23b44f093ef5dd2d\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>Adapt and thrive</h2><p>Perhaps the heaviest criticism of GoPro since it went public was its <a href=\"https://laohu8.com/S/AONE.U\">one</a>-dimensional business. The company simply manufactured and sold action cameras, so while it has always led the market, competitors also improved over time, eroding GoPro&#39;s profit margins and stifling its revenue growth.</p><p>Less income meant less money to allocate to innovation, triggering an inevitable death spiral that crippled the company&#39;s share price. But over the last three years, that has changed. GoPro has leveraged its website to create a new direct-to-consumer sales channel which now accounts for 35% of the top line, replacing some of the large retail chains it previously relied on to sell its cameras and accessories. And selling directly from its website means it keeps a larger share of the profits.</p><p>GoPro has also introduced a subscription service for loyal customers to unlock exclusive benefits. These moves have increased the company&#39;s gross margin and delivered brand new revenue streams, which offer GoPro more flexibility with its business model.</p><p>The largest benefit of all is the renewed focus on innovation. In Sept. 2021, it released the new HERO10 Black action camera, which shoots video in 5.3K High Definition. It&#39;s priced at $499, and its closest competitor in terms of technical ability comes in at $3,500 -- in other words, it&#39;s blowing away the competition.</p><h2>Soaring subscriptions</h2><p>Building a subscriber base is a totally new concept for GoPro. It includes a shift from hardware to software and carries a gross margin as high as 80%, almost double that of its main business. That means more revenue flows to the bottom line, which investors love to see.</p><p>For $49.99 per year, subscribers get unlimited cloud storage for their videos, exclusive product discounts, and the ability to livestream directly from their GoPro camera. The response from customers has been overwhelmingly positive, and over the past year, in particular, subscriber growth has soared.</p><table><thead><tr><th><p>Metric</p></th><th><p>Q3 2020</p></th><th><p>Q3 2021</p></th><th><p>Growth</p></th></tr></thead><tbody><tr><td><p>GoPro.com Subscribers</p></td><td><p>501,000</p></td><td><p>1.34 million</p></td><td><p>168%</p></td></tr></tbody></table><p>Data source: GoPro.</p><p>The subscriber figure is expected to reach 1.7 million once GoPro officially reports its full-year 2021 results. And this year, the company estimates it will generate $90 million in recurring subscription revenue. Given the potential 80% margin mentioned earlier, GoPro&#39;s profitability should continue to rise.</p><h2>Impressing Wall Street</h2><p>After holding mostly negative views on GoPro during its difficult tenure as a public company, Wall Street firms recently began to recognize its newfound success with a tidal wave of upgrades between November and December 2021.</p><p>Investment bank <b><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a></b>, which had an underweight rating on GoPro stock, has upgraded it to neutral with an $11 price target. Investment firm <b>Wedbush Securities</b> maintained its outperform rating but added a $13.50 price target. And finally, investment bank <b>JP Morgan Chase</b> is the most bullish of the three, upgrading GoPro stock from neutral to overweight with a $15 price target, representing a 42% gain from its current price.</p><p>According to the consensus analyst estimate, GoPro is expected to generate $0.94 in earnings per share in 2022. With a stock price of $10.58, that means shares trade at a forward price-to-earnings multiple of just 11.3. By comparison, the technology-centric <b>Nasdaq 100</b> index trades at a forward multiple of just under 28, so GoPro stock would need to more than double to trade in line with the broader sector.</p><p>It&#39;s never easy to find hidden gems in the stock market, but Wall Street might have uncovered one in GoPro, and the company is backing it up with a truly incredible turnaround.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Growth Stock Down 89% That Could Soar, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Growth Stock Down 89% That Could Soar, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 21:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4078":"消费电子产品","BK4504":"桥水持仓","MS":"摩根士丹利","GPRO":"GoPro","BK4127":"投资银行业与经纪业"},"source_url":"https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203805712","content_text":"It's no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are observing the collapse in price of many technology stocks right now after a strong 2021.But for action camera leader GoPro (NASDAQ:GPRO), the journey from top-of-the-world to rock bottom happened more slowly. After listing on the stock exchange in 2014, its stock hit an all-time closing high of $93.85 before a painful eight-year decline of 89% to $10.58 as of this writing. GoPro has become a rare case, though, because it's successfully turning things around.Its recent strategies have been so promising that at least three top Wall Street firms have upgraded the stock since last November. A building consensus like that might be enough to get some investors off the sidelines and into the action.Image source: Getty Images.Adapt and thrivePerhaps the heaviest criticism of GoPro since it went public was its one-dimensional business. The company simply manufactured and sold action cameras, so while it has always led the market, competitors also improved over time, eroding GoPro's profit margins and stifling its revenue growth.Less income meant less money to allocate to innovation, triggering an inevitable death spiral that crippled the company's share price. But over the last three years, that has changed. GoPro has leveraged its website to create a new direct-to-consumer sales channel which now accounts for 35% of the top line, replacing some of the large retail chains it previously relied on to sell its cameras and accessories. And selling directly from its website means it keeps a larger share of the profits.GoPro has also introduced a subscription service for loyal customers to unlock exclusive benefits. These moves have increased the company's gross margin and delivered brand new revenue streams, which offer GoPro more flexibility with its business model.The largest benefit of all is the renewed focus on innovation. In Sept. 2021, it released the new HERO10 Black action camera, which shoots video in 5.3K High Definition. It's priced at $499, and its closest competitor in terms of technical ability comes in at $3,500 -- in other words, it's blowing away the competition.Soaring subscriptionsBuilding a subscriber base is a totally new concept for GoPro. It includes a shift from hardware to software and carries a gross margin as high as 80%, almost double that of its main business. That means more revenue flows to the bottom line, which investors love to see.For $49.99 per year, subscribers get unlimited cloud storage for their videos, exclusive product discounts, and the ability to livestream directly from their GoPro camera. The response from customers has been overwhelmingly positive, and over the past year, in particular, subscriber growth has soared.MetricQ3 2020Q3 2021GrowthGoPro.com Subscribers501,0001.34 million168%Data source: GoPro.The subscriber figure is expected to reach 1.7 million once GoPro officially reports its full-year 2021 results. And this year, the company estimates it will generate $90 million in recurring subscription revenue. Given the potential 80% margin mentioned earlier, GoPro's profitability should continue to rise.Impressing Wall StreetAfter holding mostly negative views on GoPro during its difficult tenure as a public company, Wall Street firms recently began to recognize its newfound success with a tidal wave of upgrades between November and December 2021.Investment bank Morgan Stanley, which had an underweight rating on GoPro stock, has upgraded it to neutral with an $11 price target. Investment firm Wedbush Securities maintained its outperform rating but added a $13.50 price target. And finally, investment bank JP Morgan Chase is the most bullish of the three, upgrading GoPro stock from neutral to overweight with a $15 price target, representing a 42% gain from its current price.According to the consensus analyst estimate, GoPro is expected to generate $0.94 in earnings per share in 2022. With a stock price of $10.58, that means shares trade at a forward price-to-earnings multiple of just 11.3. By comparison, the technology-centric Nasdaq 100 index trades at a forward multiple of just under 28, so GoPro stock would need to more than double to trade in line with the broader sector.It's never easy to find hidden gems in the stock market, but Wall Street might have uncovered one in GoPro, and the company is backing it up with a truly incredible turnaround.","news_type":1},"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005335079,"gmtCreate":1642170860932,"gmtModify":1676533688773,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005335079","repostId":"2203712618","repostType":4,"repost":{"id":"2203712618","pubTimestamp":1642169258,"share":"https://ttm.financial/m/news/2203712618?lang=&edition=fundamental","pubTime":"2022-01-14 22:07","market":"us","language":"en","title":"Can Spotify Become the Next Google?","url":"https://stock-news.laohu8.com/highlight/detail?id=2203712618","media":"Motley Fool","summary":"Spotify's advertising strategy could take the audio industry to the next level.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GOOGL\"><b>Alphabet</b> </a>, the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are certainly a number of factors that have helped Alphabet reach this rare size, the company&#39;s general recipe for success has consisted of pairing eyeballs with unique targeting capabilities for advertisers.</p><p>Though <a href=\"https://laohu8.com/S/SPOT\"><b>Spotify</b> </a> is only a fraction of Alphabet&#39;s size, the audio-streaming giant is trying to replicate that same model, only for ears instead of eyes. Let&#39;s see whether or not the strategy can pay off.</p><h2>Spotify&#39;s advertising model</h2><p>Spotify first got its start by pioneering the &#34;freemium&#34; model for the music industry. After meeting some initial resistance from music labels about an ad-supported experience, Spotify focused most of its efforts on driving subscriptions. However, over the last couple of years, that focus has begun to change.</p><p>With the recent push into alternative forms of audio such as podcasts, audiobooks, live chats, and more, the company&#39;s advertising segment is seeing an increasing focus from Spotify&#39;s management team. CEO Daniel Ek was even quite candid about this on Spotify&#39;s second-quarter conference call when he said, &#34;Admittedly, this is an area where I previously didn&#39;t spend much time, but it&#39;s become impossible to ignore.&#34;</p><p>By the end of this year, Spotify expects to surpass 400 million total monthly active users (MAUs). In order to capitalize on all those ears, Spotify has built out a comprehensive marketplace for advertisers known as the Spotify <a href=\"https://laohu8.com/S/ADNC\">Audience</a> Network (SPAN).</p><p>SPAN allows advertisers of any size to promote their message across different forms of audio while targeting individual users based on their listening habits -- something traditional radio can&#39;t offer. Although the advertising inventory on SPAN is currently limited to podcasts or individual slots in between songs, Spotify has announced plans to add audiobooks to its platform which could serve as yet another audio format for advertisers.</p><h2>Increasing measurability</h2><p>For a long time, measuring the effectiveness of advertising campaigns was difficult. There was even a popular saying in marketing that &#34;half of advertising spend is wasted, the trouble is, you don&#39;t know which half.&#34;</p><p>Fortunately, today this problem is muted. Thanks to companies like Google, not only can advertisers reach a massive audience, but they can also assess the performance of their ad campaigns due to analytics. Audio-based ads, however, haven&#39;t made nearly as much headway in terms of measurability.</p><p>To help address this pain point, last week, Spotify began rolling out call-to-action cards for podcast ads. Now, when advertisers run a podcast ad campaign using the Spotify <a href=\"https://laohu8.com/S/1AZ.SI\">Audience</a> Network, they can include a customizable interactive pop-up with phrases like &#34;buy now&#34; or &#34;download.&#34;</p><p>For example, let&#39;s say <b>Ulta Beauty</b> was running a campaign with a 25% discount and wanted to target females between the ages of 20 and 30 who are in their car and like listening to dating-related podcasts. Spotify could provide that. And on top of it, Ulta can now add a call-to-action card with the phrase &#34;Get Coupon.&#34; This new interactive feature should not only reduce friction for listeners but should also help advertisers assess the effectiveness of their ad spending.</p><h2>Can Spotify become Google?</h2><p>Although comparing any company to Google feels discrediting to the remarkable business Google has built over the years, the value that Spotify provides to advertisers in audio bears a passing resemblance to what companies like Alphabet or <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) were able to do for the digital advertising space.</p><p>As Spotify continues to build out more functionality and include new types of audio into its advertising network, investors should expect to see the ad segment grow quickly as a percentage of Spotify&#39;s overall revenue. Last quarter, advertising only accounted for 13%, but Ek stated that he believes it could potentially comprise up to 40% or more over the next five to 10 years.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Spotify Become the Next Google?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Spotify Become the Next Google?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alphabet , the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4548":"巴美列捷福持仓","GOOG":"谷歌","SPOT":"Spotify Technology S.A."},"source_url":"https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203712618","content_text":"Alphabet , the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are certainly a number of factors that have helped Alphabet reach this rare size, the company's general recipe for success has consisted of pairing eyeballs with unique targeting capabilities for advertisers.Though Spotify  is only a fraction of Alphabet's size, the audio-streaming giant is trying to replicate that same model, only for ears instead of eyes. Let's see whether or not the strategy can pay off.Spotify's advertising modelSpotify first got its start by pioneering the \"freemium\" model for the music industry. After meeting some initial resistance from music labels about an ad-supported experience, Spotify focused most of its efforts on driving subscriptions. However, over the last couple of years, that focus has begun to change.With the recent push into alternative forms of audio such as podcasts, audiobooks, live chats, and more, the company's advertising segment is seeing an increasing focus from Spotify's management team. CEO Daniel Ek was even quite candid about this on Spotify's second-quarter conference call when he said, \"Admittedly, this is an area where I previously didn't spend much time, but it's become impossible to ignore.\"By the end of this year, Spotify expects to surpass 400 million total monthly active users (MAUs). In order to capitalize on all those ears, Spotify has built out a comprehensive marketplace for advertisers known as the Spotify Audience Network (SPAN).SPAN allows advertisers of any size to promote their message across different forms of audio while targeting individual users based on their listening habits -- something traditional radio can't offer. Although the advertising inventory on SPAN is currently limited to podcasts or individual slots in between songs, Spotify has announced plans to add audiobooks to its platform which could serve as yet another audio format for advertisers.Increasing measurabilityFor a long time, measuring the effectiveness of advertising campaigns was difficult. There was even a popular saying in marketing that \"half of advertising spend is wasted, the trouble is, you don't know which half.\"Fortunately, today this problem is muted. Thanks to companies like Google, not only can advertisers reach a massive audience, but they can also assess the performance of their ad campaigns due to analytics. Audio-based ads, however, haven't made nearly as much headway in terms of measurability.To help address this pain point, last week, Spotify began rolling out call-to-action cards for podcast ads. Now, when advertisers run a podcast ad campaign using the Spotify Audience Network, they can include a customizable interactive pop-up with phrases like \"buy now\" or \"download.\"For example, let's say Ulta Beauty was running a campaign with a 25% discount and wanted to target females between the ages of 20 and 30 who are in their car and like listening to dating-related podcasts. Spotify could provide that. And on top of it, Ulta can now add a call-to-action card with the phrase \"Get Coupon.\" This new interactive feature should not only reduce friction for listeners but should also help advertisers assess the effectiveness of their ad spending.Can Spotify become Google?Although comparing any company to Google feels discrediting to the remarkable business Google has built over the years, the value that Spotify provides to advertisers in audio bears a passing resemblance to what companies like Alphabet or Meta Platforms (NASDAQ:FB) were able to do for the digital advertising space.As Spotify continues to build out more functionality and include new types of audio into its advertising network, investors should expect to see the ad segment grow quickly as a percentage of Spotify's overall revenue. Last quarter, advertising only accounted for 13%, but Ek stated that he believes it could potentially comprise up to 40% or more over the next five to 10 years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002423377,"gmtCreate":1642075841811,"gmtModify":1676533678272,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002423377","repostId":"1119227901","repostType":4,"repost":{"id":"1119227901","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642066574,"share":"https://ttm.financial/m/news/1119227901?lang=&edition=fundamental","pubTime":"2022-01-13 17:36","market":"us","language":"en","title":"Vir Biotechnology shares rose over 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1119227901","media":"Tiger Newspress","summary":"Vir Biotechnology shares rose over 6% in premarket trading. Glaxo & Vir to supply more COVID antibod","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a> shares rose over 6% in premarket trading. Glaxo &amp; Vir to supply more COVID antibody doses in the US.</p><p><img src=\"https://static.tigerbbs.com/c86ab21aabe8a1f3f5d8adb3b045af6b\" tg-width=\"1033\" tg-height=\"645\" width=\"100%\" height=\"auto\"/></p><p><a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline </a> and partner <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology </a> announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.</p><p>The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.</p><p>The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.</p><p>Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.</p><p>The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology shares rose over 6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology shares rose over 6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-13 17:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a> shares rose over 6% in premarket trading. Glaxo &amp; Vir to supply more COVID antibody doses in the US.</p><p><img src=\"https://static.tigerbbs.com/c86ab21aabe8a1f3f5d8adb3b045af6b\" tg-width=\"1033\" tg-height=\"645\" width=\"100%\" height=\"auto\"/></p><p><a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline </a> and partner <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology </a> announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.</p><p>The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.</p><p>The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.</p><p>Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.</p><p>The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克","VIR":"Vir Biotechnology, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119227901","content_text":"Vir Biotechnology shares rose over 6% in premarket trading. Glaxo & Vir to supply more COVID antibody doses in the US.GlaxoSmithKline  and partner Vir Biotechnology  announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.","news_type":1},"isVote":1,"tweetType":1,"viewCount":737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002423926,"gmtCreate":1642075821003,"gmtModify":1676533678263,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002423926","repostId":"1173866577","repostType":4,"repost":{"id":"1173866577","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642071883,"share":"https://ttm.financial/m/news/1173866577?lang=&edition=fundamental","pubTime":"2022-01-13 19:04","market":"us","language":"en","title":"KB Home stock jumped over 6% after robust Q4 earnings growth, guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1173866577","media":"Tiger Newspress","summary":"KB Home stock jumped over 6% after robust Q4 earnings growth.Shares of KB Home jumped after the home","content":"<html><head></head><body><p>KB Home stock jumped over 6% after robust Q4 earnings growth.<img src=\"https://static.tigerbbs.com/3fc878285bf930fec7834a5cb77a9158\" tg-width=\"1024\" tg-height=\"641\" referrerpolicy=\"no-referrer\"/>Shares of KB Home jumped after the homebuilder&#39;s Q4 earnings highlight the company&#39;s &#34;outstanding growth in revenues and margins,&#34; said President and CEO Jeffrey Mezger.</p><p>Still, Q4 revenues of $1.68B miss the consensus by $30M, and up from $1.47B in Q3.</p><p>On a brighter note, diluted earnings per share of $1.91 beats the $1.77 consensus, up from $1.60 in the previous quarter.</p><p>Homes delivered of 3,679 increases 20% in Q4. The average selling price increases 9% to $451.1K. Looking forward, the company expects housing revenues to be $7.2B-7.6B in 2022 and an average selling price of $480K-490K.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KB Home stock jumped over 6% after robust Q4 earnings growth, guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKB Home stock jumped over 6% after robust Q4 earnings growth, guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-13 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>KB Home stock jumped over 6% after robust Q4 earnings growth.<img src=\"https://static.tigerbbs.com/3fc878285bf930fec7834a5cb77a9158\" tg-width=\"1024\" tg-height=\"641\" referrerpolicy=\"no-referrer\"/>Shares of KB Home jumped after the homebuilder&#39;s Q4 earnings highlight the company&#39;s &#34;outstanding growth in revenues and margins,&#34; said President and CEO Jeffrey Mezger.</p><p>Still, Q4 revenues of $1.68B miss the consensus by $30M, and up from $1.47B in Q3.</p><p>On a brighter note, diluted earnings per share of $1.91 beats the $1.77 consensus, up from $1.60 in the previous quarter.</p><p>Homes delivered of 3,679 increases 20% in Q4. The average selling price increases 9% to $451.1K. Looking forward, the company expects housing revenues to be $7.2B-7.6B in 2022 and an average selling price of $480K-490K.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KBH":"KB Home"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173866577","content_text":"KB Home stock jumped over 6% after robust Q4 earnings growth.Shares of KB Home jumped after the homebuilder's Q4 earnings highlight the company's \"outstanding growth in revenues and margins,\" said President and CEO Jeffrey Mezger.Still, Q4 revenues of $1.68B miss the consensus by $30M, and up from $1.47B in Q3.On a brighter note, diluted earnings per share of $1.91 beats the $1.77 consensus, up from $1.60 in the previous quarter.Homes delivered of 3,679 increases 20% in Q4. The average selling price increases 9% to $451.1K. Looking forward, the company expects housing revenues to be $7.2B-7.6B in 2022 and an average selling price of $480K-490K.","news_type":1},"isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002423018,"gmtCreate":1642075806767,"gmtModify":1676533678264,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002423018","repostId":"2203769284","repostType":4,"repost":{"id":"2203769284","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642074605,"share":"https://ttm.financial/m/news/2203769284?lang=&edition=fundamental","pubTime":"2022-01-13 19:50","market":"us","language":"en","title":"Delta Air Lines says company has no plans to invest in ITA Airways","url":"https://stock-news.laohu8.com/highlight/detail?id=2203769284","media":"Reuters","summary":"CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Ali","content":"<html><head></head><body><p>CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia&#39;s successor ITA Airways.</p><p>The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.</p><p>Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany&#39;s Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.</p><p>Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.</p><p>&#34;We have no plans to invest in them,&#34; Bastian told Reuters in an interview.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Air Lines says company has no plans to invest in ITA Airways</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Air Lines says company has no plans to invest in ITA Airways\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-13 19:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia&#39;s successor ITA Airways.</p><p>The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.</p><p>Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany&#39;s Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.</p><p>Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.</p><p>&#34;We have no plans to invest in them,&#34; Bastian told Reuters in an interview.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ITA":"iShares Dow Jones U.S. Aerospace","BK4500":"航空公司","BK4008":"航空公司","DAL":"达美航空"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203769284","content_text":"CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia's successor ITA Airways.The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany's Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.\"We have no plans to invest in them,\" Bastian told Reuters in an interview.","news_type":1},"isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002429707,"gmtCreate":1642075786756,"gmtModify":1676533678255,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002429707","repostId":"2203376911","repostType":4,"repost":{"id":"2203376911","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642075304,"share":"https://ttm.financial/m/news/2203376911?lang=&edition=fundamental","pubTime":"2022-01-13 20:01","market":"us","language":"en","title":"British lawmakers target Visa and Mastercard fee increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2203376911","media":"Reuters","summary":"LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees Visa    and Ma","content":"<html><head></head><body><p>LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees <a href=\"https://laohu8.com/S/V\">Visa</a>    and Mastercard charge businesses after the country&#39;s payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.</p><p>Parliament&#39;s Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.</p><p>&#34;Given that Visa and Mastercard currently dominate this space, it&#39;s vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,&#34; the chair of the committee, Mel Stride, said in a statement.</p><p>Mastercard and Visa had no immediate comment.</p><p>Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.</p><p>Britain&#39;s Payment Systems Regulator <a href=\"https://laohu8.com/S/PSR\">$(PSR)$</a> said in November that card services did not work well for smaller businesses.</p><p>It told Stride in a letter on Thursday that it will propose &#34;remedies&#34; this month to tackle rising scheme fees, which have doubled between 2014 and 2018.</p><p>&#34;Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,&#34; the PSR said. &#34;Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.&#34;</p><p>Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2374609393fa63a3a37bd24fbdaf2a30\" tg-width=\"725\" tg-height=\"435\" width=\"100%\" height=\"auto\"/><span>PSR Interchange Fees Graphic</span></p><p>Interchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain&#39;s full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.</p><p>The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.</p><p>&#34;Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,&#34; it said.</p><p>Stride said the Treasury committee would discuss the regulator&#39;s plans at a hearing in March.</p><p>Efforts in the EU to end the dominance and Mastercard have had mixed results</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>British lawmakers target Visa and Mastercard fee increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritish lawmakers target Visa and Mastercard fee increases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-13 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees <a href=\"https://laohu8.com/S/V\">Visa</a>    and Mastercard charge businesses after the country&#39;s payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.</p><p>Parliament&#39;s Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.</p><p>&#34;Given that Visa and Mastercard currently dominate this space, it&#39;s vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,&#34; the chair of the committee, Mel Stride, said in a statement.</p><p>Mastercard and Visa had no immediate comment.</p><p>Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.</p><p>Britain&#39;s Payment Systems Regulator <a href=\"https://laohu8.com/S/PSR\">$(PSR)$</a> said in November that card services did not work well for smaller businesses.</p><p>It told Stride in a letter on Thursday that it will propose &#34;remedies&#34; this month to tackle rising scheme fees, which have doubled between 2014 and 2018.</p><p>&#34;Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,&#34; the PSR said. &#34;Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.&#34;</p><p>Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2374609393fa63a3a37bd24fbdaf2a30\" tg-width=\"725\" tg-height=\"435\" width=\"100%\" height=\"auto\"/><span>PSR Interchange Fees Graphic</span></p><p>Interchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain&#39;s full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.</p><p>The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.</p><p>&#34;Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,&#34; it said.</p><p>Stride said the Treasury committee would discuss the regulator&#39;s plans at a hearing in March.</p><p>Efforts in the EU to end the dominance and Mastercard have had mixed results</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4533":"AQR资本管理(全球第二大对冲基金)","MA":"万事达","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4548":"巴美列捷福持仓","BK4566":"资本集团"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203376911","content_text":"LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees Visa    and Mastercard charge businesses after the country's payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.Parliament's Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.\"Given that Visa and Mastercard currently dominate this space, it's vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,\" the chair of the committee, Mel Stride, said in a statement.Mastercard and Visa had no immediate comment.Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.Britain's Payment Systems Regulator $(PSR)$ said in November that card services did not work well for smaller businesses.It told Stride in a letter on Thursday that it will propose \"remedies\" this month to tackle rising scheme fees, which have doubled between 2014 and 2018.\"Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,\" the PSR said. \"Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.\"Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.PSR Interchange Fees GraphicInterchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain's full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.\"Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,\" it said.Stride said the Treasury committee would discuss the regulator's plans at a hearing in March.Efforts in the EU to end the dominance and Mastercard have had mixed results","news_type":1},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002943742,"gmtCreate":1641903447991,"gmtModify":1676533660055,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002943742","repostId":"1148381899","repostType":4,"repost":{"id":"1148381899","pubTimestamp":1641902728,"share":"https://ttm.financial/m/news/1148381899?lang=&edition=fundamental","pubTime":"2022-01-11 20:05","market":"us","language":"en","title":"Investing $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income","url":"https://stock-news.laohu8.com/highlight/detail?id=1148381899","media":"Motley Fool","summary":"Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts o","content":"<html><head></head><body><p>Most of us don&#39;t just have a spare $100,000 lying around. But if you did, investing in equal parts of <a href=\"https://laohu8.com/S/AUY\">Yamana</a> Gold (NYSE:AUY), <a href=\"https://laohu8.com/S/KMI\">Kinder Morgan</a> (NYSE:KMI), and <a href=\"https://laohu8.com/S/ALV\">Autoliv</a> (NYSE:ALV) should earn you $4,000 off dividends alone in 2022 while exposing your portfolio to multiple industries.</p><p>Investing in companies that pay sizable dividends can be a great way to supplement income in retirement or simply earn passive, low-tax income without the need to sell securities. However, many high-yield dividend stocks aren&#39;t worth the risk. Yamana Gold, Kinder Morgan, and Autoliv all have strong fundamentals that can back up their dividends. Here&#39;s what makes each a great buy now.</p><p>Dig into this lustrous dividend play</p><p><b>Scott Levine(Yamana Gold):</b>Yes, you&#39;re right. Gold stocks are hardly among the usual suspects that dividend-hungry investors are considering when they&#39;re mining the market for new opportunities. Developing and sustaining gold-producing assets is a capital-intensive endeavor, and mining companies are sensitive to the ups and downs of the market price of gold; consequently, they often refrain from returning significant cash to shareholders. Yamana Gold&#39;s stock and its 3.1% dividend yield, however, looks like a glittering consideration for investors interested in increasing their passive income stream.</p><p>After setting a goal in 2019 to shore up its financial position, Yamana Gold has succeeded in lowering its debt and deleveraging. In the third quarter of 2021, Yamana reduced its debt by $222 million, which helped it to achieve a net debt-to-EBITDA(earnings before interest, taxes, depreciation, and amortization)ratio of 0.3. This secure financial position paired with the fact that the company is generating strong free cash flow -- it grew 59% from the second quarter to the third quarter -- suggests that the company&#39;s well positioned to continue returning capital to shareholders. On the company&#39;sQ3 2021 conference call, for example, Daniel Racine, the company&#39;s CEO, addressed this fact stating that Yamana&#39;s &#34;[b]alance sheet is pristine. So we can afford giving more dividends, buying back more shares, and then continue to invest, if needed, more in Canadian Malartic.&#34; Located in Quebec, Canadian Malartic, in which Yamana has a 50% ownership stake, is Canada&#39;s largest gold-producing project and Yamana&#39;s biggest gold-producing asset.</p><p>Since the price of gold is bound to experience some ups and downs, it&#39;s hard to imagine that Yamana Gold will steadily raise its dividend in each of the coming years. Nonetheless, gaining some exposure in your portfolio with anindustry-leading gold stockis a worthwhile consideration -- <a href=\"https://laohu8.com/S/AONE.U\">one</a> that is especially timely now. Changing hands at 5.5 times operating cash flow, Yamana&#39;s stock is on the discount rack, trading at a discount to its five-year average ratio of 6.3.</p><p>Kinder Morgan has transformed itself into a premier dividend stock</p><p><b>Daniel Foelber(Kinder Morgan):</b>Energy transportation and storage company Kinder Morgan has long underperformed the U.S. stock market as investors favor growth over stalwarts. Yet Kinder Morgan has quietly revolutionized its business since the oil and gas crash of 2014 and 2015, and the market may finally be taking notice.</p><p>Kinder Morgan released expectations for its 2022 financial performance before it has even reported its full-year 2021 results. The forecast included higher earnings per share, EBITDA, up to $750 million in share buybacks, and a $1.11 annualized dividend, up from 2021&#39;s $1.08 annualized dividend. At a current price of $17.17 per share, Kinder Morgan&#39;s forward dividend yield is 6.5% -- which makes itone of the highest yielding<b>S&amp;P 500</b>components.</p><p>What&#39;s more, Kinder Morgan projects it will earn $1.09 in EPS and $2.07 in distributable cash flow (DCF) per share, meaning it can cover its dividend obligation with cash. Kinder Morgan also said it expects to end this year with a net debt-to-adjusted EBITDA ratio of 4.3. Kinder Morgan&#39;s net income tends to vary, so EBITDA and DCF are the preferred metrics it uses to judge its performance and financial health. <a href=\"https://laohu8.com/S/GUID\">Guidance</a> for a 4.3 ratio is below its long-term target of 4.5. For context, Kinder Morgan ended 2020 with a 4.6 debt-to-EBITDA ratio,cut it down to 3.8 at the end of the first half of 2021,and expects to finish 2021 with a ratio of 4.</p><p>In sum, Kinder Morgan is growing its dividend and earnings while maintaining a healthy balance sheet, a sign thatit isn&#39;t overspending during the current healthy oil and gas climate.</p><p>High yields tend to require a baseline amount of risk. But Kinder Morgan has a track record for accurate guidance thanks to much of its business being contracted under long-term obligations. Kinder Morgan stands out as an option worth considering for investors looking for agreat income stock for 2022.</p><p>Autoliv is well set for a recovery in 2022</p><p><b>Lee Samaha(Autoliv):</b>It&#39;s been a challenging couple of years for automakers and their suppliers like Autoliv. <a href=\"https://laohu8.com/S/FBNC\">First</a>, the COVID-19 pandemic hit the sector hard. Next, the economic slowdown initially hit vehicle sales, and then when demand recovered, it became increasingly difficult to keep production flowing due to the pandemic. Meanwhile, the shift in consumer spending patterns created by the stay-at-home measures resulted in asemiconductor shortagethat ultimately restricted production.</p><p>According to industry observers, global light vehicle production will increase by slightly more than 1% in 2021. However, industry observers are expecting high-single-digit growth in production in 2022, and that means it&#39;s time to start looking at theauto parts suppliers.</p><p>As such, the case for buying Autoliv for 2022 doesn&#39;t just rest on its 2.4% dividend yield. <a href=\"https://laohu8.com/S/FFBC\">First</a>, as a leading provider of seatbelts, airbags, and safety wheels, Autoliv is a beneficiary of increased light vehicle production -- Wall Street analysts have the company&#39;s sales rising 15% in 2022.</p><p>Second, management believes it can grow more than the market due to market share gains and an increase in content per vehicle driven by the increasing importance of safety to consumers.</p><p>Third, management has done an excellent job in offsetting margin pressure from lower production volumes and raw material cost increases from 2019 to 2021. Those measures, and hopefully mitigation of cost inflation, could lead to substantial margin expansion in the coming years.</p><p>All told, Autoliv is well positioned to benefit from a multi-year recovery in the auto industry starting in 2022.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts of Yamana Gold (NYSE:AUY), Kinder Morgan (NYSE:KMI), and Autoliv (NYSE:ALV) should earn you $4,000 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALV":"奥托立夫","AUY":"Yamana Gold Inc","KMI":"金德尔摩根"},"source_url":"https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148381899","content_text":"Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts of Yamana Gold (NYSE:AUY), Kinder Morgan (NYSE:KMI), and Autoliv (NYSE:ALV) should earn you $4,000 off dividends alone in 2022 while exposing your portfolio to multiple industries.Investing in companies that pay sizable dividends can be a great way to supplement income in retirement or simply earn passive, low-tax income without the need to sell securities. However, many high-yield dividend stocks aren't worth the risk. Yamana Gold, Kinder Morgan, and Autoliv all have strong fundamentals that can back up their dividends. Here's what makes each a great buy now.Dig into this lustrous dividend playScott Levine(Yamana Gold):Yes, you're right. Gold stocks are hardly among the usual suspects that dividend-hungry investors are considering when they're mining the market for new opportunities. Developing and sustaining gold-producing assets is a capital-intensive endeavor, and mining companies are sensitive to the ups and downs of the market price of gold; consequently, they often refrain from returning significant cash to shareholders. Yamana Gold's stock and its 3.1% dividend yield, however, looks like a glittering consideration for investors interested in increasing their passive income stream.After setting a goal in 2019 to shore up its financial position, Yamana Gold has succeeded in lowering its debt and deleveraging. In the third quarter of 2021, Yamana reduced its debt by $222 million, which helped it to achieve a net debt-to-EBITDA(earnings before interest, taxes, depreciation, and amortization)ratio of 0.3. This secure financial position paired with the fact that the company is generating strong free cash flow -- it grew 59% from the second quarter to the third quarter -- suggests that the company's well positioned to continue returning capital to shareholders. On the company'sQ3 2021 conference call, for example, Daniel Racine, the company's CEO, addressed this fact stating that Yamana's \"[b]alance sheet is pristine. So we can afford giving more dividends, buying back more shares, and then continue to invest, if needed, more in Canadian Malartic.\" Located in Quebec, Canadian Malartic, in which Yamana has a 50% ownership stake, is Canada's largest gold-producing project and Yamana's biggest gold-producing asset.Since the price of gold is bound to experience some ups and downs, it's hard to imagine that Yamana Gold will steadily raise its dividend in each of the coming years. Nonetheless, gaining some exposure in your portfolio with anindustry-leading gold stockis a worthwhile consideration -- one that is especially timely now. Changing hands at 5.5 times operating cash flow, Yamana's stock is on the discount rack, trading at a discount to its five-year average ratio of 6.3.Kinder Morgan has transformed itself into a premier dividend stockDaniel Foelber(Kinder Morgan):Energy transportation and storage company Kinder Morgan has long underperformed the U.S. stock market as investors favor growth over stalwarts. Yet Kinder Morgan has quietly revolutionized its business since the oil and gas crash of 2014 and 2015, and the market may finally be taking notice.Kinder Morgan released expectations for its 2022 financial performance before it has even reported its full-year 2021 results. The forecast included higher earnings per share, EBITDA, up to $750 million in share buybacks, and a $1.11 annualized dividend, up from 2021's $1.08 annualized dividend. At a current price of $17.17 per share, Kinder Morgan's forward dividend yield is 6.5% -- which makes itone of the highest yieldingS&P 500components.What's more, Kinder Morgan projects it will earn $1.09 in EPS and $2.07 in distributable cash flow (DCF) per share, meaning it can cover its dividend obligation with cash. Kinder Morgan also said it expects to end this year with a net debt-to-adjusted EBITDA ratio of 4.3. Kinder Morgan's net income tends to vary, so EBITDA and DCF are the preferred metrics it uses to judge its performance and financial health. Guidance for a 4.3 ratio is below its long-term target of 4.5. For context, Kinder Morgan ended 2020 with a 4.6 debt-to-EBITDA ratio,cut it down to 3.8 at the end of the first half of 2021,and expects to finish 2021 with a ratio of 4.In sum, Kinder Morgan is growing its dividend and earnings while maintaining a healthy balance sheet, a sign thatit isn't overspending during the current healthy oil and gas climate.High yields tend to require a baseline amount of risk. But Kinder Morgan has a track record for accurate guidance thanks to much of its business being contracted under long-term obligations. Kinder Morgan stands out as an option worth considering for investors looking for agreat income stock for 2022.Autoliv is well set for a recovery in 2022Lee Samaha(Autoliv):It's been a challenging couple of years for automakers and their suppliers like Autoliv. First, the COVID-19 pandemic hit the sector hard. Next, the economic slowdown initially hit vehicle sales, and then when demand recovered, it became increasingly difficult to keep production flowing due to the pandemic. Meanwhile, the shift in consumer spending patterns created by the stay-at-home measures resulted in asemiconductor shortagethat ultimately restricted production.According to industry observers, global light vehicle production will increase by slightly more than 1% in 2021. However, industry observers are expecting high-single-digit growth in production in 2022, and that means it's time to start looking at theauto parts suppliers.As such, the case for buying Autoliv for 2022 doesn't just rest on its 2.4% dividend yield. First, as a leading provider of seatbelts, airbags, and safety wheels, Autoliv is a beneficiary of increased light vehicle production -- Wall Street analysts have the company's sales rising 15% in 2022.Second, management believes it can grow more than the market due to market share gains and an increase in content per vehicle driven by the increasing importance of safety to consumers.Third, management has done an excellent job in offsetting margin pressure from lower production volumes and raw material cost increases from 2019 to 2021. Those measures, and hopefully mitigation of cost inflation, could lead to substantial margin expansion in the coming years.All told, Autoliv is well positioned to benefit from a multi-year recovery in the auto industry starting in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006623132,"gmtCreate":1641720209269,"gmtModify":1676533642655,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006623132","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008990600,"gmtCreate":1641345219997,"gmtModify":1676533602512,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"&nbsp;[Cool]&nbsp;","listText":"&nbsp;[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008990600","repostId":"2201540088","repostType":4,"repost":{"id":"2201540088","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641338493,"share":"https://ttm.financial/m/news/2201540088?lang=&edition=fundamental","pubTime":"2022-01-05 07:21","market":"us","language":"en","title":"Intel launches graphics chips for gamers in effort to take on Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2201540088","media":"Reuters","summary":"Jan 4 (Reuters) - Intel Corp on Tuesday said that it has started shipping new graphics chips aimed a","content":"<html><head></head><body><p>Jan 4 (Reuters) - Intel Corp on Tuesday said that it has started shipping new graphics chips aimed at PC gamers, a growing segment that has long eluded the chipmaker and is dominated by larger rival Nvidia Corp.</p><p>Intel&#39;s Arc graphics chips help video games and other content look more realistic. The chips are Intel&#39;s first effort in many years in the market and will take on leader Nvidia, which had graphics chips sales of $9.8 billion in its most recent fiscal year, a 29% increase.</p><p>At the Consumer Electronics Show on Tuesday, Intel said that it has reached deals with PC makers to offer the chips in 50 different models. Among the PC makers offering the chips will be Dell Technologies, Lenovo Group Ltd and Samsung Electronics Co Ltd.</p><p>Earlier on Tuesday, Nvidia said that its latest graphics chip for gamers has been adopted in 160 models from PC makers.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel launches graphics chips for gamers in effort to take on Nvidia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel launches graphics chips for gamers in effort to take on Nvidia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-05 07:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 4 (Reuters) - Intel Corp on Tuesday said that it has started shipping new graphics chips aimed at PC gamers, a growing segment that has long eluded the chipmaker and is dominated by larger rival Nvidia Corp.</p><p>Intel&#39;s Arc graphics chips help video games and other content look more realistic. The chips are Intel&#39;s first effort in many years in the market and will take on leader Nvidia, which had graphics chips sales of $9.8 billion in its most recent fiscal year, a 29% increase.</p><p>At the Consumer Electronics Show on Tuesday, Intel said that it has reached deals with PC makers to offer the chips in 50 different models. Among the PC makers offering the chips will be Dell Technologies, Lenovo Group Ltd and Samsung Electronics Co Ltd.</p><p>Earlier on Tuesday, Nvidia said that its latest graphics chip for gamers has been adopted in 160 models from PC makers.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4529":"IDC概念","BK4554":"元宇宙及AR概念","DELL":"戴尔","BK4515":"5G概念","BK4532":"文艺复兴科技持仓","NVDA":"英伟达","00992":"联想集团","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4535":"淡马锡持仓","BK4543":"AI","BK4527":"明星科技股","BK4550":"红杉资本持仓","INTC":"英特尔","BK4141":"半导体产品","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4512":"苹果概念","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201540088","content_text":"Jan 4 (Reuters) - Intel Corp on Tuesday said that it has started shipping new graphics chips aimed at PC gamers, a growing segment that has long eluded the chipmaker and is dominated by larger rival Nvidia Corp.Intel's Arc graphics chips help video games and other content look more realistic. The chips are Intel's first effort in many years in the market and will take on leader Nvidia, which had graphics chips sales of $9.8 billion in its most recent fiscal year, a 29% increase.At the Consumer Electronics Show on Tuesday, Intel said that it has reached deals with PC makers to offer the chips in 50 different models. Among the PC makers offering the chips will be Dell Technologies, Lenovo Group Ltd and Samsung Electronics Co Ltd.Earlier on Tuesday, Nvidia said that its latest graphics chip for gamers has been adopted in 160 models from PC makers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001446752,"gmtCreate":1641308571088,"gmtModify":1676533596054,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001446752","repostId":"1166656750","repostType":4,"repost":{"id":"1166656750","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641306855,"share":"https://ttm.financial/m/news/1166656750?lang=&edition=fundamental","pubTime":"2022-01-04 22:34","market":"us","language":"en","title":"Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=1166656750","media":"Tiger Newspress","summary":"Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual productio","content":"<html><head></head><body><p>Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity.<img src=\"https://static.tigerbbs.com/cabb83091e5a3382089b512b22e31dd5\" tg-width=\"768\" tg-height=\"558\" width=\"100%\" height=\"auto\"/>The company said on Tuesday that it will nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles as the model has already attracted nearly 200,000 reservations ahead of its arrival this spring at U.S. dealers.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-04 22:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity.<img src=\"https://static.tigerbbs.com/cabb83091e5a3382089b512b22e31dd5\" tg-width=\"768\" tg-height=\"558\" width=\"100%\" height=\"auto\"/>The company said on Tuesday that it will nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles as the model has already attracted nearly 200,000 reservations ahead of its arrival this spring at U.S. dealers.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166656750","content_text":"Ford rose over 4% in morning trading for doubling F-150 Lightning electric pickup’s annual production capacity.The company said on Tuesday that it will nearly double annual production capacity for its red-hot F-150 Lightning electric pickup to 150,000 vehicles as the model has already attracted nearly 200,000 reservations ahead of its arrival this spring at U.S. dealers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001446827,"gmtCreate":1641308544390,"gmtModify":1676533596045,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001446827","repostId":"1182899517","repostType":4,"repost":{"id":"1182899517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641308410,"share":"https://ttm.financial/m/news/1182899517?lang=&edition=fundamental","pubTime":"2022-01-04 23:00","market":"us","language":"en","title":"Some Vaccine Stocks Slid in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1182899517","media":"Tiger Newspress","summary":"Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3","content":"<html><head></head><body><p>Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.<img src=\"https://static.tigerbbs.com/2b8d37f6fcb2216ad1872ca6be6dc94d\" tg-width=\"375\" tg-height=\"162\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine Stocks Slid in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine Stocks Slid in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-04 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.<img src=\"https://static.tigerbbs.com/2b8d37f6fcb2216ad1872ca6be6dc94d\" tg-width=\"375\" tg-height=\"162\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182899517","content_text":"Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001894821,"gmtCreate":1641210667085,"gmtModify":1676533583091,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001894821","repostId":"2200744775","repostType":4,"repost":{"id":"2200744775","pubTimestamp":1641210061,"share":"https://ttm.financial/m/news/2200744775?lang=&edition=fundamental","pubTime":"2022-01-03 19:41","market":"us","language":"en","title":"3 Dates for Disney Stock Investors to Circle in January","url":"https://stock-news.laohu8.com/highlight/detail?id=2200744775","media":"Motley Fool","summary":"New releases and the reopening of a popular theme park will highlight a busy month for the House of Mouse.","content":"<html><head></head><body><p>It&#39;s a new year for <b>Walt Disney</b> (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 is ready to bounce back in 2022.</p><p>Disney&#39;s always busy, and it&#39;s not going to hibernate through January. From a popular theme park reopening to highly anticipated releases there&#39;s a lot coming soon at Disney. Let&#39;s take a closer look.</p><h2>Jan. 2</h2><p>The only Disney gated attraction that has yet to reopen since the pandemic -- Walt Disney World&#39;s Typhoon Lagoon -- is getting back in business this weekend. Typhoon Lagoon was the country&#39;s most visited water park in 2019, its last full year of operation. It was also the world&#39;s second most popular water park.</p><p>Florida&#39;s resort is the only place where Disney operates a theme park, and it actually has two in the Sunshine State. It only reopened Blizzard Beach in March, but it&#39;s closing <i>that</i> park down for refurbishment when Typhoon Lagoon reopens on Sunday. A combination of staffing concerns and consumer demand is probably keeping Disney to having just <a href=\"https://laohu8.com/S/AONE.U\">one</a> theme park open at a time, but if things go well it wouldn&#39;t be a surprise to see both watery escapes open at the same time in a few months when the weather starts to heat up.</p><h2>Jan. 14</h2><p>This is a relatively slow month for Disney in terms of theatrical releases, but one of note will be <i>Deep Water</i>. The film starring Ben Affleck and Ana de Armas is being billed as an erotic psychological thriller, as the two play a married couple that have fallen out of love. They play mind games with one another, and a body count ensues.</p><p>This isn&#39;t an organic Disney production. It&#39;s part of the slate of content that the media stock picked up with its 20th Century Fox acquisition. Expectations aren&#39;t as high for this flick as the superhero and sci-fi fare that Disney will be putting out later this year, but there&#39;s always the chance for a sleeper hit. All cards are off the table if COVID-19 cases intensify to the point that folks aren&#39;t hitting up the local multiplex.</p><h2>Jan. 28</h2><p>Disney+ is a big part of the growth thesis for the House of Mouse. The platform launched in late 2019, and it&#39;s already at more than 118 million accounts worldwide. Disney has said that it doesn&#39;t expect the platform to become profitable until fiscal 2024, but its popularity has given Disney a new revenue stream.</p><p>There are a couple of new shows and movies coming to Disney+ this month. If you missed Marvel&#39;s <i>Eternals</i> at the movie theater in November you can start catching on Disney+ starting Jan. 12. You&#39;ll also get fresh weekly installments of the new <i>The Book of Boba Fett</i> series every Wednesday. Young families may be circling Jan. 28 on the calendar as that is when <i>The Ice Age Adventures of Buck Wild</i> hits the platform. The film is a spinoff of the computer animated <i>Ice Age</i> franchise. If you&#39;re thinking that you don&#39;t recall <i>Ice Age</i> as a Disney property, you&#39;re right. It&#39;s another franchise that Disney inherited when it acquired the 20th Century Fox catalog.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dates for Disney Stock Investors to Circle in January</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dates for Disney Stock Investors to Circle in January\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year for Walt Disney (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4108":"电影和娱乐","ISBC":"投资者银行","DIS":"迪士尼","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4211":"区域性银行","BK4550":"红杉资本持仓","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4524":"宅经济概念","BK4561":"索罗斯持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200744775","content_text":"It's a new year for Walt Disney (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 is ready to bounce back in 2022.Disney's always busy, and it's not going to hibernate through January. From a popular theme park reopening to highly anticipated releases there's a lot coming soon at Disney. Let's take a closer look.Jan. 2The only Disney gated attraction that has yet to reopen since the pandemic -- Walt Disney World's Typhoon Lagoon -- is getting back in business this weekend. Typhoon Lagoon was the country's most visited water park in 2019, its last full year of operation. It was also the world's second most popular water park.Florida's resort is the only place where Disney operates a theme park, and it actually has two in the Sunshine State. It only reopened Blizzard Beach in March, but it's closing that park down for refurbishment when Typhoon Lagoon reopens on Sunday. A combination of staffing concerns and consumer demand is probably keeping Disney to having just one theme park open at a time, but if things go well it wouldn't be a surprise to see both watery escapes open at the same time in a few months when the weather starts to heat up.Jan. 14This is a relatively slow month for Disney in terms of theatrical releases, but one of note will be Deep Water. The film starring Ben Affleck and Ana de Armas is being billed as an erotic psychological thriller, as the two play a married couple that have fallen out of love. They play mind games with one another, and a body count ensues.This isn't an organic Disney production. It's part of the slate of content that the media stock picked up with its 20th Century Fox acquisition. Expectations aren't as high for this flick as the superhero and sci-fi fare that Disney will be putting out later this year, but there's always the chance for a sleeper hit. All cards are off the table if COVID-19 cases intensify to the point that folks aren't hitting up the local multiplex.Jan. 28Disney+ is a big part of the growth thesis for the House of Mouse. The platform launched in late 2019, and it's already at more than 118 million accounts worldwide. Disney has said that it doesn't expect the platform to become profitable until fiscal 2024, but its popularity has given Disney a new revenue stream.There are a couple of new shows and movies coming to Disney+ this month. If you missed Marvel's Eternals at the movie theater in November you can start catching on Disney+ starting Jan. 12. You'll also get fresh weekly installments of the new The Book of Boba Fett series every Wednesday. Young families may be circling Jan. 28 on the calendar as that is when The Ice Age Adventures of Buck Wild hits the platform. The film is a spinoff of the computer animated Ice Age franchise. If you're thinking that you don't recall Ice Age as a Disney property, you're right. It's another franchise that Disney inherited when it acquired the 20th Century Fox catalog.","news_type":1},"isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001894910,"gmtCreate":1641210657440,"gmtModify":1676533583091,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001894910","repostId":"2200203447","repostType":4,"repost":{"id":"2200203447","pubTimestamp":1641210131,"share":"https://ttm.financial/m/news/2200203447?lang=&edition=fundamental","pubTime":"2022-01-03 19:42","market":"us","language":"en","title":"Will Nio Recover in 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=2200203447","media":"Motley Fool","summary":"The Chinese EV stock fell more than 40% in 2021.","content":"<html><head></head><body><p>For electric vehicle (EV) investors, China is an attractive market. Global EV sales are estimated to be roughly 6 million units for 2021. Of these, China alone is expected to account for around 2.9 million units.</p><p>Yet, investors remain skeptical about investing in Chinese stocks. Considering some key developments in China in 2021, such skepticism looks reasonable. However, assuming you&#39;ve already considered that risk in the context of your portfolio, let&#39;s discuss whether it is a good idea to buy <b>Nio</b> (NYSE:NIO) stock right now.</p><h2>Nio operates in a competitive market</h2><p>As a leading market for EVs, China obviously attracts top global players. Nio competes with established players, including <b>BYD</b> and <b>Tesla</b>, as well as with newer entrants, including <b>Li Auto</b> and <b>XPeng</b>. Further, Nio also faces competition from legacy automakers, including <b>Volkswagen</b> and <b>General Motors</b>, which are looking to capture a portion of the fast-growing Chinese EV market.</p><p>In November, BYD sold 90,546 EVs in China, compared to around 10,700 vehicles delivered by Nio. By comparison, Tesla sold 52,859 EVs in China in November.</p><h2>There is a lot to like about Nio</h2><p>After launching its first car in 2016, Nio has delivered more than 156,000 electric vehicles so far, with 80,940 delivered in 2021 (through November). The company&#39;s recent sales growth indicates a robust demand for its vehicles.</p><p><img src=\"https://static.tigerbbs.com/670d856ff0346c7e93c8e8e480af9f25\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>NIO revenue (quarterly). Data by YCharts.</p><p>Among Chinese pure-play EV companies, Nio is a top player both in terms of revenue and revenue growth. Notably, BYD  derives only a little over half of its revenue from vehicle sales. There are some key factors that differentiate Nio from its competitors.</p><p>First, Nio&#39;s innovative Battery-as-as-Service model allows its users to swap batteries of their EVs with new ones at any of the company&#39;s 700 battery swapping stations. Users can swap their discharged batteries quickly if they are short of time to recharge it. Alternatively, they may choose to swap a battery and go for a bigger or smaller pack, depending on their specific need. Nio has done more than 5.3 million battery swaps so far, indicating a robust demand for the same.</p><p>Second, Nio is launching two new models: the ET7, a luxury sedan, and the ET5, a mid-size sedan. Moreover, the company will launch a third new model in 2022, which hasn&#39;t been unveiled yet. Not many of its competitors are planning to launch as many new models in the year. Further, these upcoming models are expected to be among the best in their target segment.</p><p>Both ET5 and ET7 come with Renminbi (RMB) 680  (around $106) monthly subscription for autonomous driving updates. Further, both have different battery options, from a 75 kilowatt-hour (kWh) (70 kWh in ET7) standard-range battery to a 150 kWh battery, which can go 620 miles on a single recharge. Deliveries of ET7 are expected to commence in March and ET5 in September.</p><p>The ET5 model is priced at RMB 328,000 (roughly $51,500) while ET7&#39;s price starts from RMB 448,000 (around $70,300). These two new models are expected to receive a positive response from customers, boosting Nio&#39;s sales in 2022. That could also support the stock&#39;s price in the new year.</p><h2>Is Nio stock a buy?</h2><p>Nio stock is trading at a forward price-to-sales ratio of around 4.6. That&#39;s comparable to that of its peers Li Auto and XPeng. However, Nio&#39;s ratio has improved significantly from around 10 in January 2021.</p><p><img src=\"https://static.tigerbbs.com/ab5adec3f3bcb25400c9d421c029e336\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>NIO PS Ratio (Forward 1y). Data by YCharts.</p><p>By comparison, BYD stock is trading at a price-to-sales ratio of around 3. As Nio is still not making profits, price-to-sales ratio is useful for comparing its valuation relative to its peers. A lower ratio is considered better.</p><p>Again, Nio stock looks much better valued compared to stocks of U.S. EV companies, such as <b>Rivian</b> or <b>Lucid</b>, each of which has delivered only a few hundred vehicles so far.</p><p>Apart from the domestic China market, Nio is targeting European markets for expansion. It started deliveries in Norway in September and is looking to enter five more countries in 2022. If successful, this expansion will establish Nio as a top EV maker that can meet global quality standards.</p><p>Despite competition, Nio has been growing its sales so far. Its upcoming models, international growth plans, and innovative offerings positions it well for long-term growth. Growth prospects, combined with a relatively attractive valuation, makes Nio stock appealing right now.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Nio Recover in 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Nio Recover in 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/02/will-nio-recover-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For electric vehicle (EV) investors, China is an attractive market. Global EV sales are estimated to be roughly 6 million units for 2021. Of these, China alone is expected to account for around 2.9 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/02/will-nio-recover-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4505":"高瓴资本持仓","BK4534":"瑞士信贷持仓","BK4555":"新能源车","NIO":"蔚来","BK4504":"桥水持仓","BK4526":"热门中概股","BK4099":"汽车制造商","BK4509":"腾讯概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4531":"中概回港概念"},"source_url":"https://www.fool.com/investing/2022/01/02/will-nio-recover-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200203447","content_text":"For electric vehicle (EV) investors, China is an attractive market. Global EV sales are estimated to be roughly 6 million units for 2021. Of these, China alone is expected to account for around 2.9 million units.Yet, investors remain skeptical about investing in Chinese stocks. Considering some key developments in China in 2021, such skepticism looks reasonable. However, assuming you've already considered that risk in the context of your portfolio, let's discuss whether it is a good idea to buy Nio (NYSE:NIO) stock right now.Nio operates in a competitive marketAs a leading market for EVs, China obviously attracts top global players. Nio competes with established players, including BYD and Tesla, as well as with newer entrants, including Li Auto and XPeng. Further, Nio also faces competition from legacy automakers, including Volkswagen and General Motors, which are looking to capture a portion of the fast-growing Chinese EV market.In November, BYD sold 90,546 EVs in China, compared to around 10,700 vehicles delivered by Nio. By comparison, Tesla sold 52,859 EVs in China in November.There is a lot to like about NioAfter launching its first car in 2016, Nio has delivered more than 156,000 electric vehicles so far, with 80,940 delivered in 2021 (through November). The company's recent sales growth indicates a robust demand for its vehicles.NIO revenue (quarterly). Data by YCharts.Among Chinese pure-play EV companies, Nio is a top player both in terms of revenue and revenue growth. Notably, BYD  derives only a little over half of its revenue from vehicle sales. There are some key factors that differentiate Nio from its competitors.First, Nio's innovative Battery-as-as-Service model allows its users to swap batteries of their EVs with new ones at any of the company's 700 battery swapping stations. Users can swap their discharged batteries quickly if they are short of time to recharge it. Alternatively, they may choose to swap a battery and go for a bigger or smaller pack, depending on their specific need. Nio has done more than 5.3 million battery swaps so far, indicating a robust demand for the same.Second, Nio is launching two new models: the ET7, a luxury sedan, and the ET5, a mid-size sedan. Moreover, the company will launch a third new model in 2022, which hasn't been unveiled yet. Not many of its competitors are planning to launch as many new models in the year. Further, these upcoming models are expected to be among the best in their target segment.Both ET5 and ET7 come with Renminbi (RMB) 680  (around $106) monthly subscription for autonomous driving updates. Further, both have different battery options, from a 75 kilowatt-hour (kWh) (70 kWh in ET7) standard-range battery to a 150 kWh battery, which can go 620 miles on a single recharge. Deliveries of ET7 are expected to commence in March and ET5 in September.The ET5 model is priced at RMB 328,000 (roughly $51,500) while ET7's price starts from RMB 448,000 (around $70,300). These two new models are expected to receive a positive response from customers, boosting Nio's sales in 2022. That could also support the stock's price in the new year.Is Nio stock a buy?Nio stock is trading at a forward price-to-sales ratio of around 4.6. That's comparable to that of its peers Li Auto and XPeng. However, Nio's ratio has improved significantly from around 10 in January 2021.NIO PS Ratio (Forward 1y). Data by YCharts.By comparison, BYD stock is trading at a price-to-sales ratio of around 3. As Nio is still not making profits, price-to-sales ratio is useful for comparing its valuation relative to its peers. A lower ratio is considered better.Again, Nio stock looks much better valued compared to stocks of U.S. EV companies, such as Rivian or Lucid, each of which has delivered only a few hundred vehicles so far.Apart from the domestic China market, Nio is targeting European markets for expansion. It started deliveries in Norway in September and is looking to enter five more countries in 2022. If successful, this expansion will establish Nio as a top EV maker that can meet global quality standards.Despite competition, Nio has been growing its sales so far. Its upcoming models, international growth plans, and innovative offerings positions it well for long-term growth. Growth prospects, combined with a relatively attractive valuation, makes Nio stock appealing right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001895708,"gmtCreate":1641210647424,"gmtModify":1676533583075,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"✅&nbsp;","listText":"✅&nbsp;","text":"✅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001895708","repostId":"2200213634","repostType":4,"repost":{"id":"2200213634","pubTimestamp":1641210575,"share":"https://ttm.financial/m/news/2200213634?lang=&edition=fundamental","pubTime":"2022-01-03 19:49","market":"us","language":"en","title":"3 Biotech Stocks That Could Double in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200213634","media":"Motley Fool","summary":"They're risky. But with the high risk comes the potential for high rewards.","content":"<html><head></head><body><p>Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.</p><p>We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here&#39;s why they picked <b>Adicet Bio</b> (NASDAQ:ACET), <b><a href=\"https://laohu8.com/S/CCXI\">ChemoCentryx</a></b> (NASDAQ:CCXI), and <b>NRx Pharmaceuticals</b> (NASDAQ:NRXP).</p><h2>Turning off-the-shelf CAR-T therapy hype into reality</h2><p><b>Keith Speights (Adicet Bio)</b>: Current chimeric antigen receptor T-cell (CAR-T) therapies require the patient&#39;s own T cells to be genetically engineered then infused back into their bodies. It&#39;s an expensive and time-consuming process.</p><p>There&#39;s been a lot of hype in recent years, though, about the potential for allogeneic CAR-T therapies. These are often referred to as &#34;off-the-shelf&#34; CAR-T therapies. The T cells of individuals other than the patient are modified to fight specific types of cancer in advance. As a result, the costs and time involved are much lower than current CAR-T therapies.</p><p>Adicet Bio is well on its way to turning the hype about off-the-shelf CAR-T therapies into reality. The company reported overwhelmingly positive results in early December from a phase 1 study of ADI-001 in treating non-Hodgkin&#39;s lymphoma. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> patients had complete responses (full remission). Another patient had a near-complete response.</p><p>Granted, this was only interim data from a phase 1 study. It&#39;s still really early, and there are plenty of hurdles left to jump. However, Adicet&#39;s prospects look good at this point.</p><p>Even after its huge gain following this announcement, Adicet&#39;s market cap remains below $650 million. The biotech plans to report additional data for ADI-001 in the first half of 2022. If those results confirm Adicet&#39;s interim data, I suspect this stock could double or more in the new year.</p><h2>A new drug could be a big winner in 2022</h2><p><b>David Jagielski</b> <b>(ChemoCentryx): </b>A promising mid-cap company that has strong sales potential can bring investors the right mix of a stock that may double in value. With ChemoCentryx, its $2.6 billion market cap isn&#39;t terribly large, and there&#39;s plenty of room for its valuation to rise. Its current price-to-sales multiple of 77 suggests that it is wildly overpriced, but that number is going to come down in the future.</p><p>That&#39;s because the U.S. Food and Drug Administration (FDA) approved Tavneos (avacopan) in October. The drug, which treats people with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (an autoimmune disease that can inflame small blood vessels), could generate close to $2 billion in annual revenue at its peak, according to analyst estimates. Although ChemoCentryx likely won&#39;t get close to that figure for years, it&#39;s on the right path, and the approval should at least bolster the company&#39;s top line in 2022.</p><p>ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner <b>Vifor </b>for $20 million was the key reason the company&#39;s sales grew to $17.7 million for the period ending Sept. 30, representing a year-over-year increase of 249%.</p><p>Once ChemoCentryx provides numbers as to how many patients are being prescribed Tavneos in the U.S., the stock could get a boost, assuming those figures are encouraging. Although ChemoCentryx stock initially jumped on news of its U.S. approval on Oct. 8 from less than $20 a share to more than $38, it&#39;s still nowhere near the more than $60 it was at a year ago. And that was before there was an approval to rally around.</p><p>With ChemoCentryx now likely to start generating sales from Tavneos in 2022, plus the company pursuing indications for it, there&#39;s plenty of reason to be bullish on the stock in the near term. Multiple analysts have set price targets of over $100 for the stock, more than double from where it is today. ChemoCentryx looks like a promising stock to hold entering the new year, and doubling in value appears to be a very realistic prospect for investors.</p><h2>A high-risk, high-reward play</h2><p><b>Prosper Junior Bakiny (NRx Pharmaceuticals):</b> Things have been tough for NRx Pharmaceuticals in the past couple of months. While the company hoped to carve out a niche in the market for drugs that treat COVID-19, it ran into regulatory troubles. The FDA declined to grant emergency use authorization (EUA) to the company&#39;s experimental coronavirus medicine, Zyesami.</p><p>The agency decided against authorizing the medicine because of insufficient data regarding its potential benefits and risks. Naturally, that was a big blow to NRx Pharmaceuticals, a small-cap biotech that currently has no products on the market. But things aren&#39;t over for Zyesami just yet. Since the FDA&#39;s thumbs-down, the medicine has produced more encouraging results.</p><p>On Nov. 29, NRx Pharmaceuticals reported data purporting to show that Zyesami led to substantial improvements in severe COVID-19 patients compared to existing therapies, including <b>Gilead Sciences</b>&#39; remdesivir. NRx Pharmaceuticals also reported more positive safety data for Zyesami in mid-December.</p><p>The company is now moving ahead in its attempt to get Zyesami on the market. On Dec. 29, NRx Pharmaceuticals applied for a breakthrough designation therapy for Zyesami in COVID-19 patients with respiratory failure who have been previously treated with other treatments such as remdesivir, but to no avail. The biotech hopes to earn authorization for its medicine relatively soon, and if that happens, it could send its stock soaring through the roof. NRx Pharmaceuticals currently sports a minuscule market cap of just $290 million.</p><p>The coronavirus pandemic isn&#39;t over. With the advent of new variants of the virus that causes the diseases, such as the omicron variant, thousands are still testing positive each week, with many of them dying. Current therapy options exist, but there will be a need for more effective ones. If NRx Pharmaceuticals&#39; Zyesami earns the green light, its stock could easily double its current levels.</p><p>With that said, risks abound for this biotech. Perhaps the FDA will decline to approve Zyesami once again. NRx Pharmaceuticals is also facing a lawsuit related to the medicine. The biotech does have other pipeline candidates, but at this point, a bet on NRx Pharmaceuticals is largely a bet on the future of Zyesami. That makes the biotech very risky, but the rewards could be huge. Invest accordingly.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Biotech Stocks That Could Double in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Biotech Stocks That Could Double in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.We asked three Motley Fool contributors which biotech stocks they think could double in the...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACET":"艾切托","CCXI":"ChemoCentryx","NRXP":"NRX Pharmaceuticals Inc.","BK4139":"生物科技","BK4007":"制药"},"source_url":"https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200213634","content_text":"Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here's why they picked Adicet Bio (NASDAQ:ACET), ChemoCentryx (NASDAQ:CCXI), and NRx Pharmaceuticals (NASDAQ:NRXP).Turning off-the-shelf CAR-T therapy hype into realityKeith Speights (Adicet Bio): Current chimeric antigen receptor T-cell (CAR-T) therapies require the patient's own T cells to be genetically engineered then infused back into their bodies. It's an expensive and time-consuming process.There's been a lot of hype in recent years, though, about the potential for allogeneic CAR-T therapies. These are often referred to as \"off-the-shelf\" CAR-T therapies. The T cells of individuals other than the patient are modified to fight specific types of cancer in advance. As a result, the costs and time involved are much lower than current CAR-T therapies.Adicet Bio is well on its way to turning the hype about off-the-shelf CAR-T therapies into reality. The company reported overwhelmingly positive results in early December from a phase 1 study of ADI-001 in treating non-Hodgkin's lymphoma. Two patients had complete responses (full remission). Another patient had a near-complete response.Granted, this was only interim data from a phase 1 study. It's still really early, and there are plenty of hurdles left to jump. However, Adicet's prospects look good at this point.Even after its huge gain following this announcement, Adicet's market cap remains below $650 million. The biotech plans to report additional data for ADI-001 in the first half of 2022. If those results confirm Adicet's interim data, I suspect this stock could double or more in the new year.A new drug could be a big winner in 2022David Jagielski (ChemoCentryx): A promising mid-cap company that has strong sales potential can bring investors the right mix of a stock that may double in value. With ChemoCentryx, its $2.6 billion market cap isn't terribly large, and there's plenty of room for its valuation to rise. Its current price-to-sales multiple of 77 suggests that it is wildly overpriced, but that number is going to come down in the future.That's because the U.S. Food and Drug Administration (FDA) approved Tavneos (avacopan) in October. The drug, which treats people with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (an autoimmune disease that can inflame small blood vessels), could generate close to $2 billion in annual revenue at its peak, according to analyst estimates. Although ChemoCentryx likely won't get close to that figure for years, it's on the right path, and the approval should at least bolster the company's top line in 2022.ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner Vifor for $20 million was the key reason the company's sales grew to $17.7 million for the period ending Sept. 30, representing a year-over-year increase of 249%.Once ChemoCentryx provides numbers as to how many patients are being prescribed Tavneos in the U.S., the stock could get a boost, assuming those figures are encouraging. Although ChemoCentryx stock initially jumped on news of its U.S. approval on Oct. 8 from less than $20 a share to more than $38, it's still nowhere near the more than $60 it was at a year ago. And that was before there was an approval to rally around.With ChemoCentryx now likely to start generating sales from Tavneos in 2022, plus the company pursuing indications for it, there's plenty of reason to be bullish on the stock in the near term. Multiple analysts have set price targets of over $100 for the stock, more than double from where it is today. ChemoCentryx looks like a promising stock to hold entering the new year, and doubling in value appears to be a very realistic prospect for investors.A high-risk, high-reward playProsper Junior Bakiny (NRx Pharmaceuticals): Things have been tough for NRx Pharmaceuticals in the past couple of months. While the company hoped to carve out a niche in the market for drugs that treat COVID-19, it ran into regulatory troubles. The FDA declined to grant emergency use authorization (EUA) to the company's experimental coronavirus medicine, Zyesami.The agency decided against authorizing the medicine because of insufficient data regarding its potential benefits and risks. Naturally, that was a big blow to NRx Pharmaceuticals, a small-cap biotech that currently has no products on the market. But things aren't over for Zyesami just yet. Since the FDA's thumbs-down, the medicine has produced more encouraging results.On Nov. 29, NRx Pharmaceuticals reported data purporting to show that Zyesami led to substantial improvements in severe COVID-19 patients compared to existing therapies, including Gilead Sciences' remdesivir. NRx Pharmaceuticals also reported more positive safety data for Zyesami in mid-December.The company is now moving ahead in its attempt to get Zyesami on the market. On Dec. 29, NRx Pharmaceuticals applied for a breakthrough designation therapy for Zyesami in COVID-19 patients with respiratory failure who have been previously treated with other treatments such as remdesivir, but to no avail. The biotech hopes to earn authorization for its medicine relatively soon, and if that happens, it could send its stock soaring through the roof. NRx Pharmaceuticals currently sports a minuscule market cap of just $290 million.The coronavirus pandemic isn't over. With the advent of new variants of the virus that causes the diseases, such as the omicron variant, thousands are still testing positive each week, with many of them dying. Current therapy options exist, but there will be a need for more effective ones. If NRx Pharmaceuticals' Zyesami earns the green light, its stock could easily double its current levels.With that said, risks abound for this biotech. Perhaps the FDA will decline to approve Zyesami once again. NRx Pharmaceuticals is also facing a lawsuit related to the medicine. The biotech does have other pipeline candidates, but at this point, a bet on NRx Pharmaceuticals is largely a bet on the future of Zyesami. That makes the biotech very risky, but the rewards could be huge. Invest accordingly.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001895568,"gmtCreate":1641210631324,"gmtModify":1676533583074,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001895568","repostId":"2200403714","repostType":4,"repost":{"id":"2200403714","pubTimestamp":1641163785,"share":"https://ttm.financial/m/news/2200403714?lang=&edition=fundamental","pubTime":"2022-01-03 06:49","market":"us","language":"en","title":"December jobs report, Federal Reserve meeting minutes, CES: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2200403714","media":"Yahoo Finance","summary":"Investors can expect a busy first week of 2022, laden with key economic releases out of Washington t","content":"<html><head></head><body><p>Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market Committee’s (FOMC) latest policy-setting meeting.</p><p>It was a hectic final month of 2021 for markets, stocks rallied to new highs and the action could pour into the new year’s opening week of trading with a boost from what is known as the “January Effect” — the perception of a seasonal rise in U.S. equities during the first month of the year.</p><p>Wall Street attributes the theory to an increase in purchasing following the drop in prices that occurs in December when investors sell positions that have declined in order to take the capital loss in that calendar year&#39;s taxes. Some also think the anomaly is the result of traders using year-end cash bonuses to purchase equities the following month.</p><p>Employment data will be in the spotlight this week. The Department of Labor’s monthly jobs report due for release on Friday will offer an updated look at the strength of hiring and labor force participation — important measures of the U.S. economy, made even more consequential in recent weeks amid a backdrop of rising COVID-19 cases as investors look to assess the impact of the the latest Omicron-driven wave.</p><p>Consensus economist estimates suggest that about 400,000 jobs were added in December, with the pace of hiring nearly doubling from the fewer-than-expected 210,000 recorded in November, when forecasts predicted a half-million new jobs to return. The unemployment rate is also expected to improve further to 4.1% from 4.3% in November when it ticked down to the lowest read since March 2020.</p><p>Although the pace of non-farm payrolls is projected to have risen in December, the downside risk to estimates may be “sizable.”</p><p>“COVID caseloads have been on the rise since November, and news that Omicron could be more infectious than previous variants circulated widely during the December survey period,” Bloomberg economists wrote in a note. “Given how often households have cited fear of COVID or care-taking needs related to COVID as the most important reasons for staying out of the job market, the emergence of the Omicron variant could continue to discourage them.”</p><p>Despite steady rehiring since the peak of the pandemic, labor force participation remains short of pre-virus levels. The civilian labor force was down by about 2.4 million participants as of November, compared to February 2020. Labor issues are also fueling surging inflation levels, as companies large and small face logistical challenges, including rising business costs and supply chain bottlenecks caused by a shortage of workers.</p><p>“This severe labor market shortage — more than any other economic factor — is accounting for a massive breakdown in the normally well-oiled global supply chain,” experts at Wilmington Trust said in their 2022 Capital Markets Outlook. “Labor participation and how firms deal with global resource disorder will likely determine the path for inflation, which is the critical consideration for investors in 2022.”</p><p><img src=\"https://static.tigerbbs.com/792826db78c3c5bac082a3cd1bbe34c2\" tg-width=\"818\" tg-height=\"685\" referrerpolicy=\"no-referrer\"/></p><p>With inflation at the forefront, investors will also set their sights on the Federal Reserve as it looks to raise interest rates this year to offset swelling price levels. The pace of these hikes will determine the stock market’s path forward in the new year.</p><p>Minutes from the FOMC’s Dec. 15 policy-setting meeting, due out Wednesday, could give investors a better picture of where policymakers see interest rates going in 2022.</p><p>Fed officials indicated last month that all 18 members predict at least one 25 basis point hike next year, with the median member forecasting three rate hikes before 2022 is over. The next FOMC meeting is scheduled to take place on Jan. 25 and 26.</p><p>“What’s not changed is the focus on inflation, that’s the biggest risk,” Brigg Macadam founding partner Greg Swenson told Yahoo Finance Live, adding that the Fed changing its tone is “too little, too late.”</p><p>“They are still, by most measures, quite dovish, even with the tapering of bond purchases and the market pricing in three hikes next year, you’ll still have dramatically negative real rates,” he said. “I wouldn’t call that a hawkish Fed — maybe their tone has changed a little bit and they have definitely stopped using the word ‘transitory,’ they have all but admitted that they missed inflation and underestimated it.”</p><p>Although earnings season doesn’t fully commence until around mid-month, several notable off-cycle reports are due out this week, including ones from Jefferies, Bed Bath &amp; Beyond, and Walgreens.</p><p>CES, the Consumer Technology Association&#39;s iconic consumer electronics show will also take place from Jan. 5-7 in Las Vegas, but will end one day earlier than initially planned due to fast-spreading cases of COVID-19. The event may also have a light crowd, with some usual, big name attendees like Apple, Alphabet and Facebook&#39;s parent Meta dropping their plans to attend in-person under the circumstances.</p><h2>Economic calendar</h2><ul><li><p><b>Monday:</b> Markit US Manufacturing PMI, December final (57.7 estimated, 57.8 prior); Construction Spending, month over month, November (0.7% estimated, 0.2% prior month)</p></li><li><p><b>Tuesday:</b> ISM New Orders, December (61.5% prior month); ISM Prices Paid, December (79.3 estimated, 82.4 prior month); ISM Manufacturing, December (60.2 estimated, 61.1) prior month); ISM Employment, December (53.3 prior month); JOLTS job openings, November (11,033,000 prior month); WARDS Total Vehicle Sales, December (13,100,000 expected, 12,860,000 prior month)</p></li><li><p><b>Wednesday:</b> MBA Mortgage Applications, week ended Dec. 31 (-0.6% during prior week); ADP Employment Change, December (360,000 expected, 534,000 during prior month); Markit US Composite PMI, December final (56.9 prior month); Markit US Services PMI, December final (57.5 expected, 57.5 prior month); FOMC Meeting Minutes, December 15</p></li><li><p><b>Thursday: </b>Challenger Job Cuts, year over year, December (-77% prior); Trade Balance, November (-$74,000,000,000 expected, -$67,000,000,000); Initial Jobless Claims, week ended January 1 (199,000 expected, 198,000 during prior week) Continuing Claims, week ended January 1 (1,715,000 expected, 1,716,000 prior week); Langer Consumer Comfort, January 2 (47.9 prior); Factory Orders excluding transportation, November (1.6% prior); Factory Orders, November (1.5% expected, 1.0% prior) ISM Services Index, December (67.0 expected, 69.1 prior); Durable Goods Orders, November final (2.5% prior); Durable Goods Excluding Transportation, November final (0.8% prior); Capital Goods Orders Nondefense Excluding Aircrafts, November final (-0.1%); Capital Goods Shipments Nondefense Excluding Aircrafts, November final (0.3%)</p></li><li><p><b>Friday:</b> Revisions – Employment Report, Household Survey; Two-Month Payroll Net Revision, December (82,000 prior); Change in Nonfarm Payrolls, December (400,000 expected, 210,000 prior month); Change in Private Payrolls, December (370,000 expected, 235,000 prior month); Change in Manufacturing Payrolls, December (33,000 expected, 31,000 prior month); Unemployment Rate, December (4.1 expected, 4.3% prior); Average Hourly Earnings, month over month, December (0.4% expected, 0.3% prior month); Average Hourly Earnings, year over year (4.2% expected, 4.8% prior month); Average Weekly Hours All Employees, December (34.8 expected, 34.8 prior month); Labor Force Participation Rate, December (61.9% expected, 61.8% prior month); Underemployment Rate, December (7.8% prior month); Consumer Credit, November (22,500,000,000 expected, 16,897,000,000 prior month)</p></li></ul><h2>Earnings calendar</h2><ul><li><p><b>Monday:</b> <i>No notable reports scheduled for release</i></p></li><li><p><b>Tuesday:</b> Jefferies Financial Group (JEF), <a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> (MLKN) after market close</p></li><li><p><b>Wednesday:</b> <a href=\"https://laohu8.com/S/MULN\">Mullen Automotive</a> Inc. (MULN)</p></li><li><p><b>Thursday</b>: Bed Bath &amp; Beyond Inc. (BBY) before market open, <a href=\"https://laohu8.com/S/STZ\">Constellation Brands Inc</a>. (STZ) before market open, <a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> (WBA) before market opens, PriceSmart (PSMT) after market close</p></li><li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>December jobs report, Federal Reserve meeting minutes, CES: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDecember jobs report, Federal Reserve meeting minutes, CES: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 06:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market ...</p>\n\n<a href=\"https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4077":"互动媒体与服务","BK4076":"电脑与电子产品零售","STZ":"星座品牌","BK4143":"办公服务与用品","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4155":"大卖场与超市","PSMT":"普尔斯玛特","BBY":"百思买","BK4504":"桥水持仓","WBA":"沃尔格林联合博姿","MULN":"Mullen Automotive","JEF":"杰富瑞","FOMC":"FOMO CORP.","BK4127":"投资银行业与经纪业","BK4169":"酿酒商与葡萄酒商",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BK4567":"ESG概念",".SPX":"S&P 500 Index","MLKN":"MillerKnoll","BBBY":"3B家居","BK4128":"药品零售","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200403714","content_text":"Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market Committee’s (FOMC) latest policy-setting meeting.It was a hectic final month of 2021 for markets, stocks rallied to new highs and the action could pour into the new year’s opening week of trading with a boost from what is known as the “January Effect” — the perception of a seasonal rise in U.S. equities during the first month of the year.Wall Street attributes the theory to an increase in purchasing following the drop in prices that occurs in December when investors sell positions that have declined in order to take the capital loss in that calendar year's taxes. Some also think the anomaly is the result of traders using year-end cash bonuses to purchase equities the following month.Employment data will be in the spotlight this week. The Department of Labor’s monthly jobs report due for release on Friday will offer an updated look at the strength of hiring and labor force participation — important measures of the U.S. economy, made even more consequential in recent weeks amid a backdrop of rising COVID-19 cases as investors look to assess the impact of the the latest Omicron-driven wave.Consensus economist estimates suggest that about 400,000 jobs were added in December, with the pace of hiring nearly doubling from the fewer-than-expected 210,000 recorded in November, when forecasts predicted a half-million new jobs to return. The unemployment rate is also expected to improve further to 4.1% from 4.3% in November when it ticked down to the lowest read since March 2020.Although the pace of non-farm payrolls is projected to have risen in December, the downside risk to estimates may be “sizable.”“COVID caseloads have been on the rise since November, and news that Omicron could be more infectious than previous variants circulated widely during the December survey period,” Bloomberg economists wrote in a note. “Given how often households have cited fear of COVID or care-taking needs related to COVID as the most important reasons for staying out of the job market, the emergence of the Omicron variant could continue to discourage them.”Despite steady rehiring since the peak of the pandemic, labor force participation remains short of pre-virus levels. The civilian labor force was down by about 2.4 million participants as of November, compared to February 2020. Labor issues are also fueling surging inflation levels, as companies large and small face logistical challenges, including rising business costs and supply chain bottlenecks caused by a shortage of workers.“This severe labor market shortage — more than any other economic factor — is accounting for a massive breakdown in the normally well-oiled global supply chain,” experts at Wilmington Trust said in their 2022 Capital Markets Outlook. “Labor participation and how firms deal with global resource disorder will likely determine the path for inflation, which is the critical consideration for investors in 2022.”With inflation at the forefront, investors will also set their sights on the Federal Reserve as it looks to raise interest rates this year to offset swelling price levels. The pace of these hikes will determine the stock market’s path forward in the new year.Minutes from the FOMC’s Dec. 15 policy-setting meeting, due out Wednesday, could give investors a better picture of where policymakers see interest rates going in 2022.Fed officials indicated last month that all 18 members predict at least one 25 basis point hike next year, with the median member forecasting three rate hikes before 2022 is over. The next FOMC meeting is scheduled to take place on Jan. 25 and 26.“What’s not changed is the focus on inflation, that’s the biggest risk,” Brigg Macadam founding partner Greg Swenson told Yahoo Finance Live, adding that the Fed changing its tone is “too little, too late.”“They are still, by most measures, quite dovish, even with the tapering of bond purchases and the market pricing in three hikes next year, you’ll still have dramatically negative real rates,” he said. “I wouldn’t call that a hawkish Fed — maybe their tone has changed a little bit and they have definitely stopped using the word ‘transitory,’ they have all but admitted that they missed inflation and underestimated it.”Although earnings season doesn’t fully commence until around mid-month, several notable off-cycle reports are due out this week, including ones from Jefferies, Bed Bath & Beyond, and Walgreens.CES, the Consumer Technology Association's iconic consumer electronics show will also take place from Jan. 5-7 in Las Vegas, but will end one day earlier than initially planned due to fast-spreading cases of COVID-19. The event may also have a light crowd, with some usual, big name attendees like Apple, Alphabet and Facebook's parent Meta dropping their plans to attend in-person under the circumstances.Economic calendarMonday: Markit US Manufacturing PMI, December final (57.7 estimated, 57.8 prior); Construction Spending, month over month, November (0.7% estimated, 0.2% prior month)Tuesday: ISM New Orders, December (61.5% prior month); ISM Prices Paid, December (79.3 estimated, 82.4 prior month); ISM Manufacturing, December (60.2 estimated, 61.1) prior month); ISM Employment, December (53.3 prior month); JOLTS job openings, November (11,033,000 prior month); WARDS Total Vehicle Sales, December (13,100,000 expected, 12,860,000 prior month)Wednesday: MBA Mortgage Applications, week ended Dec. 31 (-0.6% during prior week); ADP Employment Change, December (360,000 expected, 534,000 during prior month); Markit US Composite PMI, December final (56.9 prior month); Markit US Services PMI, December final (57.5 expected, 57.5 prior month); FOMC Meeting Minutes, December 15Thursday: Challenger Job Cuts, year over year, December (-77% prior); Trade Balance, November (-$74,000,000,000 expected, -$67,000,000,000); Initial Jobless Claims, week ended January 1 (199,000 expected, 198,000 during prior week) Continuing Claims, week ended January 1 (1,715,000 expected, 1,716,000 prior week); Langer Consumer Comfort, January 2 (47.9 prior); Factory Orders excluding transportation, November (1.6% prior); Factory Orders, November (1.5% expected, 1.0% prior) ISM Services Index, December (67.0 expected, 69.1 prior); Durable Goods Orders, November final (2.5% prior); Durable Goods Excluding Transportation, November final (0.8% prior); Capital Goods Orders Nondefense Excluding Aircrafts, November final (-0.1%); Capital Goods Shipments Nondefense Excluding Aircrafts, November final (0.3%)Friday: Revisions – Employment Report, Household Survey; Two-Month Payroll Net Revision, December (82,000 prior); Change in Nonfarm Payrolls, December (400,000 expected, 210,000 prior month); Change in Private Payrolls, December (370,000 expected, 235,000 prior month); Change in Manufacturing Payrolls, December (33,000 expected, 31,000 prior month); Unemployment Rate, December (4.1 expected, 4.3% prior); Average Hourly Earnings, month over month, December (0.4% expected, 0.3% prior month); Average Hourly Earnings, year over year (4.2% expected, 4.8% prior month); Average Weekly Hours All Employees, December (34.8 expected, 34.8 prior month); Labor Force Participation Rate, December (61.9% expected, 61.8% prior month); Underemployment Rate, December (7.8% prior month); Consumer Credit, November (22,500,000,000 expected, 16,897,000,000 prior month)Earnings calendarMonday: No notable reports scheduled for releaseTuesday: Jefferies Financial Group (JEF), MillerKnoll (MLKN) after market closeWednesday: Mullen Automotive Inc. (MULN)Thursday: Bed Bath & Beyond Inc. (BBY) before market open, Constellation Brands Inc. (STZ) before market open, Walgreens Boots Alliance (WBA) before market opens, PriceSmart (PSMT) after market closeFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9001446827,"gmtCreate":1641308544390,"gmtModify":1676533596045,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001446827","repostId":"1182899517","repostType":4,"repost":{"id":"1182899517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641308410,"share":"https://ttm.financial/m/news/1182899517?lang=&edition=fundamental","pubTime":"2022-01-04 23:00","market":"us","language":"en","title":"Some Vaccine Stocks Slid in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1182899517","media":"Tiger Newspress","summary":"Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3","content":"<html><head></head><body><p>Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.<img src=\"https://static.tigerbbs.com/2b8d37f6fcb2216ad1872ca6be6dc94d\" tg-width=\"375\" tg-height=\"162\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine Stocks Slid in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine Stocks Slid in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-04 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.<img src=\"https://static.tigerbbs.com/2b8d37f6fcb2216ad1872ca6be6dc94d\" tg-width=\"375\" tg-height=\"162\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182899517","content_text":"Some vaccine stocks slid in morning trading. BioNTech SE, Moderna, Pfizer and Novavax fell between 3% and 4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003287766,"gmtCreate":1640999411024,"gmtModify":1676533561798,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Shy]&nbsp;[Shy]&nbsp;","listText":"[Shy]&nbsp;[Shy]&nbsp;","text":"[Shy] [Shy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003287766","repostId":"2195410116","repostType":4,"repost":{"id":"2195410116","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640963744,"share":"https://ttm.financial/m/news/2195410116?lang=&edition=fundamental","pubTime":"2021-12-31 23:15","market":"us","language":"en","title":"Wall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors","url":"https://stock-news.laohu8.com/highlight/detail?id=2195410116","media":"Dow Jones","summary":"General Motors, Salesforce and PayPal are among the 20 S&P 500 stocks that analysts both heavily fav","content":"<html><head></head><body><p>General Motors, <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> are among the 20 S&amp;P 500 stocks that analysts both heavily favor and expect to rise to the most</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d68bea2d0c6b7347ed8e660ad6323ef6\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Wall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.</span></p><p>As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&amp;P 500 index has a dividend yield of 1.30% to go along with its growth potential?</p><p>Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.</p><p>With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.</p><p>Below are lists of stocks among the benchmark S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index  that are rated &#34;buy&#34; or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts&#39; opinions of all 30 stocks in the Dow Jones Industrial Average.</p><p><b>Large-cap favorites</b></p><p>Among the S&amp;P 500, 93 stocks are rated a &#34;buy&#34; or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Alaska Air Group Inc.</td><td>ALK</td><td>Airlines</td><td>$51.94</td><td>$77.71</td><td>50%</td><td>93%</td><td>0%</td></tr><tr><td>Caesars Entertainment Inc.</td><td>CZR</td><td>Casinos/ Gaming</td><td>$92.99</td><td>$137.36</td><td>48%</td><td>94%</td><td>25%</td></tr><tr><td>Generac Holdings Inc.</td><td>GNRC</td><td>Electrical Products</td><td>$352.96</td><td>$514.11</td><td>46%</td><td>77%</td><td>55%</td></tr><tr><td>PayPal Holdings Inc.</td><td>PYPL</td><td>Data Processing Services</td><td>$191.88</td><td>$273.65</td><td>43%</td><td>84%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TMUSR\">T-Mobile US Inc</a>.</td><td>TMUS</td><td>Wireless Telecommunications</td><td>$116.51</td><td>$165.51</td><td>42%</td><td>81%</td><td>-14%</td></tr><tr><td>News Corp. Class A</td><td>NWSA</td><td>Publishing: Newspapers</td><td>$22.50</td><td>$31.91</td><td>42%</td><td>88%</td><td>26%</td></tr><tr><td>Global Payments Inc.</td><td>GPN</td><td>Data Processing Services</td><td>$136.29</td><td>$188.41</td><td>38%</td><td>85%</td><td>-36%</td></tr><tr><td>Southwest Airlines Co.</td><td>LUV</td><td>Airlines</td><td>$42.72</td><td>$57.32</td><td>34%</td><td>78%</td><td>-8%</td></tr><tr><td>Schlumberger NV</td><td>SLB</td><td>Oilfield Services/ Equipment</td><td>$29.82</td><td>$39.58</td><td>33%</td><td>85%</td><td>39%</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Bath &amp; Body Works Inc.</td><td>BBWI</td><td>Apparel, Footwear Retail</td><td>$69.70</td><td>$90.21</td><td>29%</td><td>86%</td><td>133%</td></tr><tr><td>Electronic Arts Inc.</td><td>EA</td><td>Recreational Products</td><td>$134.46</td><td>$173.78</td><td>29%</td><td>77%</td><td>-6%</td></tr><tr><td><a href=\"https://laohu8.com/S/PSX\">Phillips 66</a></td><td>PSX</td><td>Oil Refining/ Marketing</td><td>$72.45</td><td>$93.50</td><td>29%</td><td>79%</td><td>8%</td></tr><tr><td>Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a></td><td>MDT</td><td>Medical Specialties</td><td>$104.47</td><td>$134.52</td><td>29%</td><td>85%</td><td>-9%</td></tr><tr><td>Teleflex Inc.</td><td>TFX</td><td>Medical Specialties</td><td>$330.89</td><td>$424.11</td><td>28%</td><td>75%</td><td>-19%</td></tr><tr><td>General Motors Co.</td><td>GM</td><td>Motor Vehicles</td><td>$58.13</td><td>$74.45</td><td>28%</td><td>84%</td><td>40%</td></tr><tr><td>Pioneer Natural Resources Co.</td><td>PXD</td><td>Oil &amp; Gas Production</td><td>$181.28</td><td>$231.61</td><td>28%</td><td>86%</td><td>66%</td></tr><tr><td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td><td>SYF</td><td>Finance, Rental, Leasing</td><td>$46.26</td><td>$58.74</td><td>27%</td><td>77%</td><td>36%</td></tr><tr><td>Comcast Corp. Class A</td><td>CMCSA</td><td>Cable, Satellite TV</td><td>$50.59</td><td>$64.08</td><td>27%</td><td>79%</td><td>-2%</td></tr><tr><td>EOG Resources Inc.</td><td>EOG</td><td>Oil &amp; Gas Production</td><td>$89.18</td><td>$112.94</td><td>27%</td><td>79%</td><td>89%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p>Alaska Air Group Inc. tops the list of analysts&#39; favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry&#39;s recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..</p><p>There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&amp;P 500 energy sector returned 54%.</p><p>Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath &amp; Body Works Inc. and General Motors Co..</p><p><b>Midcap stocks expected to show the biggest gains</b></p><p>The lists of &#34;favorite&#34; stocks are confined to those covered by at least five analysts. Among components of the S&amp;P 400 Mid Cap Index, that leaves 92 stocks with at least 75% &#34;buy&#34; ratings. Here at the 20 expected to rise the most over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td><a href=\"https://laohu8.com/S/RUN\">Sunrun Inc.</a></td><td>RUN</td><td>Alternative Power Generation</td><td>$34.01</td><td>$72.61</td><td>113%</td><td>77%</td><td>-51%</td></tr><tr><td><a href=\"https://laohu8.com/S/APPS\">Digital Turbine Inc.</a></td><td>APPS</td><td>Software</td><td>$62.84</td><td>$104.00</td><td>65%</td><td>100%</td><td>11%</td></tr><tr><td>Jazz Pharmaceuticals Public Ltd. Co.</td><td>JAZZ</td><td>Pharmaceuticals</td><td>$128.26</td><td>$200.89</td><td>57%</td><td>90%</td><td>-22%</td></tr><tr><td>Lithia Motors Inc.</td><td>LAD</td><td>Specialty Stores</td><td>$297.17</td><td>$460.31</td><td>55%</td><td>80%</td><td>2%</td></tr><tr><td><a href=\"https://laohu8.com/S/CRNC\">Cerence Inc.</a></td><td>CRNC</td><td>Software</td><td>$77.59</td><td>$119.42</td><td>54%</td><td>100%</td><td>-23%</td></tr><tr><td>Callaway Golf Co.</td><td>ELY</td><td>Recreational Products</td><td>$27.63</td><td>$41.50</td><td>50%</td><td>77%</td><td>15%</td></tr><tr><td>Ziff Davis Inc.</td><td>ZD</td><td>Internet Software, Services</td><td>$111.37</td><td>$166.88</td><td>50%</td><td>100%</td><td>31%</td></tr><tr><td>Victoria&#39;s Secret &amp; Co.</td><td>VSCO</td><td>Apparel, Footwear Retail</td><td>$55.46</td><td>$82.73</td><td>49%</td><td>82%</td><td>N/A</td></tr><tr><td>LiveRamp Holdings Inc.</td><td>RAMP</td><td>Data Processing Services</td><td>$49.07</td><td>$73.18</td><td>49%</td><td>82%</td><td>-33%</td></tr><tr><td>PROG Holdings Inc.</td><td>PRG</td><td>Finance, Rental, Leasing</td><td>$44.84</td><td>$66.29</td><td>48%</td><td>75%</td><td>-17%</td></tr></tbody></table><table><tbody><tr><td><a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> Inc.</td><td>MLKN</td><td>Office Equipment, Supplies</td><td>$38.98</td><td>$57.60</td><td>48%</td><td>80%</td><td>17%</td></tr><tr><td>ChampionX Corp.</td><td>CHX</td><td>Chemicals: Specialty</td><td>$20.01</td><td>$29.00</td><td>45%</td><td>80%</td><td>31%</td></tr><tr><td>Darling Ingredients Inc.</td><td>DAR</td><td>Agricultural Commodities, Milling</td><td>$67.87</td><td>$96.79</td><td>43%</td><td>100%</td><td>18%</td></tr><tr><td>Axon Enterprise Inc.</td><td>AXON</td><td>Aerospace &amp; Defense</td><td>$156.07</td><td>$222.40</td><td>43%</td><td>91%</td><td>27%</td></tr><tr><td>EQT Corp.</td><td>EQT</td><td>Oil &amp; Gas Production</td><td>$22.04</td><td>$31.30</td><td>42%</td><td>75%</td><td>73%</td></tr><tr><td><a href=\"https://laohu8.com/S/IAA\">IAA Inc</a>.</td><td>IAA</td><td>Specialty Stores</td><td>$50.43</td><td>$70.88</td><td>41%</td><td>90%</td><td>-22%</td></tr><tr><td><a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> Inc.</td><td>HQY</td><td>Investment Managers</td><td>$43.86</td><td>$61.50</td><td>40%</td><td>75%</td><td>-37%</td></tr><tr><td><a href=\"https://laohu8.com/S/AZTA\">Azenta</a> Inc.</td><td>AZTA</td><td>Electronic Production Equipment</td><td>$103.18</td><td>$144.60</td><td>40%</td><td>83%</td><td>53%</td></tr><tr><td>Vontier Corp</td><td>VNT</td><td>Transportation</td><td>$30.89</td><td>$42.82</td><td>39%</td><td>77%</td><td>-7%</td></tr><tr><td>SailPoint Technologies Holdings Inc.</td><td>SAIL</td><td>Software</td><td>$48.85</td><td>$67.67</td><td>39%</td><td>93%</td><td>-8%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>Small-cap favorites for 2022</b></p><p>Among the S&amp;P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% &#34;buy&#34; ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>UniQure NV</td><td>QURE</td><td>Biotechnology</td><td>$20.87</td><td>$63.78</td><td>206%</td><td>89%</td><td>-42%</td></tr><tr><td><a href=\"https://laohu8.com/S/TCMD\">Tactile Systems Technology Inc</a>.</td><td>TCMD</td><td>Medical Specialties</td><td>$19.23</td><td>$52.25</td><td>172%</td><td>100%</td><td>-57%</td></tr><tr><td>Zynex Inc.</td><td>ZYXI</td><td>Medical Specialties</td><td>$10.23</td><td>$22.20</td><td>117%</td><td>80%</td><td>-24%</td></tr><tr><td>Cara Therapeutics Inc.</td><td>CARA</td><td>Biotechnology</td><td>$12.34</td><td>$26.25</td><td>113%</td><td>75%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TREE\">LendingTree</a> Inc.</td><td>TREE</td><td>Finance, Rental, Leasing</td><td>$121.91</td><td>$238.75</td><td>96%</td><td>100%</td><td>-55%</td></tr><tr><td>Joint Corp</td><td>JYNT</td><td>Hospital, Nursing Management</td><td>$64.62</td><td>$126.00</td><td>95%</td><td>83%</td><td>146%</td></tr><tr><td>Talos Energy Inc.</td><td>TALO</td><td>Oil &amp; Gas Production</td><td>$10.07</td><td>$19.00</td><td>89%</td><td>100%</td><td>22%</td></tr><tr><td><a href=\"https://laohu8.com/S/REGI\">Renewable Energy Group</a> Inc.</td><td>REGI</td><td>Chemicals</td><td>$42.78</td><td>$79.86</td><td>87%</td><td>80%</td><td>-40%</td></tr><tr><td><a href=\"https://laohu8.com/S/LPSN\">LivePerson</a> Inc.</td><td>LPSN</td><td>Internet Software, Services</td><td>$36.59</td><td>$64.31</td><td>76%</td><td>79%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/BLFS\">BioLife Solutions Inc.</a></td><td>BLFS</td><td>Medical Specialties</td><td>$37.44</td><td>$63.43</td><td>69%</td><td>78%</td><td>-6%</td></tr><tr><td>OptimizeRx Corp.</td><td>OPRX</td><td>Data Processing Services</td><td>$61.14</td><td>$103.00</td><td>68%</td><td>100%</td><td>96%</td></tr><tr><td>Cutera Inc.</td><td>CUTR</td><td>Medical Specialties</td><td>$39.26</td><td>$63.40</td><td>61%</td><td>100%</td><td>63%</td></tr><tr><td><a href=\"https://laohu8.com/S/SEM\">Select Medical Holdings</a> Corp.</td><td>SEM</td><td>Hospital, Nursing Management</td><td>$29.82</td><td>$47.40</td><td>59%</td><td>80%</td><td>9%</td></tr><tr><td>Hibbett Inc.</td><td>HIBB</td><td>Specialty Stores</td><td>$72.00</td><td>$112.17</td><td>56%</td><td>83%</td><td>57%</td></tr><tr><td><a href=\"https://laohu8.com/S/PLMR\">Palomar Holdings</a> Inc.</td><td>PLMR</td><td>Property/ Casualty Insurance</td><td>$63.76</td><td>$99.14</td><td>55%</td><td>78%</td><td>-28%</td></tr><tr><td>Coherus BioSciences Inc.</td><td>CHRS</td><td>Biotechnology</td><td>$16.74</td><td>$25.43</td><td>52%</td><td>86%</td><td>-4%</td></tr><tr><td>Celsius Holdings Inc.</td><td>CELH</td><td>Beverages: Non-Alcoholic</td><td>$73.52</td><td>$110.21</td><td>50%</td><td>75%</td><td>46%</td></tr><tr><td>James River Group Holdings Ltd.</td><td>JRVR</td><td>Property/ Casualty Insurance</td><td>$28.14</td><td>$41.86</td><td>49%</td><td>75%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/NEO\">NeoGenomics</a> Inc.</td><td>NEO</td><td>Medical/ Nursing Services</td><td>$34.15</td><td>$50.18</td><td>47%</td><td>92%</td><td>-37%</td></tr><tr><td>Vericel Corp.</td><td>VCEL</td><td>Medical Specialties</td><td>$40.11</td><td>$58.46</td><td>46%</td><td>100%</td><td>30%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>All 30 components of the Dow Jones Industrial Average</b></p><p>Here they are, ranked by how much analysts expect them to rise over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Boeing Co.</td><td>BA</td><td>Aerospace &amp; Defense</td><td>$202.71</td><td>$259.61</td><td>28%</td><td>73%</td><td>-5%</td></tr><tr><td><a href=\"https://laohu8.com/S/V\">Visa</a> Inc. Class A</td><td>V</td><td>Finance, Rental, Leasing</td><td>$217.87</td><td>$272.62</td><td>25%</td><td>92%</td><td>0%</td></tr><tr><td>Walt Disney Co.</td><td>DIS</td><td>Cable, Satellite TV</td><td>$155.93</td><td>$193.29</td><td>24%</td><td>70%</td><td>-14%</td></tr><tr><td>Merck &amp; Co. Inc.</td><td>MRK</td><td>Pharmaceuticals</td><td>$77.14</td><td>$92.70</td><td>20%</td><td>60%</td><td>2%</td></tr><tr><td>Goldman Sachs Group Inc.</td><td>GS</td><td>Investment Banks, Brokers</td><td>$385.52</td><td>$458.97</td><td>19%</td><td>67%</td><td>49%</td></tr><tr><td>Walmart Inc.</td><td>WMT</td><td>Food Retail</td><td>$143.17</td><td>$169.92</td><td>19%</td><td>80%</td><td>1%</td></tr><tr><td>Dow Inc.</td><td>DOW</td><td>Chemicals</td><td>$56.78</td><td>$66.62</td><td>17%</td><td>36%</td><td>7%</td></tr><tr><td>American Express Co.</td><td>AXP</td><td>Finance, Rental, Leasing</td><td>$164.16</td><td>$191.35</td><td>17%</td><td>46%</td><td>37%</td></tr><tr><td>Honeywell International Inc.</td><td>HON</td><td>Industrial Conglomerates</td><td>$207.11</td><td>$238.27</td><td>15%</td><td>48%</td><td>-1%</td></tr></tbody></table><p><table><tbody><tr><td>Caterpillar Inc.</td><td>CAT</td><td>Trucks, Construction, Farm Machinery</td><td>$206.08</td><td>$235.57</td><td>14%</td><td>52%</td><td>16%</td></tr><tr><td>Verizon Communications Inc.</td><td>VZ</td><td>Telecommunications</td><td>$52.25</td><td>$59.57</td><td>14%</td><td>27%</td><td>-7%</td></tr><tr><td>JPMorgan Chase &amp; Co.</td><td>JPM</td><td>Major Banks</td><td>$158.48</td><td>$179.70</td><td>13%</td><td>61%</td><td>28%</td></tr><tr><td>Chevron Corp.</td><td>CVX</td><td>Integrated Oil</td><td>$117.43</td><td>$130.74</td><td>11%</td><td>67%</td><td>46%</td></tr><tr><td>Nike Inc. Class B</td><td>NKE</td><td>Apparel, Footwear</td><td>$167.49</td><td>$185.89</td><td>11%</td><td>77%</td><td>19%</td></tr><tr><td>Microsoft Corp.</td><td>MSFT</td><td>Software</td><td>$339.32</td><td>$370.51</td><td>9%</td><td>90%</td><td>54%</td></tr><tr><td>3M Co.</td><td>MMM</td><td>Industrial Conglomerates</td><td>$177.64</td><td>$192.06</td><td>8%</td><td>14%</td><td>5%</td></tr><tr><td>Coca-Cola Co.</td><td>KO</td><td>Beverages: Non-Alcoholic</td><td>$58.78</td><td>$62.67</td><td>7%</td><td>61%</td><td>11%</td></tr><tr><td>Johnson &amp; Johnson</td><td>JNJ</td><td>Pharmaceuticals</td><td>$172.31</td><td>$183.71</td><td>7%</td><td>50%</td><td>12%</td></tr><tr><td>Intel Corp.</td><td>INTC</td><td>Semiconductors</td><td>$51.74</td><td>$54.91</td><td>6%</td><td>27%</td><td>7%</td></tr><tr><td>International Business Machines Corp.</td><td>IBM</td><td>Information Technology Services</td><td>$133.91</td><td>$142.07</td><td>6%</td><td>28%</td><td>17%</td></tr><tr><td>Amgen Inc.</td><td>AMGN</td><td>Biotechnology</td><td>$226.47</td><td>$238.09</td><td>5%</td><td>31%</td><td>2%</td></tr><tr><td>Travelers Companies Inc.</td><td>TRV</td><td>Multi-Line Insurance</td><td>$156.81</td><td>$164.06</td><td>5%</td><td>26%</td><td>14%</td></tr><tr><td>McDonald’s Corp.</td><td>MCD</td><td>Restaurants</td><td>$267.21</td><td>$276.06</td><td>3%</td><td>70%</td><td>27%</td></tr><tr><td>Home Depot Inc.</td><td>HD</td><td>Home Improvement Chains</td><td>$409.94</td><td>$416.83</td><td>2%</td><td>65%</td><td>58%</td></tr><tr><td>Walgreens Boots Alliance Inc.</td><td>WBA</td><td>Drugstore Chains</td><td>$51.99</td><td>$52.80</td><td>2%</td><td>5%</td><td>35%</td></tr><tr><td>UnitedHealth Group Inc.</td><td>UNH</td><td>Managed Health Care</td><td>$504.43</td><td>$504.20</td><td>0%</td><td>86%</td><td>46%</td></tr><tr><td>Apple Inc.</td><td>AAPL</td><td>Telecommunications Equipment</td><td>$178.20</td><td>$175.81</td><td>-1%</td><td>79%</td><td>35%</td></tr><tr><td>Cisco Systems Inc.</td><td>CSCO</td><td>Information Technology Services</td><td>$63.62</td><td>$62.69</td><td>-1%</td><td>54%</td><td>46%</td></tr><tr><td>Procter &amp; Gamble Co.</td><td>PG</td><td>Household, Personal Care</td><td>$162.77</td><td>$156.67</td><td>-4%</td><td>54%</td><td>20%</td></tr><tr><td>Source: FactSet</td></tr></tbody></table></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street analysts' favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-31 23:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>General Motors, <a href=\"https://laohu8.com/S/CRM\">Salesforce</a> and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> are among the 20 S&amp;P 500 stocks that analysts both heavily favor and expect to rise to the most</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d68bea2d0c6b7347ed8e660ad6323ef6\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Wall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.</span></p><p>As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&amp;P 500 index has a dividend yield of 1.30% to go along with its growth potential?</p><p>Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.</p><p>With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.</p><p>Below are lists of stocks among the benchmark S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index  that are rated &#34;buy&#34; or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts&#39; opinions of all 30 stocks in the Dow Jones Industrial Average.</p><p><b>Large-cap favorites</b></p><p>Among the S&amp;P 500, 93 stocks are rated a &#34;buy&#34; or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Alaska Air Group Inc.</td><td>ALK</td><td>Airlines</td><td>$51.94</td><td>$77.71</td><td>50%</td><td>93%</td><td>0%</td></tr><tr><td>Caesars Entertainment Inc.</td><td>CZR</td><td>Casinos/ Gaming</td><td>$92.99</td><td>$137.36</td><td>48%</td><td>94%</td><td>25%</td></tr><tr><td>Generac Holdings Inc.</td><td>GNRC</td><td>Electrical Products</td><td>$352.96</td><td>$514.11</td><td>46%</td><td>77%</td><td>55%</td></tr><tr><td>PayPal Holdings Inc.</td><td>PYPL</td><td>Data Processing Services</td><td>$191.88</td><td>$273.65</td><td>43%</td><td>84%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TMUSR\">T-Mobile US Inc</a>.</td><td>TMUS</td><td>Wireless Telecommunications</td><td>$116.51</td><td>$165.51</td><td>42%</td><td>81%</td><td>-14%</td></tr><tr><td>News Corp. Class A</td><td>NWSA</td><td>Publishing: Newspapers</td><td>$22.50</td><td>$31.91</td><td>42%</td><td>88%</td><td>26%</td></tr><tr><td>Global Payments Inc.</td><td>GPN</td><td>Data Processing Services</td><td>$136.29</td><td>$188.41</td><td>38%</td><td>85%</td><td>-36%</td></tr><tr><td>Southwest Airlines Co.</td><td>LUV</td><td>Airlines</td><td>$42.72</td><td>$57.32</td><td>34%</td><td>78%</td><td>-8%</td></tr><tr><td>Schlumberger NV</td><td>SLB</td><td>Oilfield Services/ Equipment</td><td>$29.82</td><td>$39.58</td><td>33%</td><td>85%</td><td>39%</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Bath &amp; Body Works Inc.</td><td>BBWI</td><td>Apparel, Footwear Retail</td><td>$69.70</td><td>$90.21</td><td>29%</td><td>86%</td><td>133%</td></tr><tr><td>Electronic Arts Inc.</td><td>EA</td><td>Recreational Products</td><td>$134.46</td><td>$173.78</td><td>29%</td><td>77%</td><td>-6%</td></tr><tr><td><a href=\"https://laohu8.com/S/PSX\">Phillips 66</a></td><td>PSX</td><td>Oil Refining/ Marketing</td><td>$72.45</td><td>$93.50</td><td>29%</td><td>79%</td><td>8%</td></tr><tr><td>Medtronic <a href=\"https://laohu8.com/S/PLC\">PLC</a></td><td>MDT</td><td>Medical Specialties</td><td>$104.47</td><td>$134.52</td><td>29%</td><td>85%</td><td>-9%</td></tr><tr><td>Teleflex Inc.</td><td>TFX</td><td>Medical Specialties</td><td>$330.89</td><td>$424.11</td><td>28%</td><td>75%</td><td>-19%</td></tr><tr><td>General Motors Co.</td><td>GM</td><td>Motor Vehicles</td><td>$58.13</td><td>$74.45</td><td>28%</td><td>84%</td><td>40%</td></tr><tr><td>Pioneer Natural Resources Co.</td><td>PXD</td><td>Oil &amp; Gas Production</td><td>$181.28</td><td>$231.61</td><td>28%</td><td>86%</td><td>66%</td></tr><tr><td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td><td>SYF</td><td>Finance, Rental, Leasing</td><td>$46.26</td><td>$58.74</td><td>27%</td><td>77%</td><td>36%</td></tr><tr><td>Comcast Corp. Class A</td><td>CMCSA</td><td>Cable, Satellite TV</td><td>$50.59</td><td>$64.08</td><td>27%</td><td>79%</td><td>-2%</td></tr><tr><td>EOG Resources Inc.</td><td>EOG</td><td>Oil &amp; Gas Production</td><td>$89.18</td><td>$112.94</td><td>27%</td><td>79%</td><td>89%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p>Alaska Air Group Inc. tops the list of analysts&#39; favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry&#39;s recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..</p><p>There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&amp;P 500 energy sector returned 54%.</p><p>Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath &amp; Body Works Inc. and General Motors Co..</p><p><b>Midcap stocks expected to show the biggest gains</b></p><p>The lists of &#34;favorite&#34; stocks are confined to those covered by at least five analysts. Among components of the S&amp;P 400 Mid Cap Index, that leaves 92 stocks with at least 75% &#34;buy&#34; ratings. Here at the 20 expected to rise the most over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td><a href=\"https://laohu8.com/S/RUN\">Sunrun Inc.</a></td><td>RUN</td><td>Alternative Power Generation</td><td>$34.01</td><td>$72.61</td><td>113%</td><td>77%</td><td>-51%</td></tr><tr><td><a href=\"https://laohu8.com/S/APPS\">Digital Turbine Inc.</a></td><td>APPS</td><td>Software</td><td>$62.84</td><td>$104.00</td><td>65%</td><td>100%</td><td>11%</td></tr><tr><td>Jazz Pharmaceuticals Public Ltd. Co.</td><td>JAZZ</td><td>Pharmaceuticals</td><td>$128.26</td><td>$200.89</td><td>57%</td><td>90%</td><td>-22%</td></tr><tr><td>Lithia Motors Inc.</td><td>LAD</td><td>Specialty Stores</td><td>$297.17</td><td>$460.31</td><td>55%</td><td>80%</td><td>2%</td></tr><tr><td><a href=\"https://laohu8.com/S/CRNC\">Cerence Inc.</a></td><td>CRNC</td><td>Software</td><td>$77.59</td><td>$119.42</td><td>54%</td><td>100%</td><td>-23%</td></tr><tr><td>Callaway Golf Co.</td><td>ELY</td><td>Recreational Products</td><td>$27.63</td><td>$41.50</td><td>50%</td><td>77%</td><td>15%</td></tr><tr><td>Ziff Davis Inc.</td><td>ZD</td><td>Internet Software, Services</td><td>$111.37</td><td>$166.88</td><td>50%</td><td>100%</td><td>31%</td></tr><tr><td>Victoria&#39;s Secret &amp; Co.</td><td>VSCO</td><td>Apparel, Footwear Retail</td><td>$55.46</td><td>$82.73</td><td>49%</td><td>82%</td><td>N/A</td></tr><tr><td>LiveRamp Holdings Inc.</td><td>RAMP</td><td>Data Processing Services</td><td>$49.07</td><td>$73.18</td><td>49%</td><td>82%</td><td>-33%</td></tr><tr><td>PROG Holdings Inc.</td><td>PRG</td><td>Finance, Rental, Leasing</td><td>$44.84</td><td>$66.29</td><td>48%</td><td>75%</td><td>-17%</td></tr></tbody></table><table><tbody><tr><td><a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> Inc.</td><td>MLKN</td><td>Office Equipment, Supplies</td><td>$38.98</td><td>$57.60</td><td>48%</td><td>80%</td><td>17%</td></tr><tr><td>ChampionX Corp.</td><td>CHX</td><td>Chemicals: Specialty</td><td>$20.01</td><td>$29.00</td><td>45%</td><td>80%</td><td>31%</td></tr><tr><td>Darling Ingredients Inc.</td><td>DAR</td><td>Agricultural Commodities, Milling</td><td>$67.87</td><td>$96.79</td><td>43%</td><td>100%</td><td>18%</td></tr><tr><td>Axon Enterprise Inc.</td><td>AXON</td><td>Aerospace &amp; Defense</td><td>$156.07</td><td>$222.40</td><td>43%</td><td>91%</td><td>27%</td></tr><tr><td>EQT Corp.</td><td>EQT</td><td>Oil &amp; Gas Production</td><td>$22.04</td><td>$31.30</td><td>42%</td><td>75%</td><td>73%</td></tr><tr><td><a href=\"https://laohu8.com/S/IAA\">IAA Inc</a>.</td><td>IAA</td><td>Specialty Stores</td><td>$50.43</td><td>$70.88</td><td>41%</td><td>90%</td><td>-22%</td></tr><tr><td><a href=\"https://laohu8.com/S/HQY\">HealthEquity</a> Inc.</td><td>HQY</td><td>Investment Managers</td><td>$43.86</td><td>$61.50</td><td>40%</td><td>75%</td><td>-37%</td></tr><tr><td><a href=\"https://laohu8.com/S/AZTA\">Azenta</a> Inc.</td><td>AZTA</td><td>Electronic Production Equipment</td><td>$103.18</td><td>$144.60</td><td>40%</td><td>83%</td><td>53%</td></tr><tr><td>Vontier Corp</td><td>VNT</td><td>Transportation</td><td>$30.89</td><td>$42.82</td><td>39%</td><td>77%</td><td>-7%</td></tr><tr><td>SailPoint Technologies Holdings Inc.</td><td>SAIL</td><td>Software</td><td>$48.85</td><td>$67.67</td><td>39%</td><td>93%</td><td>-8%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>Small-cap favorites for 2022</b></p><p>Among the S&amp;P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% &#34;buy&#34; ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>UniQure NV</td><td>QURE</td><td>Biotechnology</td><td>$20.87</td><td>$63.78</td><td>206%</td><td>89%</td><td>-42%</td></tr><tr><td><a href=\"https://laohu8.com/S/TCMD\">Tactile Systems Technology Inc</a>.</td><td>TCMD</td><td>Medical Specialties</td><td>$19.23</td><td>$52.25</td><td>172%</td><td>100%</td><td>-57%</td></tr><tr><td>Zynex Inc.</td><td>ZYXI</td><td>Medical Specialties</td><td>$10.23</td><td>$22.20</td><td>117%</td><td>80%</td><td>-24%</td></tr><tr><td>Cara Therapeutics Inc.</td><td>CARA</td><td>Biotechnology</td><td>$12.34</td><td>$26.25</td><td>113%</td><td>75%</td><td>-18%</td></tr><tr><td><a href=\"https://laohu8.com/S/TREE\">LendingTree</a> Inc.</td><td>TREE</td><td>Finance, Rental, Leasing</td><td>$121.91</td><td>$238.75</td><td>96%</td><td>100%</td><td>-55%</td></tr><tr><td>Joint Corp</td><td>JYNT</td><td>Hospital, Nursing Management</td><td>$64.62</td><td>$126.00</td><td>95%</td><td>83%</td><td>146%</td></tr><tr><td>Talos Energy Inc.</td><td>TALO</td><td>Oil &amp; Gas Production</td><td>$10.07</td><td>$19.00</td><td>89%</td><td>100%</td><td>22%</td></tr><tr><td><a href=\"https://laohu8.com/S/REGI\">Renewable Energy Group</a> Inc.</td><td>REGI</td><td>Chemicals</td><td>$42.78</td><td>$79.86</td><td>87%</td><td>80%</td><td>-40%</td></tr><tr><td><a href=\"https://laohu8.com/S/LPSN\">LivePerson</a> Inc.</td><td>LPSN</td><td>Internet Software, Services</td><td>$36.59</td><td>$64.31</td><td>76%</td><td>79%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/BLFS\">BioLife Solutions Inc.</a></td><td>BLFS</td><td>Medical Specialties</td><td>$37.44</td><td>$63.43</td><td>69%</td><td>78%</td><td>-6%</td></tr><tr><td>OptimizeRx Corp.</td><td>OPRX</td><td>Data Processing Services</td><td>$61.14</td><td>$103.00</td><td>68%</td><td>100%</td><td>96%</td></tr><tr><td>Cutera Inc.</td><td>CUTR</td><td>Medical Specialties</td><td>$39.26</td><td>$63.40</td><td>61%</td><td>100%</td><td>63%</td></tr><tr><td><a href=\"https://laohu8.com/S/SEM\">Select Medical Holdings</a> Corp.</td><td>SEM</td><td>Hospital, Nursing Management</td><td>$29.82</td><td>$47.40</td><td>59%</td><td>80%</td><td>9%</td></tr><tr><td>Hibbett Inc.</td><td>HIBB</td><td>Specialty Stores</td><td>$72.00</td><td>$112.17</td><td>56%</td><td>83%</td><td>57%</td></tr><tr><td><a href=\"https://laohu8.com/S/PLMR\">Palomar Holdings</a> Inc.</td><td>PLMR</td><td>Property/ Casualty Insurance</td><td>$63.76</td><td>$99.14</td><td>55%</td><td>78%</td><td>-28%</td></tr><tr><td>Coherus BioSciences Inc.</td><td>CHRS</td><td>Biotechnology</td><td>$16.74</td><td>$25.43</td><td>52%</td><td>86%</td><td>-4%</td></tr><tr><td>Celsius Holdings Inc.</td><td>CELH</td><td>Beverages: Non-Alcoholic</td><td>$73.52</td><td>$110.21</td><td>50%</td><td>75%</td><td>46%</td></tr><tr><td>James River Group Holdings Ltd.</td><td>JRVR</td><td>Property/ Casualty Insurance</td><td>$28.14</td><td>$41.86</td><td>49%</td><td>75%</td><td>-41%</td></tr><tr><td><a href=\"https://laohu8.com/S/NEO\">NeoGenomics</a> Inc.</td><td>NEO</td><td>Medical/ Nursing Services</td><td>$34.15</td><td>$50.18</td><td>47%</td><td>92%</td><td>-37%</td></tr><tr><td>Vericel Corp.</td><td>VCEL</td><td>Medical Specialties</td><td>$40.11</td><td>$58.46</td><td>46%</td><td>100%</td><td>30%</td></tr><tr><td></td><td>Source: FactSet</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><p><b>All 30 components of the Dow Jones Industrial Average</b></p><p>Here they are, ranked by how much analysts expect them to rise over the next year:</p><table><tbody><tr><td>Company</td><td>Ticker</td><td>Industry</td><td>Closing price -- Dec. 30</td><td>Consensus price target</td><td>Implied 12-month upside potential</td><td>Share &#34;buy&#34; ratings</td><td>Total return -- 2021 through Dec. 30</td></tr><tr><td>Salesforce.com Inc.</td><td>CRM</td><td>Software</td><td>$255.33</td><td>$331.46</td><td>30%</td><td>86%</td><td>15%</td></tr><tr><td>Boeing Co.</td><td>BA</td><td>Aerospace &amp; Defense</td><td>$202.71</td><td>$259.61</td><td>28%</td><td>73%</td><td>-5%</td></tr><tr><td><a href=\"https://laohu8.com/S/V\">Visa</a> Inc. Class A</td><td>V</td><td>Finance, Rental, Leasing</td><td>$217.87</td><td>$272.62</td><td>25%</td><td>92%</td><td>0%</td></tr><tr><td>Walt Disney Co.</td><td>DIS</td><td>Cable, Satellite TV</td><td>$155.93</td><td>$193.29</td><td>24%</td><td>70%</td><td>-14%</td></tr><tr><td>Merck &amp; Co. Inc.</td><td>MRK</td><td>Pharmaceuticals</td><td>$77.14</td><td>$92.70</td><td>20%</td><td>60%</td><td>2%</td></tr><tr><td>Goldman Sachs Group Inc.</td><td>GS</td><td>Investment Banks, Brokers</td><td>$385.52</td><td>$458.97</td><td>19%</td><td>67%</td><td>49%</td></tr><tr><td>Walmart Inc.</td><td>WMT</td><td>Food Retail</td><td>$143.17</td><td>$169.92</td><td>19%</td><td>80%</td><td>1%</td></tr><tr><td>Dow Inc.</td><td>DOW</td><td>Chemicals</td><td>$56.78</td><td>$66.62</td><td>17%</td><td>36%</td><td>7%</td></tr><tr><td>American Express Co.</td><td>AXP</td><td>Finance, Rental, Leasing</td><td>$164.16</td><td>$191.35</td><td>17%</td><td>46%</td><td>37%</td></tr><tr><td>Honeywell International Inc.</td><td>HON</td><td>Industrial Conglomerates</td><td>$207.11</td><td>$238.27</td><td>15%</td><td>48%</td><td>-1%</td></tr></tbody></table><p><table><tbody><tr><td>Caterpillar Inc.</td><td>CAT</td><td>Trucks, Construction, Farm Machinery</td><td>$206.08</td><td>$235.57</td><td>14%</td><td>52%</td><td>16%</td></tr><tr><td>Verizon Communications Inc.</td><td>VZ</td><td>Telecommunications</td><td>$52.25</td><td>$59.57</td><td>14%</td><td>27%</td><td>-7%</td></tr><tr><td>JPMorgan Chase &amp; Co.</td><td>JPM</td><td>Major Banks</td><td>$158.48</td><td>$179.70</td><td>13%</td><td>61%</td><td>28%</td></tr><tr><td>Chevron Corp.</td><td>CVX</td><td>Integrated Oil</td><td>$117.43</td><td>$130.74</td><td>11%</td><td>67%</td><td>46%</td></tr><tr><td>Nike Inc. Class B</td><td>NKE</td><td>Apparel, Footwear</td><td>$167.49</td><td>$185.89</td><td>11%</td><td>77%</td><td>19%</td></tr><tr><td>Microsoft Corp.</td><td>MSFT</td><td>Software</td><td>$339.32</td><td>$370.51</td><td>9%</td><td>90%</td><td>54%</td></tr><tr><td>3M Co.</td><td>MMM</td><td>Industrial Conglomerates</td><td>$177.64</td><td>$192.06</td><td>8%</td><td>14%</td><td>5%</td></tr><tr><td>Coca-Cola Co.</td><td>KO</td><td>Beverages: Non-Alcoholic</td><td>$58.78</td><td>$62.67</td><td>7%</td><td>61%</td><td>11%</td></tr><tr><td>Johnson &amp; Johnson</td><td>JNJ</td><td>Pharmaceuticals</td><td>$172.31</td><td>$183.71</td><td>7%</td><td>50%</td><td>12%</td></tr><tr><td>Intel Corp.</td><td>INTC</td><td>Semiconductors</td><td>$51.74</td><td>$54.91</td><td>6%</td><td>27%</td><td>7%</td></tr><tr><td>International Business Machines Corp.</td><td>IBM</td><td>Information Technology Services</td><td>$133.91</td><td>$142.07</td><td>6%</td><td>28%</td><td>17%</td></tr><tr><td>Amgen Inc.</td><td>AMGN</td><td>Biotechnology</td><td>$226.47</td><td>$238.09</td><td>5%</td><td>31%</td><td>2%</td></tr><tr><td>Travelers Companies Inc.</td><td>TRV</td><td>Multi-Line Insurance</td><td>$156.81</td><td>$164.06</td><td>5%</td><td>26%</td><td>14%</td></tr><tr><td>McDonald’s Corp.</td><td>MCD</td><td>Restaurants</td><td>$267.21</td><td>$276.06</td><td>3%</td><td>70%</td><td>27%</td></tr><tr><td>Home Depot Inc.</td><td>HD</td><td>Home Improvement Chains</td><td>$409.94</td><td>$416.83</td><td>2%</td><td>65%</td><td>58%</td></tr><tr><td>Walgreens Boots Alliance Inc.</td><td>WBA</td><td>Drugstore Chains</td><td>$51.99</td><td>$52.80</td><td>2%</td><td>5%</td><td>35%</td></tr><tr><td>UnitedHealth Group Inc.</td><td>UNH</td><td>Managed Health Care</td><td>$504.43</td><td>$504.20</td><td>0%</td><td>86%</td><td>46%</td></tr><tr><td>Apple Inc.</td><td>AAPL</td><td>Telecommunications Equipment</td><td>$178.20</td><td>$175.81</td><td>-1%</td><td>79%</td><td>35%</td></tr><tr><td>Cisco Systems Inc.</td><td>CSCO</td><td>Information Technology Services</td><td>$63.62</td><td>$62.69</td><td>-1%</td><td>54%</td><td>46%</td></tr><tr><td>Procter &amp; Gamble Co.</td><td>PG</td><td>Household, Personal Care</td><td>$162.77</td><td>$156.67</td><td>-4%</td><td>54%</td><td>20%</td></tr><tr><td>Source: FactSet</td></tr></tbody></table></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALK":"阿拉斯加航空集团有限公司","GM":"通用汽车","CZR":"凯撒娱乐","AAPL":"苹果","LUV":"西南航空","BK4500":"航空公司","BK4008":"航空公司","BK4561":"索罗斯持仓","BK4214":"汽车零售","PYPL":"PayPal","LAD":"利西亚车行"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195410116","content_text":"General Motors, Salesforce and PayPal are among the 20 S&P 500 stocks that analysts both heavily favor and expect to rise to the mostWall Street analysts on average expect the stock price of Caesars Entertainment to climb 48% over the next 12 months.As the coronavirus pandemic has stretched out, investors have continued to pour money into stocks, in part because the alternatives have been dismal. Why bother with 10-year U.S. Treasury bonds that yield a paltry 1.52% when the S&P 500 index has a dividend yield of 1.30% to go along with its growth potential?Things may change in 2022 as the Federal Reserve winds down its bond purchases that have kept long-term interest rates low. Then again, U.S. stocks have continued to rise since the Fed announced its policy changes on Dec. 15.With U.S. bond yields already so much higher than they are in the rest of the developed world, foreign investors may continue to buy U.S. bonds and keep yields at historically low levels. And that might make for a continued flow of money into U.S. stocks.Below are lists of stocks among the benchmark S&P 500 , the S&P 400 Mid Cap Index $(MID)$ and the S&P Small Cap 600 Index  that are rated \"buy\" or the equivalent by at least three out of four of Wall Street analysts polled by FactSet that are expected to rise the most over the next year. Those lists are followed by a summary of analysts' opinions of all 30 stocks in the Dow Jones Industrial Average.Large-cap favoritesAmong the S&P 500, 93 stocks are rated a \"buy\" or the equivalent by at least 75% of analysts working for brokerage firms. Here are the 20 the analysts expect to rise the most over the next year, based on consensus price targets:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Alaska Air Group Inc.ALKAirlines$51.94$77.7150%93%0%Caesars Entertainment Inc.CZRCasinos/ Gaming$92.99$137.3648%94%25%Generac Holdings Inc.GNRCElectrical Products$352.96$514.1146%77%55%PayPal Holdings Inc.PYPLData Processing Services$191.88$273.6543%84%-18%T-Mobile US Inc.TMUSWireless Telecommunications$116.51$165.5142%81%-14%News Corp. Class ANWSAPublishing: Newspapers$22.50$31.9142%88%26%Global Payments Inc.GPNData Processing Services$136.29$188.4138%85%-36%Southwest Airlines Co.LUVAirlines$42.72$57.3234%78%-8%Schlumberger NVSLBOilfield Services/ Equipment$29.82$39.5833%85%39%Salesforce.com Inc.CRMSoftware$255.33$331.4630%86%15%Bath & Body Works Inc.BBWIApparel, Footwear Retail$69.70$90.2129%86%133%Electronic Arts Inc.EARecreational Products$134.46$173.7829%77%-6%Phillips 66PSXOil Refining/ Marketing$72.45$93.5029%79%8%Medtronic PLCMDTMedical Specialties$104.47$134.5229%85%-9%Teleflex Inc.TFXMedical Specialties$330.89$424.1128%75%-19%General Motors Co.GMMotor Vehicles$58.13$74.4528%84%40%Pioneer Natural Resources Co.PXDOil & Gas Production$181.28$231.6128%86%66%Synchrony FinancialSYFFinance, Rental, Leasing$46.26$58.7427%77%36%Comcast Corp. Class ACMCSACable, Satellite TV$50.59$64.0827%79%-2%EOG Resources Inc.EOGOil & Gas Production$89.18$112.9427%79%89%Source: FactSetAlaska Air Group Inc. tops the list of analysts' favorite large-cap stocks for 2022. The shares were flat for 2021, as investors were understandably disappointed that the travel industry's recovery was stalled by new waves of coronavirus infections. Other travel and hospitality-related recovery plays on the list include Caesars Entertainment Inc.  and Southwest Airlines Co..There are four oil-related stocks on the list, three of which rose significantly during 2021. West Texas Crude oil  was up 59% for 2021 through Dec. 30 based on forward-month contracts, while the S&P 500 energy sector returned 54%.Other stocks on the list that performed very well during 2021 and are expected to do so again in 2022 include Generac Holdings Inc., Bath & Body Works Inc. and General Motors Co..Midcap stocks expected to show the biggest gainsThe lists of \"favorite\" stocks are confined to those covered by at least five analysts. Among components of the S&P 400 Mid Cap Index, that leaves 92 stocks with at least 75% \"buy\" ratings. Here at the 20 expected to rise the most over the next year:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Sunrun Inc.RUNAlternative Power Generation$34.01$72.61113%77%-51%Digital Turbine Inc.APPSSoftware$62.84$104.0065%100%11%Jazz Pharmaceuticals Public Ltd. Co.JAZZPharmaceuticals$128.26$200.8957%90%-22%Lithia Motors Inc.LADSpecialty Stores$297.17$460.3155%80%2%Cerence Inc.CRNCSoftware$77.59$119.4254%100%-23%Callaway Golf Co.ELYRecreational Products$27.63$41.5050%77%15%Ziff Davis Inc.ZDInternet Software, Services$111.37$166.8850%100%31%Victoria's Secret & Co.VSCOApparel, Footwear Retail$55.46$82.7349%82%N/ALiveRamp Holdings Inc.RAMPData Processing Services$49.07$73.1849%82%-33%PROG Holdings Inc.PRGFinance, Rental, Leasing$44.84$66.2948%75%-17%MillerKnoll Inc.MLKNOffice Equipment, Supplies$38.98$57.6048%80%17%ChampionX Corp.CHXChemicals: Specialty$20.01$29.0045%80%31%Darling Ingredients Inc.DARAgricultural Commodities, Milling$67.87$96.7943%100%18%Axon Enterprise Inc.AXONAerospace & Defense$156.07$222.4043%91%27%EQT Corp.EQTOil & Gas Production$22.04$31.3042%75%73%IAA Inc.IAASpecialty Stores$50.43$70.8841%90%-22%HealthEquity Inc.HQYInvestment Managers$43.86$61.5040%75%-37%Azenta Inc.AZTAElectronic Production Equipment$103.18$144.6040%83%53%Vontier CorpVNTTransportation$30.89$42.8239%77%-7%SailPoint Technologies Holdings Inc.SAILSoftware$48.85$67.6739%93%-8%Source: FactSetSmall-cap favorites for 2022Among the S&P Small Cap 600, 101 stocks covered by at least five analysts have at least 75% \"buy\" ratings. Analysts expect these 20 of the favored stocks to rise the most over the next 12 months:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30UniQure NVQUREBiotechnology$20.87$63.78206%89%-42%Tactile Systems Technology Inc.TCMDMedical Specialties$19.23$52.25172%100%-57%Zynex Inc.ZYXIMedical Specialties$10.23$22.20117%80%-24%Cara Therapeutics Inc.CARABiotechnology$12.34$26.25113%75%-18%LendingTree Inc.TREEFinance, Rental, Leasing$121.91$238.7596%100%-55%Joint CorpJYNTHospital, Nursing Management$64.62$126.0095%83%146%Talos Energy Inc.TALOOil & Gas Production$10.07$19.0089%100%22%Renewable Energy Group Inc.REGIChemicals$42.78$79.8687%80%-40%LivePerson Inc.LPSNInternet Software, Services$36.59$64.3176%79%-41%BioLife Solutions Inc.BLFSMedical Specialties$37.44$63.4369%78%-6%OptimizeRx Corp.OPRXData Processing Services$61.14$103.0068%100%96%Cutera Inc.CUTRMedical Specialties$39.26$63.4061%100%63%Select Medical Holdings Corp.SEMHospital, Nursing Management$29.82$47.4059%80%9%Hibbett Inc.HIBBSpecialty Stores$72.00$112.1756%83%57%Palomar Holdings Inc.PLMRProperty/ Casualty Insurance$63.76$99.1455%78%-28%Coherus BioSciences Inc.CHRSBiotechnology$16.74$25.4352%86%-4%Celsius Holdings Inc.CELHBeverages: Non-Alcoholic$73.52$110.2150%75%46%James River Group Holdings Ltd.JRVRProperty/ Casualty Insurance$28.14$41.8649%75%-41%NeoGenomics Inc.NEOMedical/ Nursing Services$34.15$50.1847%92%-37%Vericel Corp.VCELMedical Specialties$40.11$58.4646%100%30%Source: FactSetAll 30 components of the Dow Jones Industrial AverageHere they are, ranked by how much analysts expect them to rise over the next year:CompanyTickerIndustryClosing price -- Dec. 30Consensus price targetImplied 12-month upside potentialShare \"buy\" ratingsTotal return -- 2021 through Dec. 30Salesforce.com Inc.CRMSoftware$255.33$331.4630%86%15%Boeing Co.BAAerospace & Defense$202.71$259.6128%73%-5%Visa Inc. Class AVFinance, Rental, Leasing$217.87$272.6225%92%0%Walt Disney Co.DISCable, Satellite TV$155.93$193.2924%70%-14%Merck & Co. Inc.MRKPharmaceuticals$77.14$92.7020%60%2%Goldman Sachs Group Inc.GSInvestment Banks, Brokers$385.52$458.9719%67%49%Walmart Inc.WMTFood Retail$143.17$169.9219%80%1%Dow Inc.DOWChemicals$56.78$66.6217%36%7%American Express Co.AXPFinance, Rental, Leasing$164.16$191.3517%46%37%Honeywell International Inc.HONIndustrial Conglomerates$207.11$238.2715%48%-1%Caterpillar Inc.CATTrucks, Construction, Farm Machinery$206.08$235.5714%52%16%Verizon Communications Inc.VZTelecommunications$52.25$59.5714%27%-7%JPMorgan Chase & Co.JPMMajor Banks$158.48$179.7013%61%28%Chevron Corp.CVXIntegrated Oil$117.43$130.7411%67%46%Nike Inc. Class BNKEApparel, Footwear$167.49$185.8911%77%19%Microsoft Corp.MSFTSoftware$339.32$370.519%90%54%3M Co.MMMIndustrial Conglomerates$177.64$192.068%14%5%Coca-Cola Co.KOBeverages: Non-Alcoholic$58.78$62.677%61%11%Johnson & JohnsonJNJPharmaceuticals$172.31$183.717%50%12%Intel Corp.INTCSemiconductors$51.74$54.916%27%7%International Business Machines Corp.IBMInformation Technology Services$133.91$142.076%28%17%Amgen Inc.AMGNBiotechnology$226.47$238.095%31%2%Travelers Companies Inc.TRVMulti-Line Insurance$156.81$164.065%26%14%McDonald’s Corp.MCDRestaurants$267.21$276.063%70%27%Home Depot Inc.HDHome Improvement Chains$409.94$416.832%65%58%Walgreens Boots Alliance Inc.WBADrugstore Chains$51.99$52.802%5%35%UnitedHealth Group Inc.UNHManaged Health Care$504.43$504.200%86%46%Apple Inc.AAPLTelecommunications Equipment$178.20$175.81-1%79%35%Cisco Systems Inc.CSCOInformation Technology Services$63.62$62.69-1%54%46%Procter & Gamble Co.PGHousehold, Personal Care$162.77$156.67-4%54%20%Source: FactSet","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001895708,"gmtCreate":1641210647424,"gmtModify":1676533583075,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"✅&nbsp;","listText":"✅&nbsp;","text":"✅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001895708","repostId":"2200213634","repostType":4,"repost":{"id":"2200213634","pubTimestamp":1641210575,"share":"https://ttm.financial/m/news/2200213634?lang=&edition=fundamental","pubTime":"2022-01-03 19:49","market":"us","language":"en","title":"3 Biotech Stocks That Could Double in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200213634","media":"Motley Fool","summary":"They're risky. But with the high risk comes the potential for high rewards.","content":"<html><head></head><body><p>Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.</p><p>We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here&#39;s why they picked <b>Adicet Bio</b> (NASDAQ:ACET), <b><a href=\"https://laohu8.com/S/CCXI\">ChemoCentryx</a></b> (NASDAQ:CCXI), and <b>NRx Pharmaceuticals</b> (NASDAQ:NRXP).</p><h2>Turning off-the-shelf CAR-T therapy hype into reality</h2><p><b>Keith Speights (Adicet Bio)</b>: Current chimeric antigen receptor T-cell (CAR-T) therapies require the patient&#39;s own T cells to be genetically engineered then infused back into their bodies. It&#39;s an expensive and time-consuming process.</p><p>There&#39;s been a lot of hype in recent years, though, about the potential for allogeneic CAR-T therapies. These are often referred to as &#34;off-the-shelf&#34; CAR-T therapies. The T cells of individuals other than the patient are modified to fight specific types of cancer in advance. As a result, the costs and time involved are much lower than current CAR-T therapies.</p><p>Adicet Bio is well on its way to turning the hype about off-the-shelf CAR-T therapies into reality. The company reported overwhelmingly positive results in early December from a phase 1 study of ADI-001 in treating non-Hodgkin&#39;s lymphoma. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> patients had complete responses (full remission). Another patient had a near-complete response.</p><p>Granted, this was only interim data from a phase 1 study. It&#39;s still really early, and there are plenty of hurdles left to jump. However, Adicet&#39;s prospects look good at this point.</p><p>Even after its huge gain following this announcement, Adicet&#39;s market cap remains below $650 million. The biotech plans to report additional data for ADI-001 in the first half of 2022. If those results confirm Adicet&#39;s interim data, I suspect this stock could double or more in the new year.</p><h2>A new drug could be a big winner in 2022</h2><p><b>David Jagielski</b> <b>(ChemoCentryx): </b>A promising mid-cap company that has strong sales potential can bring investors the right mix of a stock that may double in value. With ChemoCentryx, its $2.6 billion market cap isn&#39;t terribly large, and there&#39;s plenty of room for its valuation to rise. Its current price-to-sales multiple of 77 suggests that it is wildly overpriced, but that number is going to come down in the future.</p><p>That&#39;s because the U.S. Food and Drug Administration (FDA) approved Tavneos (avacopan) in October. The drug, which treats people with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (an autoimmune disease that can inflame small blood vessels), could generate close to $2 billion in annual revenue at its peak, according to analyst estimates. Although ChemoCentryx likely won&#39;t get close to that figure for years, it&#39;s on the right path, and the approval should at least bolster the company&#39;s top line in 2022.</p><p>ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner <b>Vifor </b>for $20 million was the key reason the company&#39;s sales grew to $17.7 million for the period ending Sept. 30, representing a year-over-year increase of 249%.</p><p>Once ChemoCentryx provides numbers as to how many patients are being prescribed Tavneos in the U.S., the stock could get a boost, assuming those figures are encouraging. Although ChemoCentryx stock initially jumped on news of its U.S. approval on Oct. 8 from less than $20 a share to more than $38, it&#39;s still nowhere near the more than $60 it was at a year ago. And that was before there was an approval to rally around.</p><p>With ChemoCentryx now likely to start generating sales from Tavneos in 2022, plus the company pursuing indications for it, there&#39;s plenty of reason to be bullish on the stock in the near term. Multiple analysts have set price targets of over $100 for the stock, more than double from where it is today. ChemoCentryx looks like a promising stock to hold entering the new year, and doubling in value appears to be a very realistic prospect for investors.</p><h2>A high-risk, high-reward play</h2><p><b>Prosper Junior Bakiny (NRx Pharmaceuticals):</b> Things have been tough for NRx Pharmaceuticals in the past couple of months. While the company hoped to carve out a niche in the market for drugs that treat COVID-19, it ran into regulatory troubles. The FDA declined to grant emergency use authorization (EUA) to the company&#39;s experimental coronavirus medicine, Zyesami.</p><p>The agency decided against authorizing the medicine because of insufficient data regarding its potential benefits and risks. Naturally, that was a big blow to NRx Pharmaceuticals, a small-cap biotech that currently has no products on the market. But things aren&#39;t over for Zyesami just yet. Since the FDA&#39;s thumbs-down, the medicine has produced more encouraging results.</p><p>On Nov. 29, NRx Pharmaceuticals reported data purporting to show that Zyesami led to substantial improvements in severe COVID-19 patients compared to existing therapies, including <b>Gilead Sciences</b>&#39; remdesivir. NRx Pharmaceuticals also reported more positive safety data for Zyesami in mid-December.</p><p>The company is now moving ahead in its attempt to get Zyesami on the market. On Dec. 29, NRx Pharmaceuticals applied for a breakthrough designation therapy for Zyesami in COVID-19 patients with respiratory failure who have been previously treated with other treatments such as remdesivir, but to no avail. The biotech hopes to earn authorization for its medicine relatively soon, and if that happens, it could send its stock soaring through the roof. NRx Pharmaceuticals currently sports a minuscule market cap of just $290 million.</p><p>The coronavirus pandemic isn&#39;t over. With the advent of new variants of the virus that causes the diseases, such as the omicron variant, thousands are still testing positive each week, with many of them dying. Current therapy options exist, but there will be a need for more effective ones. If NRx Pharmaceuticals&#39; Zyesami earns the green light, its stock could easily double its current levels.</p><p>With that said, risks abound for this biotech. Perhaps the FDA will decline to approve Zyesami once again. NRx Pharmaceuticals is also facing a lawsuit related to the medicine. The biotech does have other pipeline candidates, but at this point, a bet on NRx Pharmaceuticals is largely a bet on the future of Zyesami. That makes the biotech very risky, but the rewards could be huge. Invest accordingly.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Biotech Stocks That Could Double in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Biotech Stocks That Could Double in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.We asked three Motley Fool contributors which biotech stocks they think could double in the...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACET":"艾切托","CCXI":"ChemoCentryx","NRXP":"NRX Pharmaceuticals Inc.","BK4139":"生物科技","BK4007":"制药"},"source_url":"https://www.fool.com/investing/2022/01/03/3-biotech-stocks-that-could-double-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200213634","content_text":"Could you get a twofold return in 2022? Some stocks just might give you a good chance at achieving that goal.We asked three Motley Fool contributors which biotech stocks they think could double in the new year. Here's why they picked Adicet Bio (NASDAQ:ACET), ChemoCentryx (NASDAQ:CCXI), and NRx Pharmaceuticals (NASDAQ:NRXP).Turning off-the-shelf CAR-T therapy hype into realityKeith Speights (Adicet Bio): Current chimeric antigen receptor T-cell (CAR-T) therapies require the patient's own T cells to be genetically engineered then infused back into their bodies. It's an expensive and time-consuming process.There's been a lot of hype in recent years, though, about the potential for allogeneic CAR-T therapies. These are often referred to as \"off-the-shelf\" CAR-T therapies. The T cells of individuals other than the patient are modified to fight specific types of cancer in advance. As a result, the costs and time involved are much lower than current CAR-T therapies.Adicet Bio is well on its way to turning the hype about off-the-shelf CAR-T therapies into reality. The company reported overwhelmingly positive results in early December from a phase 1 study of ADI-001 in treating non-Hodgkin's lymphoma. Two patients had complete responses (full remission). Another patient had a near-complete response.Granted, this was only interim data from a phase 1 study. It's still really early, and there are plenty of hurdles left to jump. However, Adicet's prospects look good at this point.Even after its huge gain following this announcement, Adicet's market cap remains below $650 million. The biotech plans to report additional data for ADI-001 in the first half of 2022. If those results confirm Adicet's interim data, I suspect this stock could double or more in the new year.A new drug could be a big winner in 2022David Jagielski (ChemoCentryx): A promising mid-cap company that has strong sales potential can bring investors the right mix of a stock that may double in value. With ChemoCentryx, its $2.6 billion market cap isn't terribly large, and there's plenty of room for its valuation to rise. Its current price-to-sales multiple of 77 suggests that it is wildly overpriced, but that number is going to come down in the future.That's because the U.S. Food and Drug Administration (FDA) approved Tavneos (avacopan) in October. The drug, which treats people with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (an autoimmune disease that can inflame small blood vessels), could generate close to $2 billion in annual revenue at its peak, according to analyst estimates. Although ChemoCentryx likely won't get close to that figure for years, it's on the right path, and the approval should at least bolster the company's top line in 2022.ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner Vifor for $20 million was the key reason the company's sales grew to $17.7 million for the period ending Sept. 30, representing a year-over-year increase of 249%.Once ChemoCentryx provides numbers as to how many patients are being prescribed Tavneos in the U.S., the stock could get a boost, assuming those figures are encouraging. Although ChemoCentryx stock initially jumped on news of its U.S. approval on Oct. 8 from less than $20 a share to more than $38, it's still nowhere near the more than $60 it was at a year ago. And that was before there was an approval to rally around.With ChemoCentryx now likely to start generating sales from Tavneos in 2022, plus the company pursuing indications for it, there's plenty of reason to be bullish on the stock in the near term. Multiple analysts have set price targets of over $100 for the stock, more than double from where it is today. ChemoCentryx looks like a promising stock to hold entering the new year, and doubling in value appears to be a very realistic prospect for investors.A high-risk, high-reward playProsper Junior Bakiny (NRx Pharmaceuticals): Things have been tough for NRx Pharmaceuticals in the past couple of months. While the company hoped to carve out a niche in the market for drugs that treat COVID-19, it ran into regulatory troubles. The FDA declined to grant emergency use authorization (EUA) to the company's experimental coronavirus medicine, Zyesami.The agency decided against authorizing the medicine because of insufficient data regarding its potential benefits and risks. Naturally, that was a big blow to NRx Pharmaceuticals, a small-cap biotech that currently has no products on the market. But things aren't over for Zyesami just yet. Since the FDA's thumbs-down, the medicine has produced more encouraging results.On Nov. 29, NRx Pharmaceuticals reported data purporting to show that Zyesami led to substantial improvements in severe COVID-19 patients compared to existing therapies, including Gilead Sciences' remdesivir. NRx Pharmaceuticals also reported more positive safety data for Zyesami in mid-December.The company is now moving ahead in its attempt to get Zyesami on the market. On Dec. 29, NRx Pharmaceuticals applied for a breakthrough designation therapy for Zyesami in COVID-19 patients with respiratory failure who have been previously treated with other treatments such as remdesivir, but to no avail. The biotech hopes to earn authorization for its medicine relatively soon, and if that happens, it could send its stock soaring through the roof. NRx Pharmaceuticals currently sports a minuscule market cap of just $290 million.The coronavirus pandemic isn't over. With the advent of new variants of the virus that causes the diseases, such as the omicron variant, thousands are still testing positive each week, with many of them dying. Current therapy options exist, but there will be a need for more effective ones. If NRx Pharmaceuticals' Zyesami earns the green light, its stock could easily double its current levels.With that said, risks abound for this biotech. Perhaps the FDA will decline to approve Zyesami once again. NRx Pharmaceuticals is also facing a lawsuit related to the medicine. The biotech does have other pipeline candidates, but at this point, a bet on NRx Pharmaceuticals is largely a bet on the future of Zyesami. That makes the biotech very risky, but the rewards could be huge. Invest accordingly.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001084274,"gmtCreate":1641104943990,"gmtModify":1676533573029,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001084274","repostId":"2200444738","repostType":4,"repost":{"id":"2200444738","pubTimestamp":1641099600,"share":"https://ttm.financial/m/news/2200444738?lang=&edition=fundamental","pubTime":"2022-01-02 13:00","market":"us","language":"en","title":"If I Could Buy Only 1 Stock in 2022, This Would Be It","url":"https://stock-news.laohu8.com/highlight/detail?id=2200444738","media":"Motley Fool","summary":"Our favorite stock picks for the coming year.","content":"<html><head></head><body><p>We&#39;re firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.</p><p>We asked some of our Fool.com contributors to whittle their favorites down to their top choice to buy in 2022 if they could only pick <a href=\"https://laohu8.com/S/AONE.U\">one</a>. Here&#39;s why <b><a href=\"https://laohu8.com/S/MMM\">3M</a></b> (NYSE:MMM), <b>Brookfield Asset Management </b>(NYSE:BAM), and <b>Brookfield Renewable</b> (NYSE:BEP)(NYSE:BEPC) topped their lists as the one stock they&#39;d buy this year. </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a909bb3cfb7abaedc74cfef9296edc0a\" tg-width=\"700\" tg-height=\"423\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>A diversified giant that&#39;s still on sale</h2><p><b>Reuben Gregg Brewer (3M):</b> Benjamin Graham, renowned value investor and mentor to Warren Buffet, explains that investors are partnered with &#34;Mr. Market,&#34; a mercurial fellow prone to fits of despair and jubilation. When he&#39;s overly excited, you should consider selling to him; when he&#39;s pessimistic, you should think about buying. Right now, Mr. Market is very downbeat on diversified international industrial giant 3M. One way to see this is that the company&#39;s dividend yield, at around 3.3%, is near the top end of its historical range.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/35404c30dd22bffd6cc4a1450aa485c9\" tg-width=\"720\" tg-height=\"433\" width=\"100%\" height=\"auto\"/><span>MMM Dividend Yield data by YCharts</span></p><p>Graham had some other advice when it came to actually selecting stocks. Specifically, he argued that most investors would be wise sticking to large, financially strong companies, with strong dividend histories. 3M stacks up well on these measures. It has a market cap of $100 billion, which makes it a mega-cap stock. Its balance sheet is investment-grade rated by the major credit agencies, so it&#39;s financially strong. And it has increased its dividend annually for over 60 years, making it a very elite Dividend King.</p><p>So why is Mr. Market pessimistic? The answer is a mixture of slowing growth and some product and environmental lawsuits. These are notable problems, but they&#39;re not insurmountable. On the business front, the industrial giant&#39;s operations wax and wane over time just like any other company. Given its history and focus on innovation, it should eventually get back on a better track. As for the lawsuits, they could be costly, but it&#39;s likely that 3M will be able to handle the hit. In the end, this is an attractively priced name with a great history that is dealing with issues that seem transitory.</p><h2>A proven value creator</h2><p><b>Matt DiLallo (Brookfield Asset Management):</b> I like to invest. Because of that, I routinely purchase a variety of stocks. However, if I could only buy one in the coming year, Brookfield Asset Management would be my top choice.</p><p>For starters, I love the company&#39;s management. CEO Bruce Flatt is a personal favorite of mine. He&#39;s right up there with Warren Buffett in my book as one of the best value investors around. I enjoy reading his quarterly letter to shareholders, which Flatt fills with investing and economic insight. He&#39;s also a proven value creator. Since becoming CEO in 2002, he&#39;s helped Brookfield deliver a 15.7% total annualized return, pulverizing the <b>S&amp;P 500</b>&#39;s 10.6% total return during that time frame. </p><p>I also like the company&#39;s business model. Brookfield is a leading global alternative asset manager focused on real estate, infrastructure, and renewable energy -- three of my favorite investing themes. An investment in Brookfield provides broad exposure to those three asset classes and many more. Brookfield invests directly across those themes and manages private equity funds focused on those sectors.</p><p>Finally, Brookfield has enormous upside potential. It expects to double its fee-bearing assets under management over the next five years. Combine that with performance-based earnings on its funds and the compounding value of its balance sheet investments, and it has the potential of generating up to 25% annualized total returns over the next five years. That upside, along with all the other positives, is why I&#39;d buy Brookfield if it were the only stock I could purchase this year. </p><h2>Investors are overlooking the growth potential here</h2><p><b>Neha Chamaria</b> <b>(Brookfield Renewable)</b>: 2021 is turning out to be a record-setting year for global renewable electricity addition, but this could just be the beginning. Yet shares of one of the largest pure-play renewables companies that&#39;s growing at a steady pace have languished this year, which is why Brookfield Renewable would be at the top of my shopping list of stocks to buy in 2022.</p><p>Brookfield Renewable, in fact, generated record funds from operations (FFO) in its third quarter and believes it could grow FFO by nearly 20% per year through 2026 through a combination of organic and inorganic growth. 2021 was also a solid year in terms of growth initiatives, with Brookfield Renewable expanding its U.S. distributed-generation business by nearly five times, signing agreements to acquire multiple late-stage solar development projects in the U.S. and even making meaningful headway in the high-potential green hydrogen space.</p><p>Brookfield Renewable&#39;s current development pipeline is larger than ever, and the company is committed to growing dividends annually by 5% to 9%. That shouldn&#39;t be tough given the solid pace of growth in its FFO. That dividend growth, its dividend yield of 3.4%, and the humongous growth potential in renewable energy are the biggest reasons why I consider Brookfield Renewable a top stock for 2022.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If I Could Buy Only 1 Stock in 2022, This Would Be It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf I Could Buy Only 1 Stock in 2022, This Would Be It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-02 13:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.We asked some of our Fool.com contributors to whittle their favorites down to ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4206":"工业集团企业","BAM":"布鲁克菲尔德资产管理","BEPC":"Brookfield Renewable Corp.","BK4133":"新能源发电业者","BEP":"Brookfield Renewable Partners LP","BK4534":"瑞士信贷持仓","BK4512":"苹果概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4135":"资产管理与托管银行","MMM":"3M"},"source_url":"https://www.fool.com/investing/2022/01/01/if-i-could-buy-only-1-stock-in-2022-this-would-be/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200444738","content_text":"We're firm believers in the benefit of owning a diversified portfolio of stocks. However, we all have our favorite stocks.We asked some of our Fool.com contributors to whittle their favorites down to their top choice to buy in 2022 if they could only pick one. Here's why 3M (NYSE:MMM), Brookfield Asset Management (NYSE:BAM), and Brookfield Renewable (NYSE:BEP)(NYSE:BEPC) topped their lists as the one stock they'd buy this year. Image source: Getty Images.A diversified giant that's still on saleReuben Gregg Brewer (3M): Benjamin Graham, renowned value investor and mentor to Warren Buffet, explains that investors are partnered with \"Mr. Market,\" a mercurial fellow prone to fits of despair and jubilation. When he's overly excited, you should consider selling to him; when he's pessimistic, you should think about buying. Right now, Mr. Market is very downbeat on diversified international industrial giant 3M. One way to see this is that the company's dividend yield, at around 3.3%, is near the top end of its historical range.MMM Dividend Yield data by YChartsGraham had some other advice when it came to actually selecting stocks. Specifically, he argued that most investors would be wise sticking to large, financially strong companies, with strong dividend histories. 3M stacks up well on these measures. It has a market cap of $100 billion, which makes it a mega-cap stock. Its balance sheet is investment-grade rated by the major credit agencies, so it's financially strong. And it has increased its dividend annually for over 60 years, making it a very elite Dividend King.So why is Mr. Market pessimistic? The answer is a mixture of slowing growth and some product and environmental lawsuits. These are notable problems, but they're not insurmountable. On the business front, the industrial giant's operations wax and wane over time just like any other company. Given its history and focus on innovation, it should eventually get back on a better track. As for the lawsuits, they could be costly, but it's likely that 3M will be able to handle the hit. In the end, this is an attractively priced name with a great history that is dealing with issues that seem transitory.A proven value creatorMatt DiLallo (Brookfield Asset Management): I like to invest. Because of that, I routinely purchase a variety of stocks. However, if I could only buy one in the coming year, Brookfield Asset Management would be my top choice.For starters, I love the company's management. CEO Bruce Flatt is a personal favorite of mine. He's right up there with Warren Buffett in my book as one of the best value investors around. I enjoy reading his quarterly letter to shareholders, which Flatt fills with investing and economic insight. He's also a proven value creator. Since becoming CEO in 2002, he's helped Brookfield deliver a 15.7% total annualized return, pulverizing the S&P 500's 10.6% total return during that time frame. I also like the company's business model. Brookfield is a leading global alternative asset manager focused on real estate, infrastructure, and renewable energy -- three of my favorite investing themes. An investment in Brookfield provides broad exposure to those three asset classes and many more. Brookfield invests directly across those themes and manages private equity funds focused on those sectors.Finally, Brookfield has enormous upside potential. It expects to double its fee-bearing assets under management over the next five years. Combine that with performance-based earnings on its funds and the compounding value of its balance sheet investments, and it has the potential of generating up to 25% annualized total returns over the next five years. That upside, along with all the other positives, is why I'd buy Brookfield if it were the only stock I could purchase this year. Investors are overlooking the growth potential hereNeha Chamaria (Brookfield Renewable): 2021 is turning out to be a record-setting year for global renewable electricity addition, but this could just be the beginning. Yet shares of one of the largest pure-play renewables companies that's growing at a steady pace have languished this year, which is why Brookfield Renewable would be at the top of my shopping list of stocks to buy in 2022.Brookfield Renewable, in fact, generated record funds from operations (FFO) in its third quarter and believes it could grow FFO by nearly 20% per year through 2026 through a combination of organic and inorganic growth. 2021 was also a solid year in terms of growth initiatives, with Brookfield Renewable expanding its U.S. distributed-generation business by nearly five times, signing agreements to acquire multiple late-stage solar development projects in the U.S. and even making meaningful headway in the high-potential green hydrogen space.Brookfield Renewable's current development pipeline is larger than ever, and the company is committed to growing dividends annually by 5% to 9%. That shouldn't be tough given the solid pace of growth in its FFO. That dividend growth, its dividend yield of 3.4%, and the humongous growth potential in renewable energy are the biggest reasons why I consider Brookfield Renewable a top stock for 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002943742,"gmtCreate":1641903447991,"gmtModify":1676533660055,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002943742","repostId":"1148381899","repostType":4,"repost":{"id":"1148381899","pubTimestamp":1641902728,"share":"https://ttm.financial/m/news/1148381899?lang=&edition=fundamental","pubTime":"2022-01-11 20:05","market":"us","language":"en","title":"Investing $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income","url":"https://stock-news.laohu8.com/highlight/detail?id=1148381899","media":"Motley Fool","summary":"Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts o","content":"<html><head></head><body><p>Most of us don&#39;t just have a spare $100,000 lying around. But if you did, investing in equal parts of <a href=\"https://laohu8.com/S/AUY\">Yamana</a> Gold (NYSE:AUY), <a href=\"https://laohu8.com/S/KMI\">Kinder Morgan</a> (NYSE:KMI), and <a href=\"https://laohu8.com/S/ALV\">Autoliv</a> (NYSE:ALV) should earn you $4,000 off dividends alone in 2022 while exposing your portfolio to multiple industries.</p><p>Investing in companies that pay sizable dividends can be a great way to supplement income in retirement or simply earn passive, low-tax income without the need to sell securities. However, many high-yield dividend stocks aren&#39;t worth the risk. Yamana Gold, Kinder Morgan, and Autoliv all have strong fundamentals that can back up their dividends. Here&#39;s what makes each a great buy now.</p><p>Dig into this lustrous dividend play</p><p><b>Scott Levine(Yamana Gold):</b>Yes, you&#39;re right. Gold stocks are hardly among the usual suspects that dividend-hungry investors are considering when they&#39;re mining the market for new opportunities. Developing and sustaining gold-producing assets is a capital-intensive endeavor, and mining companies are sensitive to the ups and downs of the market price of gold; consequently, they often refrain from returning significant cash to shareholders. Yamana Gold&#39;s stock and its 3.1% dividend yield, however, looks like a glittering consideration for investors interested in increasing their passive income stream.</p><p>After setting a goal in 2019 to shore up its financial position, Yamana Gold has succeeded in lowering its debt and deleveraging. In the third quarter of 2021, Yamana reduced its debt by $222 million, which helped it to achieve a net debt-to-EBITDA(earnings before interest, taxes, depreciation, and amortization)ratio of 0.3. This secure financial position paired with the fact that the company is generating strong free cash flow -- it grew 59% from the second quarter to the third quarter -- suggests that the company&#39;s well positioned to continue returning capital to shareholders. On the company&#39;sQ3 2021 conference call, for example, Daniel Racine, the company&#39;s CEO, addressed this fact stating that Yamana&#39;s &#34;[b]alance sheet is pristine. So we can afford giving more dividends, buying back more shares, and then continue to invest, if needed, more in Canadian Malartic.&#34; Located in Quebec, Canadian Malartic, in which Yamana has a 50% ownership stake, is Canada&#39;s largest gold-producing project and Yamana&#39;s biggest gold-producing asset.</p><p>Since the price of gold is bound to experience some ups and downs, it&#39;s hard to imagine that Yamana Gold will steadily raise its dividend in each of the coming years. Nonetheless, gaining some exposure in your portfolio with anindustry-leading gold stockis a worthwhile consideration -- <a href=\"https://laohu8.com/S/AONE.U\">one</a> that is especially timely now. Changing hands at 5.5 times operating cash flow, Yamana&#39;s stock is on the discount rack, trading at a discount to its five-year average ratio of 6.3.</p><p>Kinder Morgan has transformed itself into a premier dividend stock</p><p><b>Daniel Foelber(Kinder Morgan):</b>Energy transportation and storage company Kinder Morgan has long underperformed the U.S. stock market as investors favor growth over stalwarts. Yet Kinder Morgan has quietly revolutionized its business since the oil and gas crash of 2014 and 2015, and the market may finally be taking notice.</p><p>Kinder Morgan released expectations for its 2022 financial performance before it has even reported its full-year 2021 results. The forecast included higher earnings per share, EBITDA, up to $750 million in share buybacks, and a $1.11 annualized dividend, up from 2021&#39;s $1.08 annualized dividend. At a current price of $17.17 per share, Kinder Morgan&#39;s forward dividend yield is 6.5% -- which makes itone of the highest yielding<b>S&amp;P 500</b>components.</p><p>What&#39;s more, Kinder Morgan projects it will earn $1.09 in EPS and $2.07 in distributable cash flow (DCF) per share, meaning it can cover its dividend obligation with cash. Kinder Morgan also said it expects to end this year with a net debt-to-adjusted EBITDA ratio of 4.3. Kinder Morgan&#39;s net income tends to vary, so EBITDA and DCF are the preferred metrics it uses to judge its performance and financial health. <a href=\"https://laohu8.com/S/GUID\">Guidance</a> for a 4.3 ratio is below its long-term target of 4.5. For context, Kinder Morgan ended 2020 with a 4.6 debt-to-EBITDA ratio,cut it down to 3.8 at the end of the first half of 2021,and expects to finish 2021 with a ratio of 4.</p><p>In sum, Kinder Morgan is growing its dividend and earnings while maintaining a healthy balance sheet, a sign thatit isn&#39;t overspending during the current healthy oil and gas climate.</p><p>High yields tend to require a baseline amount of risk. But Kinder Morgan has a track record for accurate guidance thanks to much of its business being contracted under long-term obligations. Kinder Morgan stands out as an option worth considering for investors looking for agreat income stock for 2022.</p><p>Autoliv is well set for a recovery in 2022</p><p><b>Lee Samaha(Autoliv):</b>It&#39;s been a challenging couple of years for automakers and their suppliers like Autoliv. <a href=\"https://laohu8.com/S/FBNC\">First</a>, the COVID-19 pandemic hit the sector hard. Next, the economic slowdown initially hit vehicle sales, and then when demand recovered, it became increasingly difficult to keep production flowing due to the pandemic. Meanwhile, the shift in consumer spending patterns created by the stay-at-home measures resulted in asemiconductor shortagethat ultimately restricted production.</p><p>According to industry observers, global light vehicle production will increase by slightly more than 1% in 2021. However, industry observers are expecting high-single-digit growth in production in 2022, and that means it&#39;s time to start looking at theauto parts suppliers.</p><p>As such, the case for buying Autoliv for 2022 doesn&#39;t just rest on its 2.4% dividend yield. <a href=\"https://laohu8.com/S/FFBC\">First</a>, as a leading provider of seatbelts, airbags, and safety wheels, Autoliv is a beneficiary of increased light vehicle production -- Wall Street analysts have the company&#39;s sales rising 15% in 2022.</p><p>Second, management believes it can grow more than the market due to market share gains and an increase in content per vehicle driven by the increasing importance of safety to consumers.</p><p>Third, management has done an excellent job in offsetting margin pressure from lower production volumes and raw material cost increases from 2019 to 2021. Those measures, and hopefully mitigation of cost inflation, could lead to substantial margin expansion in the coming years.</p><p>All told, Autoliv is well positioned to benefit from a multi-year recovery in the auto industry starting in 2022.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting $100,000 in This Basket of Dividend Stocks Should Give You $4,000 in 2022 Income\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts of Yamana Gold (NYSE:AUY), Kinder Morgan (NYSE:KMI), and Autoliv (NYSE:ALV) should earn you $4,000 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALV":"奥托立夫","AUY":"Yamana Gold Inc","KMI":"金德尔摩根"},"source_url":"https://www.fool.com/investing/2022/01/11/investing-100000-in-this-basket-of-dividend-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148381899","content_text":"Most of us don't just have a spare $100,000 lying around. But if you did, investing in equal parts of Yamana Gold (NYSE:AUY), Kinder Morgan (NYSE:KMI), and Autoliv (NYSE:ALV) should earn you $4,000 off dividends alone in 2022 while exposing your portfolio to multiple industries.Investing in companies that pay sizable dividends can be a great way to supplement income in retirement or simply earn passive, low-tax income without the need to sell securities. However, many high-yield dividend stocks aren't worth the risk. Yamana Gold, Kinder Morgan, and Autoliv all have strong fundamentals that can back up their dividends. Here's what makes each a great buy now.Dig into this lustrous dividend playScott Levine(Yamana Gold):Yes, you're right. Gold stocks are hardly among the usual suspects that dividend-hungry investors are considering when they're mining the market for new opportunities. Developing and sustaining gold-producing assets is a capital-intensive endeavor, and mining companies are sensitive to the ups and downs of the market price of gold; consequently, they often refrain from returning significant cash to shareholders. Yamana Gold's stock and its 3.1% dividend yield, however, looks like a glittering consideration for investors interested in increasing their passive income stream.After setting a goal in 2019 to shore up its financial position, Yamana Gold has succeeded in lowering its debt and deleveraging. In the third quarter of 2021, Yamana reduced its debt by $222 million, which helped it to achieve a net debt-to-EBITDA(earnings before interest, taxes, depreciation, and amortization)ratio of 0.3. This secure financial position paired with the fact that the company is generating strong free cash flow -- it grew 59% from the second quarter to the third quarter -- suggests that the company's well positioned to continue returning capital to shareholders. On the company'sQ3 2021 conference call, for example, Daniel Racine, the company's CEO, addressed this fact stating that Yamana's \"[b]alance sheet is pristine. So we can afford giving more dividends, buying back more shares, and then continue to invest, if needed, more in Canadian Malartic.\" Located in Quebec, Canadian Malartic, in which Yamana has a 50% ownership stake, is Canada's largest gold-producing project and Yamana's biggest gold-producing asset.Since the price of gold is bound to experience some ups and downs, it's hard to imagine that Yamana Gold will steadily raise its dividend in each of the coming years. Nonetheless, gaining some exposure in your portfolio with anindustry-leading gold stockis a worthwhile consideration -- one that is especially timely now. Changing hands at 5.5 times operating cash flow, Yamana's stock is on the discount rack, trading at a discount to its five-year average ratio of 6.3.Kinder Morgan has transformed itself into a premier dividend stockDaniel Foelber(Kinder Morgan):Energy transportation and storage company Kinder Morgan has long underperformed the U.S. stock market as investors favor growth over stalwarts. Yet Kinder Morgan has quietly revolutionized its business since the oil and gas crash of 2014 and 2015, and the market may finally be taking notice.Kinder Morgan released expectations for its 2022 financial performance before it has even reported its full-year 2021 results. The forecast included higher earnings per share, EBITDA, up to $750 million in share buybacks, and a $1.11 annualized dividend, up from 2021's $1.08 annualized dividend. At a current price of $17.17 per share, Kinder Morgan's forward dividend yield is 6.5% -- which makes itone of the highest yieldingS&P 500components.What's more, Kinder Morgan projects it will earn $1.09 in EPS and $2.07 in distributable cash flow (DCF) per share, meaning it can cover its dividend obligation with cash. Kinder Morgan also said it expects to end this year with a net debt-to-adjusted EBITDA ratio of 4.3. Kinder Morgan's net income tends to vary, so EBITDA and DCF are the preferred metrics it uses to judge its performance and financial health. Guidance for a 4.3 ratio is below its long-term target of 4.5. For context, Kinder Morgan ended 2020 with a 4.6 debt-to-EBITDA ratio,cut it down to 3.8 at the end of the first half of 2021,and expects to finish 2021 with a ratio of 4.In sum, Kinder Morgan is growing its dividend and earnings while maintaining a healthy balance sheet, a sign thatit isn't overspending during the current healthy oil and gas climate.High yields tend to require a baseline amount of risk. But Kinder Morgan has a track record for accurate guidance thanks to much of its business being contracted under long-term obligations. Kinder Morgan stands out as an option worth considering for investors looking for agreat income stock for 2022.Autoliv is well set for a recovery in 2022Lee Samaha(Autoliv):It's been a challenging couple of years for automakers and their suppliers like Autoliv. First, the COVID-19 pandemic hit the sector hard. Next, the economic slowdown initially hit vehicle sales, and then when demand recovered, it became increasingly difficult to keep production flowing due to the pandemic. Meanwhile, the shift in consumer spending patterns created by the stay-at-home measures resulted in asemiconductor shortagethat ultimately restricted production.According to industry observers, global light vehicle production will increase by slightly more than 1% in 2021. However, industry observers are expecting high-single-digit growth in production in 2022, and that means it's time to start looking at theauto parts suppliers.As such, the case for buying Autoliv for 2022 doesn't just rest on its 2.4% dividend yield. First, as a leading provider of seatbelts, airbags, and safety wheels, Autoliv is a beneficiary of increased light vehicle production -- Wall Street analysts have the company's sales rising 15% in 2022.Second, management believes it can grow more than the market due to market share gains and an increase in content per vehicle driven by the increasing importance of safety to consumers.Third, management has done an excellent job in offsetting margin pressure from lower production volumes and raw material cost increases from 2019 to 2021. Those measures, and hopefully mitigation of cost inflation, could lead to substantial margin expansion in the coming years.All told, Autoliv is well positioned to benefit from a multi-year recovery in the auto industry starting in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005335079,"gmtCreate":1642170860932,"gmtModify":1676533688773,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005335079","repostId":"2203712618","repostType":4,"repost":{"id":"2203712618","pubTimestamp":1642169258,"share":"https://ttm.financial/m/news/2203712618?lang=&edition=fundamental","pubTime":"2022-01-14 22:07","market":"us","language":"en","title":"Can Spotify Become the Next Google?","url":"https://stock-news.laohu8.com/highlight/detail?id=2203712618","media":"Motley Fool","summary":"Spotify's advertising strategy could take the audio industry to the next level.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GOOGL\"><b>Alphabet</b> </a>, the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are certainly a number of factors that have helped Alphabet reach this rare size, the company&#39;s general recipe for success has consisted of pairing eyeballs with unique targeting capabilities for advertisers.</p><p>Though <a href=\"https://laohu8.com/S/SPOT\"><b>Spotify</b> </a> is only a fraction of Alphabet&#39;s size, the audio-streaming giant is trying to replicate that same model, only for ears instead of eyes. Let&#39;s see whether or not the strategy can pay off.</p><h2>Spotify&#39;s advertising model</h2><p>Spotify first got its start by pioneering the &#34;freemium&#34; model for the music industry. After meeting some initial resistance from music labels about an ad-supported experience, Spotify focused most of its efforts on driving subscriptions. However, over the last couple of years, that focus has begun to change.</p><p>With the recent push into alternative forms of audio such as podcasts, audiobooks, live chats, and more, the company&#39;s advertising segment is seeing an increasing focus from Spotify&#39;s management team. CEO Daniel Ek was even quite candid about this on Spotify&#39;s second-quarter conference call when he said, &#34;Admittedly, this is an area where I previously didn&#39;t spend much time, but it&#39;s become impossible to ignore.&#34;</p><p>By the end of this year, Spotify expects to surpass 400 million total monthly active users (MAUs). In order to capitalize on all those ears, Spotify has built out a comprehensive marketplace for advertisers known as the Spotify <a href=\"https://laohu8.com/S/ADNC\">Audience</a> Network (SPAN).</p><p>SPAN allows advertisers of any size to promote their message across different forms of audio while targeting individual users based on their listening habits -- something traditional radio can&#39;t offer. Although the advertising inventory on SPAN is currently limited to podcasts or individual slots in between songs, Spotify has announced plans to add audiobooks to its platform which could serve as yet another audio format for advertisers.</p><h2>Increasing measurability</h2><p>For a long time, measuring the effectiveness of advertising campaigns was difficult. There was even a popular saying in marketing that &#34;half of advertising spend is wasted, the trouble is, you don&#39;t know which half.&#34;</p><p>Fortunately, today this problem is muted. Thanks to companies like Google, not only can advertisers reach a massive audience, but they can also assess the performance of their ad campaigns due to analytics. Audio-based ads, however, haven&#39;t made nearly as much headway in terms of measurability.</p><p>To help address this pain point, last week, Spotify began rolling out call-to-action cards for podcast ads. Now, when advertisers run a podcast ad campaign using the Spotify <a href=\"https://laohu8.com/S/1AZ.SI\">Audience</a> Network, they can include a customizable interactive pop-up with phrases like &#34;buy now&#34; or &#34;download.&#34;</p><p>For example, let&#39;s say <b>Ulta Beauty</b> was running a campaign with a 25% discount and wanted to target females between the ages of 20 and 30 who are in their car and like listening to dating-related podcasts. Spotify could provide that. And on top of it, Ulta can now add a call-to-action card with the phrase &#34;Get Coupon.&#34; This new interactive feature should not only reduce friction for listeners but should also help advertisers assess the effectiveness of their ad spending.</p><h2>Can Spotify become Google?</h2><p>Although comparing any company to Google feels discrediting to the remarkable business Google has built over the years, the value that Spotify provides to advertisers in audio bears a passing resemblance to what companies like Alphabet or <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB) were able to do for the digital advertising space.</p><p>As Spotify continues to build out more functionality and include new types of audio into its advertising network, investors should expect to see the ad segment grow quickly as a percentage of Spotify&#39;s overall revenue. Last quarter, advertising only accounted for 13%, but Ek stated that he believes it could potentially comprise up to 40% or more over the next five to 10 years.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Spotify Become the Next Google?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Spotify Become the Next Google?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alphabet , the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4548":"巴美列捷福持仓","GOOG":"谷歌","SPOT":"Spotify Technology S.A."},"source_url":"https://www.fool.com/investing/2022/01/14/can-spotify-become-the-next-google/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203712618","content_text":"Alphabet , the parent company of the search giant Google, has delivered remarkable financial results over the last two decades and today sits at a market cap of roughly $1.9 trillion. While there are certainly a number of factors that have helped Alphabet reach this rare size, the company's general recipe for success has consisted of pairing eyeballs with unique targeting capabilities for advertisers.Though Spotify  is only a fraction of Alphabet's size, the audio-streaming giant is trying to replicate that same model, only for ears instead of eyes. Let's see whether or not the strategy can pay off.Spotify's advertising modelSpotify first got its start by pioneering the \"freemium\" model for the music industry. After meeting some initial resistance from music labels about an ad-supported experience, Spotify focused most of its efforts on driving subscriptions. However, over the last couple of years, that focus has begun to change.With the recent push into alternative forms of audio such as podcasts, audiobooks, live chats, and more, the company's advertising segment is seeing an increasing focus from Spotify's management team. CEO Daniel Ek was even quite candid about this on Spotify's second-quarter conference call when he said, \"Admittedly, this is an area where I previously didn't spend much time, but it's become impossible to ignore.\"By the end of this year, Spotify expects to surpass 400 million total monthly active users (MAUs). In order to capitalize on all those ears, Spotify has built out a comprehensive marketplace for advertisers known as the Spotify Audience Network (SPAN).SPAN allows advertisers of any size to promote their message across different forms of audio while targeting individual users based on their listening habits -- something traditional radio can't offer. Although the advertising inventory on SPAN is currently limited to podcasts or individual slots in between songs, Spotify has announced plans to add audiobooks to its platform which could serve as yet another audio format for advertisers.Increasing measurabilityFor a long time, measuring the effectiveness of advertising campaigns was difficult. There was even a popular saying in marketing that \"half of advertising spend is wasted, the trouble is, you don't know which half.\"Fortunately, today this problem is muted. Thanks to companies like Google, not only can advertisers reach a massive audience, but they can also assess the performance of their ad campaigns due to analytics. Audio-based ads, however, haven't made nearly as much headway in terms of measurability.To help address this pain point, last week, Spotify began rolling out call-to-action cards for podcast ads. Now, when advertisers run a podcast ad campaign using the Spotify Audience Network, they can include a customizable interactive pop-up with phrases like \"buy now\" or \"download.\"For example, let's say Ulta Beauty was running a campaign with a 25% discount and wanted to target females between the ages of 20 and 30 who are in their car and like listening to dating-related podcasts. Spotify could provide that. And on top of it, Ulta can now add a call-to-action card with the phrase \"Get Coupon.\" This new interactive feature should not only reduce friction for listeners but should also help advertisers assess the effectiveness of their ad spending.Can Spotify become Google?Although comparing any company to Google feels discrediting to the remarkable business Google has built over the years, the value that Spotify provides to advertisers in audio bears a passing resemblance to what companies like Alphabet or Meta Platforms (NASDAQ:FB) were able to do for the digital advertising space.As Spotify continues to build out more functionality and include new types of audio into its advertising network, investors should expect to see the ad segment grow quickly as a percentage of Spotify's overall revenue. Last quarter, advertising only accounted for 13%, but Ek stated that he believes it could potentially comprise up to 40% or more over the next five to 10 years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":745,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003287833,"gmtCreate":1640999392768,"gmtModify":1676533561782,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003287833","repostId":"2195448557","repostType":4,"repost":{"id":"2195448557","pubTimestamp":1640964603,"share":"https://ttm.financial/m/news/2195448557?lang=&edition=fundamental","pubTime":"2021-12-31 23:30","market":"us","language":"en","title":"Could Apple's Market Cap Hit $4 Trillion in 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=2195448557","media":"Motley Fool","summary":"As the Street wonders when Apple can break through the $3 trillion mark, investors should look even further ahead: Is a $4 trillion market cap on the horizon?","content":"<html><head></head><body><p>Shares of technology giant <b>Apple</b> (NASDAQ:AAPL) soared in 2021. As of Dec. 30, the stock had gained 34% in 2021. This put the market cap at more than $2.9 trillion.</p><p>While many recent headlines about the company have focused on its market capitalization approaching $3 trillion, investors might be wise to consider an even more bullish target: $4 trillion. Indeed, a close look at the stock suggests that a $4 trillion market cap could be within reach for the tech company in the near future -- possibly even within 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/759ce68147322ebcd7995f48e3873e6e\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>The path to $4 trillion</h2><p>A close look at Apple stock&#39;s conservative valuation and the company&#39;s broad-based momentum makes a good case for shares being undervalued today, setting the stage for a potential $4 trillion market capitalization in 2022.</p><p>The first way Apple stock could gain is simply through expansion in its valuation multiple. Some megacap stocks trade at substantially higher multiples relative to their free cash flow (FCF) than Apple does. If Apple can close the gap and command a similar premium, multiple expansion alone could help the stock rise substantially.</p><p>Consider that <b>Microsoft</b> (NASDAQ:MSFT) trades at 42 times its free cash flow. Apple, meanwhile, trades at only 31 times its FCF. Apple&#39;s stock price would have to rise 35% for its FCF valuation multiple to match Microsoft&#39;s. This alone would put the company&#39;s market capitalization at about $4 trillion.</p><p>There is actually a good case for Apple stock&#39;s valuation to see multiple expansion in the coming years: The tech giant&#39;s services business, which is a more reliable revenue source than its products, is growing as a percentage of Apple&#39;s total business. With a more predictable and reliable revenue source (that appears to still have lots of upside) increasingly driving Apple&#39;s growth, investors may start rewarding the stock with higher valuation multiples. In fiscal 2021, Apple&#39;s services revenue was 19% of revenue, up from less than 18% of revenue two years ago and 15% three years ago.</p><p>But even without this much multiple expansion, strong fundamentals could lift Apple shares meaningfully in 2022 and beyond. Consider that the company is seeing strong double-digit revenue growth recently, with record fiscal fourth-quarter revenue across every geographic and product segment. Specifically, Apple&#39;s fiscal fourth-quarter revenue came in at $83.4 billion, up from $64.7 billion in the year-ago quarter. But management estimates that revenue for the period would have been $6 billion higher if it weren&#39;t for supply constraints during the period.</p><p>Suffice to say, Apple&#39;s business is firing on all cylinders. With momentum in every geographic and product segment, it wouldn&#39;t be surprising to see double-digit growth rates in the company&#39;s revenue and free cash flow in fiscal 2022, providing solid substance for more share gains.</p><h2>Expect a bumpy ride</h2><p>While it is possible that Apple&#39;s market capitalization swells to $4 trillion before the end of 2022, there are no guarantees in investing. Even if everything goes well for Apple as a business, the stock itself could do poorly in the near term. Sometimes, for one reason or another, stocks fall in and out of favor. So even though shares appear undervalued today, the stock could fall before it rises.</p><p>And there&#39;s always a chance that Apple sees multiple <i>compression</i> instead of multiple expansion. While Apple&#39;s business fundamentals appear worthy of a Microsoft-like premium, the company&#39;s shares have usually traded at a discount to Microsoft&#39;s in terms of valuation multiples because Microsoft&#39;s business model is considered to be more sustainable and less dependent on blockbuster product hits like new iPhones. Apple notably also makes more than half of its sales from a single product: the iPhone. Its heavy reliance on a single product segment generally makes Wall Street view the stock as risker than Microsoft, which has a business primarily made up of recurring revenue from various software and services sources.</p><p>But given Apple&#39;s long history of pricing power, loyal customers, and an ability to bring to market products in entirely new categories every now and then, the tech company will likely keep succeeding -- and its market cap could march toward $4 trillion.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Could Apple's Market Cap Hit $4 Trillion in 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCould Apple's Market Cap Hit $4 Trillion in 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/31/could-apples-market-cap-hit-4-trillion-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of technology giant Apple (NASDAQ:AAPL) soared in 2021. As of Dec. 30, the stock had gained 34% in 2021. This put the market cap at more than $2.9 trillion.While many recent headlines about the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/31/could-apples-market-cap-hit-4-trillion-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4503":"景林资产持仓","MSFT":"微软","BK4097":"系统软件","BK4505":"高瓴资本持仓","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4515":"5G概念","FCF":"第一联邦金融","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4525":"远程办公概念","BK4211":"区域性银行","BK4566":"资本集团","BK4535":"淡马锡持仓","AAPL":"苹果","BK4501":"段永平概念","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4538":"云计算","BK4550":"红杉资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/31/could-apples-market-cap-hit-4-trillion-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195448557","content_text":"Shares of technology giant Apple (NASDAQ:AAPL) soared in 2021. As of Dec. 30, the stock had gained 34% in 2021. This put the market cap at more than $2.9 trillion.While many recent headlines about the company have focused on its market capitalization approaching $3 trillion, investors might be wise to consider an even more bullish target: $4 trillion. Indeed, a close look at the stock suggests that a $4 trillion market cap could be within reach for the tech company in the near future -- possibly even within 2022.Image source: Getty Images.The path to $4 trillionA close look at Apple stock's conservative valuation and the company's broad-based momentum makes a good case for shares being undervalued today, setting the stage for a potential $4 trillion market capitalization in 2022.The first way Apple stock could gain is simply through expansion in its valuation multiple. Some megacap stocks trade at substantially higher multiples relative to their free cash flow (FCF) than Apple does. If Apple can close the gap and command a similar premium, multiple expansion alone could help the stock rise substantially.Consider that Microsoft (NASDAQ:MSFT) trades at 42 times its free cash flow. Apple, meanwhile, trades at only 31 times its FCF. Apple's stock price would have to rise 35% for its FCF valuation multiple to match Microsoft's. This alone would put the company's market capitalization at about $4 trillion.There is actually a good case for Apple stock's valuation to see multiple expansion in the coming years: The tech giant's services business, which is a more reliable revenue source than its products, is growing as a percentage of Apple's total business. With a more predictable and reliable revenue source (that appears to still have lots of upside) increasingly driving Apple's growth, investors may start rewarding the stock with higher valuation multiples. In fiscal 2021, Apple's services revenue was 19% of revenue, up from less than 18% of revenue two years ago and 15% three years ago.But even without this much multiple expansion, strong fundamentals could lift Apple shares meaningfully in 2022 and beyond. Consider that the company is seeing strong double-digit revenue growth recently, with record fiscal fourth-quarter revenue across every geographic and product segment. Specifically, Apple's fiscal fourth-quarter revenue came in at $83.4 billion, up from $64.7 billion in the year-ago quarter. But management estimates that revenue for the period would have been $6 billion higher if it weren't for supply constraints during the period.Suffice to say, Apple's business is firing on all cylinders. With momentum in every geographic and product segment, it wouldn't be surprising to see double-digit growth rates in the company's revenue and free cash flow in fiscal 2022, providing solid substance for more share gains.Expect a bumpy rideWhile it is possible that Apple's market capitalization swells to $4 trillion before the end of 2022, there are no guarantees in investing. Even if everything goes well for Apple as a business, the stock itself could do poorly in the near term. Sometimes, for one reason or another, stocks fall in and out of favor. So even though shares appear undervalued today, the stock could fall before it rises.And there's always a chance that Apple sees multiple compression instead of multiple expansion. While Apple's business fundamentals appear worthy of a Microsoft-like premium, the company's shares have usually traded at a discount to Microsoft's in terms of valuation multiples because Microsoft's business model is considered to be more sustainable and less dependent on blockbuster product hits like new iPhones. Apple notably also makes more than half of its sales from a single product: the iPhone. Its heavy reliance on a single product segment generally makes Wall Street view the stock as risker than Microsoft, which has a business primarily made up of recurring revenue from various software and services sources.But given Apple's long history of pricing power, loyal customers, and an ability to bring to market products in entirely new categories every now and then, the tech company will likely keep succeeding -- and its market cap could march toward $4 trillion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":12,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002429707,"gmtCreate":1642075786756,"gmtModify":1676533678255,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002429707","repostId":"2203376911","repostType":4,"repost":{"id":"2203376911","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642075304,"share":"https://ttm.financial/m/news/2203376911?lang=&edition=fundamental","pubTime":"2022-01-13 20:01","market":"us","language":"en","title":"British lawmakers target Visa and Mastercard fee increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2203376911","media":"Reuters","summary":"LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees Visa    and Ma","content":"<html><head></head><body><p>LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees <a href=\"https://laohu8.com/S/V\">Visa</a>    and Mastercard charge businesses after the country&#39;s payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.</p><p>Parliament&#39;s Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.</p><p>&#34;Given that Visa and Mastercard currently dominate this space, it&#39;s vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,&#34; the chair of the committee, Mel Stride, said in a statement.</p><p>Mastercard and Visa had no immediate comment.</p><p>Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.</p><p>Britain&#39;s Payment Systems Regulator <a href=\"https://laohu8.com/S/PSR\">$(PSR)$</a> said in November that card services did not work well for smaller businesses.</p><p>It told Stride in a letter on Thursday that it will propose &#34;remedies&#34; this month to tackle rising scheme fees, which have doubled between 2014 and 2018.</p><p>&#34;Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,&#34; the PSR said. &#34;Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.&#34;</p><p>Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2374609393fa63a3a37bd24fbdaf2a30\" tg-width=\"725\" tg-height=\"435\" width=\"100%\" height=\"auto\"/><span>PSR Interchange Fees Graphic</span></p><p>Interchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain&#39;s full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.</p><p>The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.</p><p>&#34;Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,&#34; it said.</p><p>Stride said the Treasury committee would discuss the regulator&#39;s plans at a hearing in March.</p><p>Efforts in the EU to end the dominance and Mastercard have had mixed results</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>British lawmakers target Visa and Mastercard fee increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritish lawmakers target Visa and Mastercard fee increases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-13 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees <a href=\"https://laohu8.com/S/V\">Visa</a>    and Mastercard charge businesses after the country&#39;s payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.</p><p>Parliament&#39;s Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.</p><p>&#34;Given that Visa and Mastercard currently dominate this space, it&#39;s vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,&#34; the chair of the committee, Mel Stride, said in a statement.</p><p>Mastercard and Visa had no immediate comment.</p><p>Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.</p><p>Britain&#39;s Payment Systems Regulator <a href=\"https://laohu8.com/S/PSR\">$(PSR)$</a> said in November that card services did not work well for smaller businesses.</p><p>It told Stride in a letter on Thursday that it will propose &#34;remedies&#34; this month to tackle rising scheme fees, which have doubled between 2014 and 2018.</p><p>&#34;Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,&#34; the PSR said. &#34;Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.&#34;</p><p>Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2374609393fa63a3a37bd24fbdaf2a30\" tg-width=\"725\" tg-height=\"435\" width=\"100%\" height=\"auto\"/><span>PSR Interchange Fees Graphic</span></p><p>Interchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain&#39;s full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.</p><p>The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.</p><p>&#34;Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,&#34; it said.</p><p>Stride said the Treasury committee would discuss the regulator&#39;s plans at a hearing in March.</p><p>Efforts in the EU to end the dominance and Mastercard have had mixed results</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4533":"AQR资本管理(全球第二大对冲基金)","MA":"万事达","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4548":"巴美列捷福持仓","BK4566":"资本集团"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203376911","content_text":"LONDON, Jan 13 (Reuters) - British lawmakers plan to scrutinise increases in the fees Visa    and Mastercard charge businesses after the country's payments regulator found no evidence to justify the rises, a parliamentary committee said on Thursday.Parliament's Treasury Select Committee said the companies, whose networks account for 99% of card transactions in Britain, had increased the scheme and interchange fees paid by businesses to card issuers when a card is used.\"Given that Visa and Mastercard currently dominate this space, it's vital to ensure that there is sufficient regulation and competition in the market so that businesses are not subject to ever-increasing servicing costs,\" the chair of the committee, Mel Stride, said in a statement.Mastercard and Visa had no immediate comment.Businesses pay scheme fees to be part of a payments network and interchange fees that are based on individual transactions. Increases in fees merchants pay to card issuers are typically passed on to consumers, regulators have said.Britain's Payment Systems Regulator $(PSR)$ said in November that card services did not work well for smaller businesses.It told Stride in a letter on Thursday that it will propose \"remedies\" this month to tackle rising scheme fees, which have doubled between 2014 and 2018.\"Our analysis indicates a substantial proportion of these increases were not explained by changes in the volume, value or mix of transactions,\" the PSR said. \"Our ongoing engagement with merchants suggests that they have continued to significantly increase since then.\"Amazon.com    said in November it would stop taking payments from Visa credit cards in Britain from mid-January due to rising fees.PSR Interchange Fees GraphicInterchange fees for purchases by British consumers from the European Union rose last year after an EU cap ended due to Britain's full departure from the bloc at the end of 2020. Fees for purchases in Britain, however, remain capped under UK rules.The PSR said it was closely monitoring the increases in cross-border interchange fees in October by Visa and Mastercard, saying it had seen no significant changes in costs for issuers.\"Our proposed work will be looking more closely at the reasoning behind the recent increases and whether this indicates any themes or concerns that warrant action from us,\" it said.Stride said the Treasury committee would discuss the regulator's plans at a hearing in March.Efforts in the EU to end the dominance and Mastercard have had mixed results","news_type":1},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001894821,"gmtCreate":1641210667085,"gmtModify":1676533583091,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001894821","repostId":"2200744775","repostType":4,"repost":{"id":"2200744775","pubTimestamp":1641210061,"share":"https://ttm.financial/m/news/2200744775?lang=&edition=fundamental","pubTime":"2022-01-03 19:41","market":"us","language":"en","title":"3 Dates for Disney Stock Investors to Circle in January","url":"https://stock-news.laohu8.com/highlight/detail?id=2200744775","media":"Motley Fool","summary":"New releases and the reopening of a popular theme park will highlight a busy month for the House of Mouse.","content":"<html><head></head><body><p>It&#39;s a new year for <b>Walt Disney</b> (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 is ready to bounce back in 2022.</p><p>Disney&#39;s always busy, and it&#39;s not going to hibernate through January. From a popular theme park reopening to highly anticipated releases there&#39;s a lot coming soon at Disney. Let&#39;s take a closer look.</p><h2>Jan. 2</h2><p>The only Disney gated attraction that has yet to reopen since the pandemic -- Walt Disney World&#39;s Typhoon Lagoon -- is getting back in business this weekend. Typhoon Lagoon was the country&#39;s most visited water park in 2019, its last full year of operation. It was also the world&#39;s second most popular water park.</p><p>Florida&#39;s resort is the only place where Disney operates a theme park, and it actually has two in the Sunshine State. It only reopened Blizzard Beach in March, but it&#39;s closing <i>that</i> park down for refurbishment when Typhoon Lagoon reopens on Sunday. A combination of staffing concerns and consumer demand is probably keeping Disney to having just <a href=\"https://laohu8.com/S/AONE.U\">one</a> theme park open at a time, but if things go well it wouldn&#39;t be a surprise to see both watery escapes open at the same time in a few months when the weather starts to heat up.</p><h2>Jan. 14</h2><p>This is a relatively slow month for Disney in terms of theatrical releases, but one of note will be <i>Deep Water</i>. The film starring Ben Affleck and Ana de Armas is being billed as an erotic psychological thriller, as the two play a married couple that have fallen out of love. They play mind games with one another, and a body count ensues.</p><p>This isn&#39;t an organic Disney production. It&#39;s part of the slate of content that the media stock picked up with its 20th Century Fox acquisition. Expectations aren&#39;t as high for this flick as the superhero and sci-fi fare that Disney will be putting out later this year, but there&#39;s always the chance for a sleeper hit. All cards are off the table if COVID-19 cases intensify to the point that folks aren&#39;t hitting up the local multiplex.</p><h2>Jan. 28</h2><p>Disney+ is a big part of the growth thesis for the House of Mouse. The platform launched in late 2019, and it&#39;s already at more than 118 million accounts worldwide. Disney has said that it doesn&#39;t expect the platform to become profitable until fiscal 2024, but its popularity has given Disney a new revenue stream.</p><p>There are a couple of new shows and movies coming to Disney+ this month. If you missed Marvel&#39;s <i>Eternals</i> at the movie theater in November you can start catching on Disney+ starting Jan. 12. You&#39;ll also get fresh weekly installments of the new <i>The Book of Boba Fett</i> series every Wednesday. Young families may be circling Jan. 28 on the calendar as that is when <i>The Ice Age Adventures of Buck Wild</i> hits the platform. The film is a spinoff of the computer animated <i>Ice Age</i> franchise. If you&#39;re thinking that you don&#39;t recall <i>Ice Age</i> as a Disney property, you&#39;re right. It&#39;s another franchise that Disney inherited when it acquired the 20th Century Fox catalog.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dates for Disney Stock Investors to Circle in January</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dates for Disney Stock Investors to Circle in January\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 19:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year for Walt Disney (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4108":"电影和娱乐","ISBC":"投资者银行","DIS":"迪士尼","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4211":"区域性银行","BK4550":"红杉资本持仓","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4524":"宅经济概念","BK4561":"索罗斯持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2022/01/02/3-dates-for-disney-stock-investors-to-circle-in-ja/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200744775","content_text":"It's a new year for Walt Disney (NYSE:DIS). After a disappointing 2021 -- fundamentally the media giant did fine, but the shares did decline nearly 15% last year -- the worst performer in the Dow 30 is ready to bounce back in 2022.Disney's always busy, and it's not going to hibernate through January. From a popular theme park reopening to highly anticipated releases there's a lot coming soon at Disney. Let's take a closer look.Jan. 2The only Disney gated attraction that has yet to reopen since the pandemic -- Walt Disney World's Typhoon Lagoon -- is getting back in business this weekend. Typhoon Lagoon was the country's most visited water park in 2019, its last full year of operation. It was also the world's second most popular water park.Florida's resort is the only place where Disney operates a theme park, and it actually has two in the Sunshine State. It only reopened Blizzard Beach in March, but it's closing that park down for refurbishment when Typhoon Lagoon reopens on Sunday. A combination of staffing concerns and consumer demand is probably keeping Disney to having just one theme park open at a time, but if things go well it wouldn't be a surprise to see both watery escapes open at the same time in a few months when the weather starts to heat up.Jan. 14This is a relatively slow month for Disney in terms of theatrical releases, but one of note will be Deep Water. The film starring Ben Affleck and Ana de Armas is being billed as an erotic psychological thriller, as the two play a married couple that have fallen out of love. They play mind games with one another, and a body count ensues.This isn't an organic Disney production. It's part of the slate of content that the media stock picked up with its 20th Century Fox acquisition. Expectations aren't as high for this flick as the superhero and sci-fi fare that Disney will be putting out later this year, but there's always the chance for a sleeper hit. All cards are off the table if COVID-19 cases intensify to the point that folks aren't hitting up the local multiplex.Jan. 28Disney+ is a big part of the growth thesis for the House of Mouse. The platform launched in late 2019, and it's already at more than 118 million accounts worldwide. Disney has said that it doesn't expect the platform to become profitable until fiscal 2024, but its popularity has given Disney a new revenue stream.There are a couple of new shows and movies coming to Disney+ this month. If you missed Marvel's Eternals at the movie theater in November you can start catching on Disney+ starting Jan. 12. You'll also get fresh weekly installments of the new The Book of Boba Fett series every Wednesday. Young families may be circling Jan. 28 on the calendar as that is when The Ice Age Adventures of Buck Wild hits the platform. The film is a spinoff of the computer animated Ice Age franchise. If you're thinking that you don't recall Ice Age as a Disney property, you're right. It's another franchise that Disney inherited when it acquired the 20th Century Fox catalog.","news_type":1},"isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009705469,"gmtCreate":1640786525493,"gmtModify":1676533541377,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009705469","repostId":"2195457957","repostType":4,"isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004410985,"gmtCreate":1642655657908,"gmtModify":1676533732934,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004410985","repostId":"1178411704","repostType":4,"repost":{"id":"1178411704","pubTimestamp":1642649050,"share":"https://ttm.financial/m/news/1178411704?lang=&edition=fundamental","pubTime":"2022-01-20 11:24","market":"us","language":"en","title":"Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1178411704","media":"Benzinga","summary":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposur","content":"<html><head></head><body><p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.</p><p>Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.</p><p>Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.</p><p>The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration &amp; Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.</p><p>ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.</p><p>Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.</p><p>Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.</p><p>BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.</p><p>Here are a few other key Ark Invest trades on Wednesday:</p><p>Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 11:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKX":"ARK Space Exploration & Innovation ETF","ARKK":"ARK Innovation ETF","NFLX":"奈飞"},"source_url":"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178411704","content_text":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration & Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.Here are a few other key Ark Invest trades on Wednesday:Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002423018,"gmtCreate":1642075806767,"gmtModify":1676533678264,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002423018","repostId":"2203769284","repostType":4,"repost":{"id":"2203769284","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642074605,"share":"https://ttm.financial/m/news/2203769284?lang=&edition=fundamental","pubTime":"2022-01-13 19:50","market":"us","language":"en","title":"Delta Air Lines says company has no plans to invest in ITA Airways","url":"https://stock-news.laohu8.com/highlight/detail?id=2203769284","media":"Reuters","summary":"CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Ali","content":"<html><head></head><body><p>CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia&#39;s successor ITA Airways.</p><p>The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.</p><p>Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany&#39;s Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.</p><p>Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.</p><p>&#34;We have no plans to invest in them,&#34; Bastian told Reuters in an interview.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Air Lines says company has no plans to invest in ITA Airways</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Air Lines says company has no plans to invest in ITA Airways\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-13 19:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia&#39;s successor ITA Airways.</p><p>The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.</p><p>Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany&#39;s Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.</p><p>Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.</p><p>&#34;We have no plans to invest in them,&#34; Bastian told Reuters in an interview.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ITA":"iShares Dow Jones U.S. Aerospace","BK4500":"航空公司","BK4008":"航空公司","DAL":"达美航空"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203769284","content_text":"CHICAGO, Jan 13 (Reuters) - Delta Air Lines Inc    on Thursday said it has no plans to invest in Alitalia's successor ITA Airways.The Italian carrier is looking for an equity partnership and has started informal talks with some potential partners, both in Europe and overseas.Sources close to ITA Airways told Reuters that the Italian carrier has been in contact with Germany's Lufthansa   , British Airways    and Delta Air, adding that formal talks could start by the end of March.Last month, Delta launched a reciprocal codeshare agreement with ITA Airways. In an interview Chief Executive Ed Bastian said the U.S. carrier is working on the codeshare relationship.\"We have no plans to invest in them,\" Bastian told Reuters in an interview.","news_type":1},"isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001895568,"gmtCreate":1641210631324,"gmtModify":1676533583074,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001895568","repostId":"2200403714","repostType":4,"repost":{"id":"2200403714","pubTimestamp":1641163785,"share":"https://ttm.financial/m/news/2200403714?lang=&edition=fundamental","pubTime":"2022-01-03 06:49","market":"us","language":"en","title":"December jobs report, Federal Reserve meeting minutes, CES: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2200403714","media":"Yahoo Finance","summary":"Investors can expect a busy first week of 2022, laden with key economic releases out of Washington t","content":"<html><head></head><body><p>Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market Committee’s (FOMC) latest policy-setting meeting.</p><p>It was a hectic final month of 2021 for markets, stocks rallied to new highs and the action could pour into the new year’s opening week of trading with a boost from what is known as the “January Effect” — the perception of a seasonal rise in U.S. equities during the first month of the year.</p><p>Wall Street attributes the theory to an increase in purchasing following the drop in prices that occurs in December when investors sell positions that have declined in order to take the capital loss in that calendar year&#39;s taxes. Some also think the anomaly is the result of traders using year-end cash bonuses to purchase equities the following month.</p><p>Employment data will be in the spotlight this week. The Department of Labor’s monthly jobs report due for release on Friday will offer an updated look at the strength of hiring and labor force participation — important measures of the U.S. economy, made even more consequential in recent weeks amid a backdrop of rising COVID-19 cases as investors look to assess the impact of the the latest Omicron-driven wave.</p><p>Consensus economist estimates suggest that about 400,000 jobs were added in December, with the pace of hiring nearly doubling from the fewer-than-expected 210,000 recorded in November, when forecasts predicted a half-million new jobs to return. The unemployment rate is also expected to improve further to 4.1% from 4.3% in November when it ticked down to the lowest read since March 2020.</p><p>Although the pace of non-farm payrolls is projected to have risen in December, the downside risk to estimates may be “sizable.”</p><p>“COVID caseloads have been on the rise since November, and news that Omicron could be more infectious than previous variants circulated widely during the December survey period,” Bloomberg economists wrote in a note. “Given how often households have cited fear of COVID or care-taking needs related to COVID as the most important reasons for staying out of the job market, the emergence of the Omicron variant could continue to discourage them.”</p><p>Despite steady rehiring since the peak of the pandemic, labor force participation remains short of pre-virus levels. The civilian labor force was down by about 2.4 million participants as of November, compared to February 2020. Labor issues are also fueling surging inflation levels, as companies large and small face logistical challenges, including rising business costs and supply chain bottlenecks caused by a shortage of workers.</p><p>“This severe labor market shortage — more than any other economic factor — is accounting for a massive breakdown in the normally well-oiled global supply chain,” experts at Wilmington Trust said in their 2022 Capital Markets Outlook. “Labor participation and how firms deal with global resource disorder will likely determine the path for inflation, which is the critical consideration for investors in 2022.”</p><p><img src=\"https://static.tigerbbs.com/792826db78c3c5bac082a3cd1bbe34c2\" tg-width=\"818\" tg-height=\"685\" referrerpolicy=\"no-referrer\"/></p><p>With inflation at the forefront, investors will also set their sights on the Federal Reserve as it looks to raise interest rates this year to offset swelling price levels. The pace of these hikes will determine the stock market’s path forward in the new year.</p><p>Minutes from the FOMC’s Dec. 15 policy-setting meeting, due out Wednesday, could give investors a better picture of where policymakers see interest rates going in 2022.</p><p>Fed officials indicated last month that all 18 members predict at least one 25 basis point hike next year, with the median member forecasting three rate hikes before 2022 is over. The next FOMC meeting is scheduled to take place on Jan. 25 and 26.</p><p>“What’s not changed is the focus on inflation, that’s the biggest risk,” Brigg Macadam founding partner Greg Swenson told Yahoo Finance Live, adding that the Fed changing its tone is “too little, too late.”</p><p>“They are still, by most measures, quite dovish, even with the tapering of bond purchases and the market pricing in three hikes next year, you’ll still have dramatically negative real rates,” he said. “I wouldn’t call that a hawkish Fed — maybe their tone has changed a little bit and they have definitely stopped using the word ‘transitory,’ they have all but admitted that they missed inflation and underestimated it.”</p><p>Although earnings season doesn’t fully commence until around mid-month, several notable off-cycle reports are due out this week, including ones from Jefferies, Bed Bath &amp; Beyond, and Walgreens.</p><p>CES, the Consumer Technology Association&#39;s iconic consumer electronics show will also take place from Jan. 5-7 in Las Vegas, but will end one day earlier than initially planned due to fast-spreading cases of COVID-19. The event may also have a light crowd, with some usual, big name attendees like Apple, Alphabet and Facebook&#39;s parent Meta dropping their plans to attend in-person under the circumstances.</p><h2>Economic calendar</h2><ul><li><p><b>Monday:</b> Markit US Manufacturing PMI, December final (57.7 estimated, 57.8 prior); Construction Spending, month over month, November (0.7% estimated, 0.2% prior month)</p></li><li><p><b>Tuesday:</b> ISM New Orders, December (61.5% prior month); ISM Prices Paid, December (79.3 estimated, 82.4 prior month); ISM Manufacturing, December (60.2 estimated, 61.1) prior month); ISM Employment, December (53.3 prior month); JOLTS job openings, November (11,033,000 prior month); WARDS Total Vehicle Sales, December (13,100,000 expected, 12,860,000 prior month)</p></li><li><p><b>Wednesday:</b> MBA Mortgage Applications, week ended Dec. 31 (-0.6% during prior week); ADP Employment Change, December (360,000 expected, 534,000 during prior month); Markit US Composite PMI, December final (56.9 prior month); Markit US Services PMI, December final (57.5 expected, 57.5 prior month); FOMC Meeting Minutes, December 15</p></li><li><p><b>Thursday: </b>Challenger Job Cuts, year over year, December (-77% prior); Trade Balance, November (-$74,000,000,000 expected, -$67,000,000,000); Initial Jobless Claims, week ended January 1 (199,000 expected, 198,000 during prior week) Continuing Claims, week ended January 1 (1,715,000 expected, 1,716,000 prior week); Langer Consumer Comfort, January 2 (47.9 prior); Factory Orders excluding transportation, November (1.6% prior); Factory Orders, November (1.5% expected, 1.0% prior) ISM Services Index, December (67.0 expected, 69.1 prior); Durable Goods Orders, November final (2.5% prior); Durable Goods Excluding Transportation, November final (0.8% prior); Capital Goods Orders Nondefense Excluding Aircrafts, November final (-0.1%); Capital Goods Shipments Nondefense Excluding Aircrafts, November final (0.3%)</p></li><li><p><b>Friday:</b> Revisions – Employment Report, Household Survey; Two-Month Payroll Net Revision, December (82,000 prior); Change in Nonfarm Payrolls, December (400,000 expected, 210,000 prior month); Change in Private Payrolls, December (370,000 expected, 235,000 prior month); Change in Manufacturing Payrolls, December (33,000 expected, 31,000 prior month); Unemployment Rate, December (4.1 expected, 4.3% prior); Average Hourly Earnings, month over month, December (0.4% expected, 0.3% prior month); Average Hourly Earnings, year over year (4.2% expected, 4.8% prior month); Average Weekly Hours All Employees, December (34.8 expected, 34.8 prior month); Labor Force Participation Rate, December (61.9% expected, 61.8% prior month); Underemployment Rate, December (7.8% prior month); Consumer Credit, November (22,500,000,000 expected, 16,897,000,000 prior month)</p></li></ul><h2>Earnings calendar</h2><ul><li><p><b>Monday:</b> <i>No notable reports scheduled for release</i></p></li><li><p><b>Tuesday:</b> Jefferies Financial Group (JEF), <a href=\"https://laohu8.com/S/MLKN\">MillerKnoll</a> (MLKN) after market close</p></li><li><p><b>Wednesday:</b> <a href=\"https://laohu8.com/S/MULN\">Mullen Automotive</a> Inc. (MULN)</p></li><li><p><b>Thursday</b>: Bed Bath &amp; Beyond Inc. (BBY) before market open, <a href=\"https://laohu8.com/S/STZ\">Constellation Brands Inc</a>. (STZ) before market open, <a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> (WBA) before market opens, PriceSmart (PSMT) after market close</p></li><li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>December jobs report, Federal Reserve meeting minutes, CES: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDecember jobs report, Federal Reserve meeting minutes, CES: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 06:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market ...</p>\n\n<a href=\"https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4077":"互动媒体与服务","BK4076":"电脑与电子产品零售","STZ":"星座品牌","BK4143":"办公服务与用品","SPY.AU":"SPDR® S&P 500® ETF Trust","BK4155":"大卖场与超市","PSMT":"普尔斯玛特","BBY":"百思买","BK4504":"桥水持仓","WBA":"沃尔格林联合博姿","MULN":"Mullen Automotive","JEF":"杰富瑞","FOMC":"FOMO CORP.","BK4127":"投资银行业与经纪业","BK4169":"酿酒商与葡萄酒商",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BK4567":"ESG概念",".SPX":"S&P 500 Index","MLKN":"MillerKnoll","BBBY":"3B家居","BK4128":"药品零售","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://finance.yahoo.com/news/december-jobs-report-fomc-meeting-minutes-what-to-know-this-week-171353443.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200403714","content_text":"Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market Committee’s (FOMC) latest policy-setting meeting.It was a hectic final month of 2021 for markets, stocks rallied to new highs and the action could pour into the new year’s opening week of trading with a boost from what is known as the “January Effect” — the perception of a seasonal rise in U.S. equities during the first month of the year.Wall Street attributes the theory to an increase in purchasing following the drop in prices that occurs in December when investors sell positions that have declined in order to take the capital loss in that calendar year's taxes. Some also think the anomaly is the result of traders using year-end cash bonuses to purchase equities the following month.Employment data will be in the spotlight this week. The Department of Labor’s monthly jobs report due for release on Friday will offer an updated look at the strength of hiring and labor force participation — important measures of the U.S. economy, made even more consequential in recent weeks amid a backdrop of rising COVID-19 cases as investors look to assess the impact of the the latest Omicron-driven wave.Consensus economist estimates suggest that about 400,000 jobs were added in December, with the pace of hiring nearly doubling from the fewer-than-expected 210,000 recorded in November, when forecasts predicted a half-million new jobs to return. The unemployment rate is also expected to improve further to 4.1% from 4.3% in November when it ticked down to the lowest read since March 2020.Although the pace of non-farm payrolls is projected to have risen in December, the downside risk to estimates may be “sizable.”“COVID caseloads have been on the rise since November, and news that Omicron could be more infectious than previous variants circulated widely during the December survey period,” Bloomberg economists wrote in a note. “Given how often households have cited fear of COVID or care-taking needs related to COVID as the most important reasons for staying out of the job market, the emergence of the Omicron variant could continue to discourage them.”Despite steady rehiring since the peak of the pandemic, labor force participation remains short of pre-virus levels. The civilian labor force was down by about 2.4 million participants as of November, compared to February 2020. Labor issues are also fueling surging inflation levels, as companies large and small face logistical challenges, including rising business costs and supply chain bottlenecks caused by a shortage of workers.“This severe labor market shortage — more than any other economic factor — is accounting for a massive breakdown in the normally well-oiled global supply chain,” experts at Wilmington Trust said in their 2022 Capital Markets Outlook. “Labor participation and how firms deal with global resource disorder will likely determine the path for inflation, which is the critical consideration for investors in 2022.”With inflation at the forefront, investors will also set their sights on the Federal Reserve as it looks to raise interest rates this year to offset swelling price levels. The pace of these hikes will determine the stock market’s path forward in the new year.Minutes from the FOMC’s Dec. 15 policy-setting meeting, due out Wednesday, could give investors a better picture of where policymakers see interest rates going in 2022.Fed officials indicated last month that all 18 members predict at least one 25 basis point hike next year, with the median member forecasting three rate hikes before 2022 is over. The next FOMC meeting is scheduled to take place on Jan. 25 and 26.“What’s not changed is the focus on inflation, that’s the biggest risk,” Brigg Macadam founding partner Greg Swenson told Yahoo Finance Live, adding that the Fed changing its tone is “too little, too late.”“They are still, by most measures, quite dovish, even with the tapering of bond purchases and the market pricing in three hikes next year, you’ll still have dramatically negative real rates,” he said. “I wouldn’t call that a hawkish Fed — maybe their tone has changed a little bit and they have definitely stopped using the word ‘transitory,’ they have all but admitted that they missed inflation and underestimated it.”Although earnings season doesn’t fully commence until around mid-month, several notable off-cycle reports are due out this week, including ones from Jefferies, Bed Bath & Beyond, and Walgreens.CES, the Consumer Technology Association's iconic consumer electronics show will also take place from Jan. 5-7 in Las Vegas, but will end one day earlier than initially planned due to fast-spreading cases of COVID-19. The event may also have a light crowd, with some usual, big name attendees like Apple, Alphabet and Facebook's parent Meta dropping their plans to attend in-person under the circumstances.Economic calendarMonday: Markit US Manufacturing PMI, December final (57.7 estimated, 57.8 prior); Construction Spending, month over month, November (0.7% estimated, 0.2% prior month)Tuesday: ISM New Orders, December (61.5% prior month); ISM Prices Paid, December (79.3 estimated, 82.4 prior month); ISM Manufacturing, December (60.2 estimated, 61.1) prior month); ISM Employment, December (53.3 prior month); JOLTS job openings, November (11,033,000 prior month); WARDS Total Vehicle Sales, December (13,100,000 expected, 12,860,000 prior month)Wednesday: MBA Mortgage Applications, week ended Dec. 31 (-0.6% during prior week); ADP Employment Change, December (360,000 expected, 534,000 during prior month); Markit US Composite PMI, December final (56.9 prior month); Markit US Services PMI, December final (57.5 expected, 57.5 prior month); FOMC Meeting Minutes, December 15Thursday: Challenger Job Cuts, year over year, December (-77% prior); Trade Balance, November (-$74,000,000,000 expected, -$67,000,000,000); Initial Jobless Claims, week ended January 1 (199,000 expected, 198,000 during prior week) Continuing Claims, week ended January 1 (1,715,000 expected, 1,716,000 prior week); Langer Consumer Comfort, January 2 (47.9 prior); Factory Orders excluding transportation, November (1.6% prior); Factory Orders, November (1.5% expected, 1.0% prior) ISM Services Index, December (67.0 expected, 69.1 prior); Durable Goods Orders, November final (2.5% prior); Durable Goods Excluding Transportation, November final (0.8% prior); Capital Goods Orders Nondefense Excluding Aircrafts, November final (-0.1%); Capital Goods Shipments Nondefense Excluding Aircrafts, November final (0.3%)Friday: Revisions – Employment Report, Household Survey; Two-Month Payroll Net Revision, December (82,000 prior); Change in Nonfarm Payrolls, December (400,000 expected, 210,000 prior month); Change in Private Payrolls, December (370,000 expected, 235,000 prior month); Change in Manufacturing Payrolls, December (33,000 expected, 31,000 prior month); Unemployment Rate, December (4.1 expected, 4.3% prior); Average Hourly Earnings, month over month, December (0.4% expected, 0.3% prior month); Average Hourly Earnings, year over year (4.2% expected, 4.8% prior month); Average Weekly Hours All Employees, December (34.8 expected, 34.8 prior month); Labor Force Participation Rate, December (61.9% expected, 61.8% prior month); Underemployment Rate, December (7.8% prior month); Consumer Credit, November (22,500,000,000 expected, 16,897,000,000 prior month)Earnings calendarMonday: No notable reports scheduled for releaseTuesday: Jefferies Financial Group (JEF), MillerKnoll (MLKN) after market closeWednesday: Mullen Automotive Inc. (MULN)Thursday: Bed Bath & Beyond Inc. (BBY) before market open, Constellation Brands Inc. (STZ) before market open, Walgreens Boots Alliance (WBA) before market opens, PriceSmart (PSMT) after market closeFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003287196,"gmtCreate":1640999380338,"gmtModify":1676533561779,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Happy]&nbsp;[Sad]&nbsp;","listText":"[Happy]&nbsp;[Sad]&nbsp;","text":"[Happy] [Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003287196","repostId":"1114332157","repostType":4,"repost":{"id":"1114332157","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640995557,"share":"https://ttm.financial/m/news/1114332157?lang=&edition=fundamental","pubTime":"2022-01-01 08:05","market":"us","language":"en","title":"U.S. Stocks End Lower on New Year’s Eve, but S&P 500, Dow, Nasdaq Score Big Gains for 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1114332157","media":"Dow Jones","summary":"S&P 500 gains about 27% this year, its best yearly advance since 2019.Major U.S. stock indexes close","content":"<html><head></head><body><p>S&amp;P 500 gains about 27% this year, its best yearly advance since 2019.</p><p>Major U.S. stock indexes closed lower Friday, as risk appetite waned on <a href=\"https://laohu8.com/S/NGD\">New</a> Year’s Eve, but the S&amp;P 500, Dow Jones Industrial Average and <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite all closed out the month, quarter and year with gains despite the pandemic.</p><p><b>How did stock benchmarks trade?</b></p><p>The Dow Jones Industrial Average fell 59.78 points, or 0.2%, to close at 36,338.30.</p><p>The S&amp;P 500 SPX slipped 12.55 points, or 0.3%, to finish at 4,766.18.</p><p>The Nasdaq Composite Index dropped 96.59 points, or 0.6%, to end at 15,644.97.</p><p>On Thursday, the Dow closed down 90.55 points, or 0.3%, to 36,398.08, the S&amp;P 500 index fell 14.33 points, or 0.3%, to close at 4,778.73, the Nasdaq Composite Index declined 24.65 points to 15,741.56, a 0.2% loss.</p><p>For the week, the Dow logged a 1.1% gain, the S&amp;P 500 rose 0.9% and the Nasdaq shed about 0.1%. For December, the Dow gained 5.4%, the S&amp;P 500 climbed 4.4% and the Nasdaq edged up 0.7%. All three benchmarks also booked gains for the fourth quarter, with the Dow climbing 7.4%, the S&amp;P 500 jumping 10.7% and the Nasdaq advancing 8.3%.</p><p>For 2021, the S&amp;P 500 soared 26.9%, beating both the Nasdaq’s 21.4% rise and the Dow’s 18.7% climb.</p><p><b>What drove the market?</b></p><p>Major U.S. stock indexes fell in the final trading session of the year, as market participants closed out their trading logs for 2021, but the S&amp;P 500 and Dow remained less 1% off their record highs. They also scored their best yearly gains since 2019, before the pandemic disrupted daily life across the globe.</p><p>“Today should be a relatively quiet day,” said Matthew Bartolini, head of SPDR Americas Research at <a href=\"https://laohu8.com/S/STT\">State</a> Street Global Advisors, in a phone interview Friday morning. Trading is thin, he said, with “more market movements” potentially coming toward the end of the day as investors closed out their positions for the year.</p><p>Thinner holiday volumes meant potential choppiness in the action in the final session of 2021, following a strong start to the past week of December, as investors assessed the path ahead for markets, a path that has been colored by a global pandemic that already has lasted about two years.</p><p>Despite recent dips, both the Dow and the S&amp;P 500 posted record-high closes this week, with the rise for equities supported by the belief that disruptions from the omicron variant that causes COVID-19 won’t be lasting.</p><p>The seven-day average of COVID-19 cases in the U.S. has risen at a parabolic pace to 344,543 on Thursday, up from 301,477 on Wednesday, which is up about fourfold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a <a href=\"https://laohu8.com/S/NYT\">New York Times</a> tracker. Hospitalizations also kept climbing, but at a slower pace, as the daily average reached 81,847 on Thursday.</p><p>Airlines canceled hundreds of flights Thursday because of labor shortages after thousands were scrubbed during the Christmas weekend, while the Federal Aviation Administration warned of possible delays tied to the virus at the agency. Also, the Centers for Disease Control and Prevention has recommended that Americans avoid taking cruises, whether they are vaccinated or not.</p><p><a href=\"https://laohu8.com/S/JPM\">JPMorgan Chase</a> &amp; Co. is <a href=\"https://laohu8.com/S/AONE.U\">one</a> prominent bank that has offered its employees the option of working from home to start 2022. The money-center bank run by Jamie Dimon is “allowing for more flexibility during the first two weeks of January to work from home (if your role allows) at your manager’s discretion,” Bloomberg reported, citing a Thursday memo to employees.</p><p>However, in South Africa, where the omicron variant of COVID was first identified, the government said the country’s latest viral wave had subsided and it would be easing restrictions. In the U.S., while daily COVID cases soared to a record high, the CDC said that hospitalizations or deaths as a result of omicron are comparatively low. And White House medical expert Anthony Fauci has said that he is expecting the omicron outbreak to peak by the end of January.</p><p>There was no U.S. economic data scheduled for release due to the New Year’s Eve holiday and the bond market closed an hour earlier at 2 p.m. <a href=\"https://laohu8.com/S/EML\">Eastern</a> <a href=\"https://laohu8.com/S/TIME\">Time</a> on Friday.</p><p>The U.S. stock market’s strong performance in 2021 has been driven by corporate earnings growth, said State Street’s Bartolini, with the S&amp;P 500 index scoring a third straight year of double-digit gains.</p><p>“I think everyone just kinda wants to close out the year on a good note,” he said. “Market returns aside, it’s been quite a turbulent year.”</p><p><b>Which companies were in focus?</b></p><p><a href=\"https://laohu8.com/S/AEIS\">Advanced</a> Micro Devices Inc. <a href=\"https://laohu8.com/S/AMD\">AMD</a> said Thursday that its acquisition of fellow semiconductor company <a href=\"https://laohu8.com/S/XLNX\">Xilinx</a> Inc. XLNX would not close by the end of 2021, but that it expects the deal to be sealed early in the new year. Shares of AMD and Xilinx closed 0.9% lower Friday.</p><p>Shares of Zepp Health Corp. ZEPP were flat, after the <a href=\"https://laohu8.com/S/CAAS\">China</a>-based smart health technology company cut its fourth-quarter revenue outlook, citing a “greater than anticipated effects of COVID” and a more persistent global shortage of semiconductors.</p><p>The U.K. <a href=\"https://laohu8.com/S/MDCO\">Medicines</a> and <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> products Regulatory Agency said it has approved <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s PFE Paxlovid oral antiviral for people with mild to moderate COVID-19 who have at least one risk factor for developing severe illness. Shares of Pfizer rose 1.1%.</p><p><b>How did other assets fare?</b></p><p>The yield on the 10-year Treasury note was trading around 1.496%, marking its biggest yearly yield climb since 2013.</p><p>The ICE U.S. Dollar Index, a measure of the currency against a basket of six major rivals, fell 0.3%.</p><p>Oil futures fell, with <a href=\"https://laohu8.com/S/WSTC\">West</a> Texas Intermediate crude for February delivery declining 2.3% to settle at $75.21 a barrel. WTI rose more than 55% in 2021, its largely annual gain in 12 years.</p><p>Gold futures for February delivery GCG22 rose 0.8% to settle at $1,828.60 an ounce Friday. The precious metal fell 3.6% in 2021.</p><p>Bitcoin was up 1.7% at $47,985.</p><p>The FTSE 10 fell about 0.2% Friday, but ended the year with gains of 14.3%. The Stoxx Europe declined 0.2% Friday and posted gains of around 22.2% for 2021.</p><p>In Asian trade, the Shanghai Composite ended 0.6% higher Friday, logging a 4.8% gain for the year. The Hang Seng Index HSI climbed 1.2% Friday, but remained down 14.1% for the year. China’s CSI 300 booked a 0.4% advance Friday, but lost 5.2% for the year. The NIKKEI 225 index gained 4.9% in 2021, with Japan’s market closed on Friday.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stocks End Lower on New Year’s Eve, but S&P 500, Dow, Nasdaq Score Big Gains for 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stocks End Lower on New Year’s Eve, but S&P 500, Dow, Nasdaq Score Big Gains for 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-01-01 08:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>S&amp;P 500 gains about 27% this year, its best yearly advance since 2019.</p><p>Major U.S. stock indexes closed lower Friday, as risk appetite waned on <a href=\"https://laohu8.com/S/NGD\">New</a> Year’s Eve, but the S&amp;P 500, Dow Jones Industrial Average and <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite all closed out the month, quarter and year with gains despite the pandemic.</p><p><b>How did stock benchmarks trade?</b></p><p>The Dow Jones Industrial Average fell 59.78 points, or 0.2%, to close at 36,338.30.</p><p>The S&amp;P 500 SPX slipped 12.55 points, or 0.3%, to finish at 4,766.18.</p><p>The Nasdaq Composite Index dropped 96.59 points, or 0.6%, to end at 15,644.97.</p><p>On Thursday, the Dow closed down 90.55 points, or 0.3%, to 36,398.08, the S&amp;P 500 index fell 14.33 points, or 0.3%, to close at 4,778.73, the Nasdaq Composite Index declined 24.65 points to 15,741.56, a 0.2% loss.</p><p>For the week, the Dow logged a 1.1% gain, the S&amp;P 500 rose 0.9% and the Nasdaq shed about 0.1%. For December, the Dow gained 5.4%, the S&amp;P 500 climbed 4.4% and the Nasdaq edged up 0.7%. All three benchmarks also booked gains for the fourth quarter, with the Dow climbing 7.4%, the S&amp;P 500 jumping 10.7% and the Nasdaq advancing 8.3%.</p><p>For 2021, the S&amp;P 500 soared 26.9%, beating both the Nasdaq’s 21.4% rise and the Dow’s 18.7% climb.</p><p><b>What drove the market?</b></p><p>Major U.S. stock indexes fell in the final trading session of the year, as market participants closed out their trading logs for 2021, but the S&amp;P 500 and Dow remained less 1% off their record highs. They also scored their best yearly gains since 2019, before the pandemic disrupted daily life across the globe.</p><p>“Today should be a relatively quiet day,” said Matthew Bartolini, head of SPDR Americas Research at <a href=\"https://laohu8.com/S/STT\">State</a> Street Global Advisors, in a phone interview Friday morning. Trading is thin, he said, with “more market movements” potentially coming toward the end of the day as investors closed out their positions for the year.</p><p>Thinner holiday volumes meant potential choppiness in the action in the final session of 2021, following a strong start to the past week of December, as investors assessed the path ahead for markets, a path that has been colored by a global pandemic that already has lasted about two years.</p><p>Despite recent dips, both the Dow and the S&amp;P 500 posted record-high closes this week, with the rise for equities supported by the belief that disruptions from the omicron variant that causes COVID-19 won’t be lasting.</p><p>The seven-day average of COVID-19 cases in the U.S. has risen at a parabolic pace to 344,543 on Thursday, up from 301,477 on Wednesday, which is up about fourfold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a <a href=\"https://laohu8.com/S/NYT\">New York Times</a> tracker. Hospitalizations also kept climbing, but at a slower pace, as the daily average reached 81,847 on Thursday.</p><p>Airlines canceled hundreds of flights Thursday because of labor shortages after thousands were scrubbed during the Christmas weekend, while the Federal Aviation Administration warned of possible delays tied to the virus at the agency. Also, the Centers for Disease Control and Prevention has recommended that Americans avoid taking cruises, whether they are vaccinated or not.</p><p><a href=\"https://laohu8.com/S/JPM\">JPMorgan Chase</a> &amp; Co. is <a href=\"https://laohu8.com/S/AONE.U\">one</a> prominent bank that has offered its employees the option of working from home to start 2022. The money-center bank run by Jamie Dimon is “allowing for more flexibility during the first two weeks of January to work from home (if your role allows) at your manager’s discretion,” Bloomberg reported, citing a Thursday memo to employees.</p><p>However, in South Africa, where the omicron variant of COVID was first identified, the government said the country’s latest viral wave had subsided and it would be easing restrictions. In the U.S., while daily COVID cases soared to a record high, the CDC said that hospitalizations or deaths as a result of omicron are comparatively low. And White House medical expert Anthony Fauci has said that he is expecting the omicron outbreak to peak by the end of January.</p><p>There was no U.S. economic data scheduled for release due to the New Year’s Eve holiday and the bond market closed an hour earlier at 2 p.m. <a href=\"https://laohu8.com/S/EML\">Eastern</a> <a href=\"https://laohu8.com/S/TIME\">Time</a> on Friday.</p><p>The U.S. stock market’s strong performance in 2021 has been driven by corporate earnings growth, said State Street’s Bartolini, with the S&amp;P 500 index scoring a third straight year of double-digit gains.</p><p>“I think everyone just kinda wants to close out the year on a good note,” he said. “Market returns aside, it’s been quite a turbulent year.”</p><p><b>Which companies were in focus?</b></p><p><a href=\"https://laohu8.com/S/AEIS\">Advanced</a> Micro Devices Inc. <a href=\"https://laohu8.com/S/AMD\">AMD</a> said Thursday that its acquisition of fellow semiconductor company <a href=\"https://laohu8.com/S/XLNX\">Xilinx</a> Inc. XLNX would not close by the end of 2021, but that it expects the deal to be sealed early in the new year. Shares of AMD and Xilinx closed 0.9% lower Friday.</p><p>Shares of Zepp Health Corp. ZEPP were flat, after the <a href=\"https://laohu8.com/S/CAAS\">China</a>-based smart health technology company cut its fourth-quarter revenue outlook, citing a “greater than anticipated effects of COVID” and a more persistent global shortage of semiconductors.</p><p>The U.K. <a href=\"https://laohu8.com/S/MDCO\">Medicines</a> and <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> products Regulatory Agency said it has approved <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s PFE Paxlovid oral antiviral for people with mild to moderate COVID-19 who have at least one risk factor for developing severe illness. Shares of Pfizer rose 1.1%.</p><p><b>How did other assets fare?</b></p><p>The yield on the 10-year Treasury note was trading around 1.496%, marking its biggest yearly yield climb since 2013.</p><p>The ICE U.S. Dollar Index, a measure of the currency against a basket of six major rivals, fell 0.3%.</p><p>Oil futures fell, with <a href=\"https://laohu8.com/S/WSTC\">West</a> Texas Intermediate crude for February delivery declining 2.3% to settle at $75.21 a barrel. WTI rose more than 55% in 2021, its largely annual gain in 12 years.</p><p>Gold futures for February delivery GCG22 rose 0.8% to settle at $1,828.60 an ounce Friday. The precious metal fell 3.6% in 2021.</p><p>Bitcoin was up 1.7% at $47,985.</p><p>The FTSE 10 fell about 0.2% Friday, but ended the year with gains of 14.3%. The Stoxx Europe declined 0.2% Friday and posted gains of around 22.2% for 2021.</p><p>In Asian trade, the Shanghai Composite ended 0.6% higher Friday, logging a 4.8% gain for the year. The Hang Seng Index HSI climbed 1.2% Friday, but remained down 14.1% for the year. China’s CSI 300 booked a 0.4% advance Friday, but lost 5.2% for the year. The NIKKEI 225 index gained 4.9% in 2021, with Japan’s market closed on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPXU":"三倍做空标普500ETF","NGD":"New Gold","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","BK4504":"桥水持仓",".SPX":"S&P 500 Index","UPRO":"三倍做多标普500ETF","OEX":"标普100","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","BK4017":"黄金","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","SH":"标普500反向ETF","SPY":"标普500ETF","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114332157","content_text":"S&P 500 gains about 27% this year, its best yearly advance since 2019.Major U.S. stock indexes closed lower Friday, as risk appetite waned on New Year’s Eve, but the S&P 500, Dow Jones Industrial Average and Nasdaq Composite all closed out the month, quarter and year with gains despite the pandemic.How did stock benchmarks trade?The Dow Jones Industrial Average fell 59.78 points, or 0.2%, to close at 36,338.30.The S&P 500 SPX slipped 12.55 points, or 0.3%, to finish at 4,766.18.The Nasdaq Composite Index dropped 96.59 points, or 0.6%, to end at 15,644.97.On Thursday, the Dow closed down 90.55 points, or 0.3%, to 36,398.08, the S&P 500 index fell 14.33 points, or 0.3%, to close at 4,778.73, the Nasdaq Composite Index declined 24.65 points to 15,741.56, a 0.2% loss.For the week, the Dow logged a 1.1% gain, the S&P 500 rose 0.9% and the Nasdaq shed about 0.1%. For December, the Dow gained 5.4%, the S&P 500 climbed 4.4% and the Nasdaq edged up 0.7%. All three benchmarks also booked gains for the fourth quarter, with the Dow climbing 7.4%, the S&P 500 jumping 10.7% and the Nasdaq advancing 8.3%.For 2021, the S&P 500 soared 26.9%, beating both the Nasdaq’s 21.4% rise and the Dow’s 18.7% climb.What drove the market?Major U.S. stock indexes fell in the final trading session of the year, as market participants closed out their trading logs for 2021, but the S&P 500 and Dow remained less 1% off their record highs. They also scored their best yearly gains since 2019, before the pandemic disrupted daily life across the globe.“Today should be a relatively quiet day,” said Matthew Bartolini, head of SPDR Americas Research at State Street Global Advisors, in a phone interview Friday morning. Trading is thin, he said, with “more market movements” potentially coming toward the end of the day as investors closed out their positions for the year.Thinner holiday volumes meant potential choppiness in the action in the final session of 2021, following a strong start to the past week of December, as investors assessed the path ahead for markets, a path that has been colored by a global pandemic that already has lasted about two years.Despite recent dips, both the Dow and the S&P 500 posted record-high closes this week, with the rise for equities supported by the belief that disruptions from the omicron variant that causes COVID-19 won’t be lasting.The seven-day average of COVID-19 cases in the U.S. has risen at a parabolic pace to 344,543 on Thursday, up from 301,477 on Wednesday, which is up about fourfold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a New York Times tracker. Hospitalizations also kept climbing, but at a slower pace, as the daily average reached 81,847 on Thursday.Airlines canceled hundreds of flights Thursday because of labor shortages after thousands were scrubbed during the Christmas weekend, while the Federal Aviation Administration warned of possible delays tied to the virus at the agency. Also, the Centers for Disease Control and Prevention has recommended that Americans avoid taking cruises, whether they are vaccinated or not.JPMorgan Chase & Co. is one prominent bank that has offered its employees the option of working from home to start 2022. The money-center bank run by Jamie Dimon is “allowing for more flexibility during the first two weeks of January to work from home (if your role allows) at your manager’s discretion,” Bloomberg reported, citing a Thursday memo to employees.However, in South Africa, where the omicron variant of COVID was first identified, the government said the country’s latest viral wave had subsided and it would be easing restrictions. In the U.S., while daily COVID cases soared to a record high, the CDC said that hospitalizations or deaths as a result of omicron are comparatively low. And White House medical expert Anthony Fauci has said that he is expecting the omicron outbreak to peak by the end of January.There was no U.S. economic data scheduled for release due to the New Year’s Eve holiday and the bond market closed an hour earlier at 2 p.m. Eastern Time on Friday.The U.S. stock market’s strong performance in 2021 has been driven by corporate earnings growth, said State Street’s Bartolini, with the S&P 500 index scoring a third straight year of double-digit gains.“I think everyone just kinda wants to close out the year on a good note,” he said. “Market returns aside, it’s been quite a turbulent year.”Which companies were in focus?Advanced Micro Devices Inc. AMD said Thursday that its acquisition of fellow semiconductor company Xilinx Inc. XLNX would not close by the end of 2021, but that it expects the deal to be sealed early in the new year. Shares of AMD and Xilinx closed 0.9% lower Friday.Shares of Zepp Health Corp. ZEPP were flat, after the China-based smart health technology company cut its fourth-quarter revenue outlook, citing a “greater than anticipated effects of COVID” and a more persistent global shortage of semiconductors.The U.K. Medicines and Healthcare products Regulatory Agency said it has approved Pfizer’s PFE Paxlovid oral antiviral for people with mild to moderate COVID-19 who have at least one risk factor for developing severe illness. Shares of Pfizer rose 1.1%.How did other assets fare?The yield on the 10-year Treasury note was trading around 1.496%, marking its biggest yearly yield climb since 2013.The ICE U.S. Dollar Index, a measure of the currency against a basket of six major rivals, fell 0.3%.Oil futures fell, with West Texas Intermediate crude for February delivery declining 2.3% to settle at $75.21 a barrel. WTI rose more than 55% in 2021, its largely annual gain in 12 years.Gold futures for February delivery GCG22 rose 0.8% to settle at $1,828.60 an ounce Friday. The precious metal fell 3.6% in 2021.Bitcoin was up 1.7% at $47,985.The FTSE 10 fell about 0.2% Friday, but ended the year with gains of 14.3%. The Stoxx Europe declined 0.2% Friday and posted gains of around 22.2% for 2021.In Asian trade, the Shanghai Composite ended 0.6% higher Friday, logging a 4.8% gain for the year. The Hang Seng Index HSI climbed 1.2% Friday, but remained down 14.1% for the year. China’s CSI 300 booked a 0.4% advance Friday, but lost 5.2% for the year. The NIKKEI 225 index gained 4.9% in 2021, with Japan’s market closed on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009704093,"gmtCreate":1640786575462,"gmtModify":1676533541376,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009704093","repostId":"2195024452","repostType":4,"repost":{"id":"2195024452","pubTimestamp":1640785532,"share":"https://ttm.financial/m/news/2195024452?lang=&edition=fundamental","pubTime":"2021-12-29 21:45","market":"us","language":"en","title":"3 No-Brainer Warren Buffett Stocks to Buy for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2195024452","media":"Motley Fool","summary":"These Buffett stocks look primed for huge things in the near future.","content":"<html><head></head><body><p>A quick look at the top 10 stocks that legendary investor Warren Buffett owns through his company, <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B), reveals that seven of them gained at least 25% in 2021, five at least 35%, and the top performer almost 48%, as of this writing. The <b>S&amp;P 500</b> index, in comparison, is up 27% so far this year. While Berkshire owns a large number of stocks and not just these 10, these numbers show why so many investors follow Buffett&#39;s stock-picking style, or often simply buy the stocks he does.</p><p>I don&#39;t quite recommend putting your money in a stock just because Buffett has, but Berkshire&#39;s portfolio is an excellent hunting ground if you&#39;re looking for stock ideas. Here are three Buffett stocks that I think are no-brainer buys before the year ends.</p><h2>The fears are overrated, and catalysts underrated</h2><p><b><a href=\"https://laohu8.com/S/V\">Visa</a></b> (NYSE:V) shares have hugely disappointed in the second half of 2021, partly because of its ongoing feud with <b>Amazon</b> (NASDAQ:AMZN) and renewed fears of COVID-19 shutdowns that could hit consumer spending. While the latter is a risk that&#39;s not going to affect Visa alone, the company is eager to resolve issues with Amazon, and that could just be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the big triggers for Visa stock in 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b000f014a3a804feeb670a6bd605ee12\" tg-width=\"700\" tg-height=\"481\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><p>Amazon intends to ban payments using Visa cards on its platform beginning Jan. 19 because of high transaction fees. Visa has expressed surprise over Amazon&#39;s decision, saying such transaction fees are regulated in the U.K., and is already negotiating with the e-commerce giant. There&#39;s a good chance Amazon might retreat, as the move could cost Amazon U.K. nearly 1.4 billion British pounds, according to  British newspaper <i>The Independent</i>.</p><p>So while it strives to settle its dispute with Amazon, Visa hasn&#39;t lost focus on innovation and growth. For example, it just acquired CurrencyCloud for nearly $925 million. While CurrencyCloud&#39;s cloud-based platform allows cross-border foreign currency exchange services across 180 countries and even has access to RippleNet under its partnership with Ripple, which owns the popular namesake cryptocurrency, Visa has also reportedly partnered with 60 crypto platforms to launch cards that facilitate digital currency spending.</p><p>Visa&#39;s operational performance doesn&#39;t leave much room for complaint, either -- its payments volume rose 16%, and revenue and net income grew 10% and 13%, respectively, in the fiscal year ended Sept. 30. With Visa also increasing its dividend by 17% and the world increasingly switching from cash to digital payments in this pandemic, this Buffett stock is a must-own for any long-term investor.</p><h2>No longer the boring auto stock</h2><p>Shares of legacy automaker <b>General Motors</b> (NYSE:GM) rallied roughly 37% this year as of this writing, but the stock is still trading significantly below its five-year average price-to-earnings ratio. Given the pace at which GM is going all out to exploit the electric-vehicle (EV) boom, the stock looks primed for stronger days ahead.</p><p>In mid-2021, General Motors outlined ambitious plans to invest $35 billion on electric and autonomous vehicles between 2020 and 2035. By 2030, GM projects its EV revenue to jump to nearly $90 billion, from an estimate $10 billion in 2023.</p><p>On Dec. 17, GM delivered its first GMC Hummer EV pickup. The same day, GM&#39;s wholly owned subsidiary BrightDrop also delivered the first of its 500 all-electric EV600 vehicles to <b>FedEx</b>. Days later, GM announced plans to expand its EV technology beyond its own brands by supplying EV components and solutions to help others electrify their fleet, including in the marine industry. GM&#39;s majority-owned subsidiary Cruise also expects the automaker to start manufacturing a driverless vehicle called Origin in 2023.</p><p>In short, there&#39;s a lot happening at GM that should excite auto investors and pique the interest of any investor looking to buy a Buffett stock right now.</p><h2>A top bet on the world&#39;s largest EV market</h2><p>For several months now, I&#39;ve been pounding the table on another auto stock Buffett owns: <b>BYD</b> (OTC:BYDDY). Several investors have been wary of investing in Chinese stocks, given the potential risk of delisting from the U.S. that they face, but BYD is also already listed on the Hong Kong stock exchange. <i>And</i> the company is firing on all cylinders from an operational point of view.</p><p>BYD is one of the world&#39;s largest EV manufacturers as well as one of the largest lithium-ion battery manufacturers in China, which is also the world&#39;s largest EV market. BYD is currently the largest seller of new energy vehicles (NEVs) in China, with its monthly sales approaching the 1 million mark. At this pace, BYD could corner 25% of China&#39;s NEV market in 2022.</p><p>Notably, BYD is also rapidly expanding its footprint outside China, particularly in Europe. BYD already builds and sells electric buses in the United States. There&#39;s a lot more happening at BYD, too: In December alone, BYD announced that it&#39;ll launch its second model in Singapore in 2022 and will increase its stake in its joint venture with <b>Daimler </b>to 90%. BYD is also entering the autonomous-driving space through a joint venture, which could pave the way for much bigger things for the automaker. On top of all that, BYD is reportedly in talks with <b>Toyota</b> to help launch the latter&#39;s electric cars in China.</p><p>With China&#39;s NEV sales growing at a torrid pace and the lithium-ion battery market exploding, BYD is positioned stronger than ever to cash in on the boom, making it a no-brainer Buffett stock to own.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 No-Brainer Warren Buffett Stocks to Buy for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 No-Brainer Warren Buffett Stocks to Buy for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 21:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/29/3-no-brainer-warren-buffett-stocks-to-buy-for-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A quick look at the top 10 stocks that legendary investor Warren Buffett owns through his company, Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), reveals that seven of them gained at least 25% in 2021, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/29/3-no-brainer-warren-buffett-stocks-to-buy-for-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.B":"伯克希尔B","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BRK.A":"伯克希尔","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","AMZN":"亚马逊","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","V":"Visa","BYDDY":"比亚迪ADR","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4538":"云计算","BK4550":"红杉资本持仓","GM":"通用汽车","BK4503":"景林资产持仓","01211":"比亚迪股份","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4099":"汽车制造商","BK4548":"巴美列捷福持仓","BK4176":"多领域控股","BK4106":"数据处理与外包服务"},"source_url":"https://www.fool.com/investing/2021/12/29/3-no-brainer-warren-buffett-stocks-to-buy-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195024452","content_text":"A quick look at the top 10 stocks that legendary investor Warren Buffett owns through his company, Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), reveals that seven of them gained at least 25% in 2021, five at least 35%, and the top performer almost 48%, as of this writing. The S&P 500 index, in comparison, is up 27% so far this year. While Berkshire owns a large number of stocks and not just these 10, these numbers show why so many investors follow Buffett's stock-picking style, or often simply buy the stocks he does.I don't quite recommend putting your money in a stock just because Buffett has, but Berkshire's portfolio is an excellent hunting ground if you're looking for stock ideas. Here are three Buffett stocks that I think are no-brainer buys before the year ends.The fears are overrated, and catalysts underratedVisa (NYSE:V) shares have hugely disappointed in the second half of 2021, partly because of its ongoing feud with Amazon (NASDAQ:AMZN) and renewed fears of COVID-19 shutdowns that could hit consumer spending. While the latter is a risk that's not going to affect Visa alone, the company is eager to resolve issues with Amazon, and that could just be one of the big triggers for Visa stock in 2022.Image source: Getty Images.Amazon intends to ban payments using Visa cards on its platform beginning Jan. 19 because of high transaction fees. Visa has expressed surprise over Amazon's decision, saying such transaction fees are regulated in the U.K., and is already negotiating with the e-commerce giant. There's a good chance Amazon might retreat, as the move could cost Amazon U.K. nearly 1.4 billion British pounds, according to  British newspaper The Independent.So while it strives to settle its dispute with Amazon, Visa hasn't lost focus on innovation and growth. For example, it just acquired CurrencyCloud for nearly $925 million. While CurrencyCloud's cloud-based platform allows cross-border foreign currency exchange services across 180 countries and even has access to RippleNet under its partnership with Ripple, which owns the popular namesake cryptocurrency, Visa has also reportedly partnered with 60 crypto platforms to launch cards that facilitate digital currency spending.Visa's operational performance doesn't leave much room for complaint, either -- its payments volume rose 16%, and revenue and net income grew 10% and 13%, respectively, in the fiscal year ended Sept. 30. With Visa also increasing its dividend by 17% and the world increasingly switching from cash to digital payments in this pandemic, this Buffett stock is a must-own for any long-term investor.No longer the boring auto stockShares of legacy automaker General Motors (NYSE:GM) rallied roughly 37% this year as of this writing, but the stock is still trading significantly below its five-year average price-to-earnings ratio. Given the pace at which GM is going all out to exploit the electric-vehicle (EV) boom, the stock looks primed for stronger days ahead.In mid-2021, General Motors outlined ambitious plans to invest $35 billion on electric and autonomous vehicles between 2020 and 2035. By 2030, GM projects its EV revenue to jump to nearly $90 billion, from an estimate $10 billion in 2023.On Dec. 17, GM delivered its first GMC Hummer EV pickup. The same day, GM's wholly owned subsidiary BrightDrop also delivered the first of its 500 all-electric EV600 vehicles to FedEx. Days later, GM announced plans to expand its EV technology beyond its own brands by supplying EV components and solutions to help others electrify their fleet, including in the marine industry. GM's majority-owned subsidiary Cruise also expects the automaker to start manufacturing a driverless vehicle called Origin in 2023.In short, there's a lot happening at GM that should excite auto investors and pique the interest of any investor looking to buy a Buffett stock right now.A top bet on the world's largest EV marketFor several months now, I've been pounding the table on another auto stock Buffett owns: BYD (OTC:BYDDY). Several investors have been wary of investing in Chinese stocks, given the potential risk of delisting from the U.S. that they face, but BYD is also already listed on the Hong Kong stock exchange. And the company is firing on all cylinders from an operational point of view.BYD is one of the world's largest EV manufacturers as well as one of the largest lithium-ion battery manufacturers in China, which is also the world's largest EV market. BYD is currently the largest seller of new energy vehicles (NEVs) in China, with its monthly sales approaching the 1 million mark. At this pace, BYD could corner 25% of China's NEV market in 2022.Notably, BYD is also rapidly expanding its footprint outside China, particularly in Europe. BYD already builds and sells electric buses in the United States. There's a lot more happening at BYD, too: In December alone, BYD announced that it'll launch its second model in Singapore in 2022 and will increase its stake in its joint venture with Daimler to 90%. BYD is also entering the autonomous-driving space through a joint venture, which could pave the way for much bigger things for the automaker. On top of all that, BYD is reportedly in talks with Toyota to help launch the latter's electric cars in China.With China's NEV sales growing at a torrid pace and the lithium-ion battery market exploding, BYD is positioned stronger than ever to cash in on the boom, making it a no-brainer Buffett stock to own.","news_type":1},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009705563,"gmtCreate":1640786512107,"gmtModify":1676533541369,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009705563","repostId":"1105117108","repostType":4,"repost":{"id":"1105117108","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640782444,"share":"https://ttm.financial/m/news/1105117108?lang=&edition=fundamental","pubTime":"2021-12-29 20:54","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1105117108","media":"Tiger Newspress","summary":"U.S. stock index futures rose on Wednesday, as heavyweight Tesla gained, while hopes that the Omicro","content":"<html><head></head><body><p>U.S. stock index futures rose on Wednesday, as heavyweight Tesla gained, while hopes that the Omicron coronavirus variant is less deadly than the previous strain calmed investors amid daily cases in the country hitting a record high.</p><p>At 7:43 a.m. ET, Dow e-minis were up 3 points, or 0.06%, S&amp;P 500 e-minis were up 3 points, or 0.01%, and Nasdaq 100 e-minis were up 29.25 points, or 0.18%.</p><p><img src=\"https://static.tigerbbs.com/7ceef07d87ec8d52d1c5d44cfe0e4400\" tg-width=\"1080\" tg-height=\"409\" referrerpolicy=\"no-referrer\"/></p><p><b>Stocks making the biggest moves premarket:</b></p><p><b>FuelCell Energy(FCEL)</b> – The fuel cell technology company lost 7 cents per share for its latest quarter, wider than the 4-cent loss predicted by analysts. Revenue also fell below analyst forecasts, and the stock slumped 9% in premarket trading.</p><p><b>BioNTech(BNTX) </b>– The drug maker&#39;s shares fell 3.1% in the premarket, potentially extending the stock&#39;s losing streak to 7 days. BioNTech has fallen 16% over the past 6 sessions. Rival vaccine maker <b>Moderna(MRNA)</b> is in a similar slump, falling for the past six sessions and falling 18% over that stretch. Moderna dropped 1.6% in premarket action.</p><p><b>Tesla(TSLA)</b> – Tesla rose 1% in premarket trading, following news that CEO Elon Musk completed the exercising of all his stock options for next year. That signals the end of recent stock sales by Musk to cover tax bills generated by the exercise of those options.</p><p><b>Rivian(RIVN)</b> – Rivian dropped 2.2% in premarket trading,following the company reportedly made a decision to delay the bigger battery pack for its electric pickup all the way to 2023.</p><p><b>Cal-Maine Foods(CALM)</b> – The nation&#39;s largest egg producer earned 2 cents per share for its latest quarter, well short of the 30-cent consensus estimate. Sales were better-than-expected, but the bottom line was hit by higher costs for packaging and labor. Cal-Maine shares tumbled 7.1% in the premarket.</p><p><b>Alibaba(BABA)</b> – The China-based e-commerce giant is considering the sale of its 30% stake in social media advertising company <b>Weibo(WB)</b> to state-owned Shanghai Media Group, according to a Bloomberg report. Alibaba fell 1% in premarket action, while Weibo edged lower by 0.3%.</p><p><b>Didi Global(DIDI) </b>– Didi was down 2.4% in premarket trading after Reuters reported the Chinese ride-hailing company will use the “listing by introduction” method to list in Hong Kong, as it moves to delist in New York. That method would issue no new shares and raise no capital.</p><p><b>Victoria’s Secret(VSCO)</b> – The intimate apparel retailer announced a $250 million accelerated share repurchase program.Its shares jumped 9% in premarket trading.</p><p><b>Akamai Technologies(AKAM)</b> – Akamai rose 1.2% in the premarket after D.A. Davidson rated the internet content delivery company a “buy” in new coverage. The firm set a price target of $143 per share, compared with Tuesday’s close of $118.45.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-29 20:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stock index futures rose on Wednesday, as heavyweight Tesla gained, while hopes that the Omicron coronavirus variant is less deadly than the previous strain calmed investors amid daily cases in the country hitting a record high.</p><p>At 7:43 a.m. ET, Dow e-minis were up 3 points, or 0.06%, S&amp;P 500 e-minis were up 3 points, or 0.01%, and Nasdaq 100 e-minis were up 29.25 points, or 0.18%.</p><p><img src=\"https://static.tigerbbs.com/7ceef07d87ec8d52d1c5d44cfe0e4400\" tg-width=\"1080\" tg-height=\"409\" referrerpolicy=\"no-referrer\"/></p><p><b>Stocks making the biggest moves premarket:</b></p><p><b>FuelCell Energy(FCEL)</b> – The fuel cell technology company lost 7 cents per share for its latest quarter, wider than the 4-cent loss predicted by analysts. Revenue also fell below analyst forecasts, and the stock slumped 9% in premarket trading.</p><p><b>BioNTech(BNTX) </b>– The drug maker&#39;s shares fell 3.1% in the premarket, potentially extending the stock&#39;s losing streak to 7 days. BioNTech has fallen 16% over the past 6 sessions. Rival vaccine maker <b>Moderna(MRNA)</b> is in a similar slump, falling for the past six sessions and falling 18% over that stretch. Moderna dropped 1.6% in premarket action.</p><p><b>Tesla(TSLA)</b> – Tesla rose 1% in premarket trading, following news that CEO Elon Musk completed the exercising of all his stock options for next year. That signals the end of recent stock sales by Musk to cover tax bills generated by the exercise of those options.</p><p><b>Rivian(RIVN)</b> – Rivian dropped 2.2% in premarket trading,following the company reportedly made a decision to delay the bigger battery pack for its electric pickup all the way to 2023.</p><p><b>Cal-Maine Foods(CALM)</b> – The nation&#39;s largest egg producer earned 2 cents per share for its latest quarter, well short of the 30-cent consensus estimate. Sales were better-than-expected, but the bottom line was hit by higher costs for packaging and labor. Cal-Maine shares tumbled 7.1% in the premarket.</p><p><b>Alibaba(BABA)</b> – The China-based e-commerce giant is considering the sale of its 30% stake in social media advertising company <b>Weibo(WB)</b> to state-owned Shanghai Media Group, according to a Bloomberg report. Alibaba fell 1% in premarket action, while Weibo edged lower by 0.3%.</p><p><b>Didi Global(DIDI) </b>– Didi was down 2.4% in premarket trading after Reuters reported the Chinese ride-hailing company will use the “listing by introduction” method to list in Hong Kong, as it moves to delist in New York. That method would issue no new shares and raise no capital.</p><p><b>Victoria’s Secret(VSCO)</b> – The intimate apparel retailer announced a $250 million accelerated share repurchase program.Its shares jumped 9% in premarket trading.</p><p><b>Akamai Technologies(AKAM)</b> – Akamai rose 1.2% in the premarket after D.A. Davidson rated the internet content delivery company a “buy” in new coverage. The firm set a price target of $143 per share, compared with Tuesday’s close of $118.45.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","MRNA":"Moderna, Inc.",".SPX":"S&P 500 Index","CALM":"Cal-Maine Foods","WB":"微博","BABA":"阿里巴巴","TSLA":"特斯拉","DIDI":"滴滴(已退市)","AKAM":"阿克迈","VSCO":"维多利亚的秘密","RIVN":"Rivian Automotive, Inc.","FCEL":"燃料电池能源"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105117108","content_text":"U.S. stock index futures rose on Wednesday, as heavyweight Tesla gained, while hopes that the Omicron coronavirus variant is less deadly than the previous strain calmed investors amid daily cases in the country hitting a record high.At 7:43 a.m. ET, Dow e-minis were up 3 points, or 0.06%, S&P 500 e-minis were up 3 points, or 0.01%, and Nasdaq 100 e-minis were up 29.25 points, or 0.18%.Stocks making the biggest moves premarket:FuelCell Energy(FCEL) – The fuel cell technology company lost 7 cents per share for its latest quarter, wider than the 4-cent loss predicted by analysts. Revenue also fell below analyst forecasts, and the stock slumped 9% in premarket trading.BioNTech(BNTX) – The drug maker's shares fell 3.1% in the premarket, potentially extending the stock's losing streak to 7 days. BioNTech has fallen 16% over the past 6 sessions. Rival vaccine maker Moderna(MRNA) is in a similar slump, falling for the past six sessions and falling 18% over that stretch. Moderna dropped 1.6% in premarket action.Tesla(TSLA) – Tesla rose 1% in premarket trading, following news that CEO Elon Musk completed the exercising of all his stock options for next year. That signals the end of recent stock sales by Musk to cover tax bills generated by the exercise of those options.Rivian(RIVN) – Rivian dropped 2.2% in premarket trading,following the company reportedly made a decision to delay the bigger battery pack for its electric pickup all the way to 2023.Cal-Maine Foods(CALM) – The nation's largest egg producer earned 2 cents per share for its latest quarter, well short of the 30-cent consensus estimate. Sales were better-than-expected, but the bottom line was hit by higher costs for packaging and labor. Cal-Maine shares tumbled 7.1% in the premarket.Alibaba(BABA) – The China-based e-commerce giant is considering the sale of its 30% stake in social media advertising company Weibo(WB) to state-owned Shanghai Media Group, according to a Bloomberg report. Alibaba fell 1% in premarket action, while Weibo edged lower by 0.3%.Didi Global(DIDI) – Didi was down 2.4% in premarket trading after Reuters reported the Chinese ride-hailing company will use the “listing by introduction” method to list in Hong Kong, as it moves to delist in New York. That method would issue no new shares and raise no capital.Victoria’s Secret(VSCO) – The intimate apparel retailer announced a $250 million accelerated share repurchase program.Its shares jumped 9% in premarket trading.Akamai Technologies(AKAM) – Akamai rose 1.2% in the premarket after D.A. Davidson rated the internet content delivery company a “buy” in new coverage. The firm set a price target of $143 per share, compared with Tuesday’s close of $118.45.","news_type":1},"isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009915062,"gmtCreate":1640426348867,"gmtModify":1676533520690,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009915062","repostId":"1159652805","repostType":4,"repost":{"id":"1159652805","pubTimestamp":1640397611,"share":"https://ttm.financial/m/news/1159652805?lang=&edition=fundamental","pubTime":"2021-12-25 10:00","market":"us","language":"en","title":"Electric boat developer Forza X1 files for a $29 million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159652805","media":"Renaissance Capital","summary":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday wi","content":"<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.</p>\n<p>The company states that it&nbsp;aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.</p>\n<p>The Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol&nbsp;FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electric boat developer Forza X1 files for a $29 million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectric boat developer Forza X1 files for a $29 million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159652805","content_text":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.\nThe Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164993620,"gmtCreate":1624164144060,"gmtModify":1703829948231,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164993620","repostId":"1126454279","repostType":2,"repost":{"id":"1126454279","pubTimestamp":1624151746,"share":"https://ttm.financial/m/news/1126454279?lang=&edition=fundamental","pubTime":"2021-06-20 09:15","market":"us","language":"en","title":"A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens","url":"https://stock-news.laohu8.com/highlight/detail?id=1126454279","media":"fool","summary":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\n","content":"<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.</p>\n<p>Since the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followed<b>S&amp;P 500</b>(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.</p>\n<p><b>History is pretty clear that trouble lies ahead</b></p>\n<p>For example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&amp;P 500 and have yet to see anything close to a double-digit correction.</p>\n<p>To add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&amp;P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.</p>\n<p>On a valuation basis, the S&amp;P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&amp;P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.</p>\n<p>Make no mistake about it -- a stock market crash is coming.</p>\n<p>Every crash or correction is an opportunity for patient investors to make money</p>\n<p>However, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.</p>\n<p><b>CrowdStrike Holdings</b></p>\n<p>Cybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stock<b>CrowdStrike Holdings</b>(NASDAQ:CRWD)can thrive in any environment.</p>\n<p>CrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.</p>\n<p>We can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.</p>\n<p><b>Facebook</b></p>\n<p>Brand-name businesses can make patient investors a fortune, and social media giant<b>Facebook</b>(NASDAQ:FB)is the perfect example.</p>\n<p>When the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.</p>\n<p>But here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.</p>\n<p><b>NextEra Energy</b></p>\n<p>Another high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stock<b>NextEra Energy</b>(NYSE:NEE).</p>\n<p>Did I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.</p>\n<p>In addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.</p>\n<p><b>Visa</b></p>\n<p>When the next stock market crash arrives, payment processing kingpin<b>Visa</b>(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.</p>\n<p>Buying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.</p>\n<p>The other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.</p>\n<p><b>Amazon</b></p>\n<p>Lastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemoth<b>Amazon</b>(NASDAQ:AMZN).</p>\n<p>Amazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.</p>\n<p>What about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.</p>\n<p>But it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Stock Market Crash Is Coming: 5 High-Conviction Stocks to Buy Hand Over Fist When It Happens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-20 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NEP":"Nextera Energy Partners","V":"Visa","CRWD":"CrowdStrike Holdings, Inc.","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/06/19/stock-market-crash-coming-5-high-conviction-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126454279","content_text":"It might be the last thing you want to hear, but it's the truth:A stock market crash is inevitable.\nSince the March 23, 2020 bottom, investors have enjoyed a historically strong bounce-back rally -- the widely followedS&P 500(SNPINDEX:^GSPC)has gained an impressive 90%. But both history and valuation metrics unequivocally suggest that a big drop is upcoming for the stock market.\nHistory is pretty clear that trouble lies ahead\nFor example, there have beenone or two double-digit percentage declineswithin the three years following a bottom in each of the previous eight bear markets prior to the coronavirus crash (i.e., dating back to 1960). Although bull markets tend to last years, rebounds from a bear market are never this smooth. We're nearly 15 months past the March 2020 bear-market bottom in the S&P 500 and have yet to see anything close to a double-digit correction.\nTo add to this point, data from market analytics firm Yardeni Research shows that there have been 38 double-digit declines in the S&P 500 over the past 71 years. That's a crash or correction, on average,every 1.87 years. Though the market doesn't adhere to averages, it does give a general sense of when to expect these hiccups.\nOn a valuation basis, the S&P 500's Shiller price-to-earnings (P/E) ratio is a waving red flag. The S&P 500's Shiller P/E -- a measure of inflation-adjusted earnings over the previous 10 years -- almost hit 38 earlier this week. That more than doubles its 151-year average, and it's the highest level in nearly two decades. The previous four times the Shiller P/E surpassed and held above 30 during a bull market rally, the indexsubsequently declined by a minimum of 20%.\nMake no mistake about it -- a stock market crash is coming.\nEvery crash or correction is an opportunity for patient investors to make money\nHowever, a crash is no reason to duck and cover. While history may signal trouble ahead, it also tells us that each and every double-digit decline has been a buying opportunity. Eventually, every big drop in the major indexes is erased by a bull-market rally. When the next crash does occur, the following five high-conviction stocks can be confidently bought hand over fist.\nCrowdStrike Holdings\nCybersecurity is projected to beone of the safest double-digit growth trendsthis decade. No matter the size of the business or the state of the U.S./global economy, protecting enterprise and consumer data is paramount. This means cloud-based cybersecurity stockCrowdStrike Holdings(NASDAQ:CRWD)can thrive in any environment.\nCrowdStrike's successderives from its cloud-native Falcon security platform. Because it's built in the cloud and relies on artificial intelligence, it's growing smarter at identifying and responding to threats all the time. It's currently overseeing 6 trillion events on a weekly basis, and it's far more cost-effective at protecting data than on-premise solutions.\nWe can also look to the company's income statements to see clear-cut evidence that businesses favor CrowdStrike's cybersecurity platform. It's been retaining 98% of its clients, has seen existing clients spend 23% to 47% more on a year-over-year basis for the past 12 quarters, and recently reported that 64% of its customers have purchased at least four cloud module subscriptions. Scaling with its customers is CrowdStrike's ticket to big-time cash flow expansion.\nFacebook\nBrand-name businesses can make patient investors a fortune, and social media giantFacebook(NASDAQ:FB)is the perfect example.\nWhen the curtain closed on March, Facebook tallied 2.85 billion monthly active users (MAU) visiting its namesake site and an additional 600 million unique MAUs visiting WhatsApp or Instagram, which it also owns. All told, this equates to44% of the global populationinteracting with its owned sites each month. There's simply no social media platform businesses can go to get their message to a broader (or potentially targeted) audience, which is why Facebook ad-pricing power is so strong.\nBut here's the kicker: Facebookhasn't even put the pedal to the metal. Although it's on track to generate more than $100 billion in advertising revenue in 2021, nearly all of these ad sales are coming from its namesake site and Instagram. WhatsApp and Facebook Messenger, which are two of the six most-visited social sites in the world, aren't being meaningfully monetized as of yet. Further, the company's Oculus virtual reality devices are still in the early stage of their growth. Suffice it to say, Facebook offers ample upside as its other operating segments are monetized and mature.\nNextEra Energy\nAnother high-conviction stock to buy hand over fist the next time a crash or steep correction strikes is electric utility stockNextEra Energy(NYSE:NEE).\nDid I put you to sleep when I said \"electric utility stock?\" Electric utilities are traditionally known for their market-topping dividend yields and persistently low growth rates. But this doesn't describe NextEra Energy. NextEra has aggressively invested in renewable energy projects and is leading the country in solar and wind capacity. As a result of these investments, its electric generation costs have declined and its compound annual growth ratehas consistently been in the high single digitsfor more than a decade. It also doesn't hurt that NextEra is front-running any potential green-energy legislation that might come out of Washington.\nIn addition to growth rates that are well above the sector average, NextEra still benefits from the predictability of energy demand. For instance, its regulated utilities (i.e., those not powered by renewable energy) require approval from state utility commissions before price hikes can be passed along to households. This might sound like an inconvenience, but it's actually great news. It means NextEra won't be exposed to potentially volatile wholesale pricing.\nVisa\nWhen the next stock market crash arrives, payment processing kingpinVisa(NYSE:V)is a winning company to confidently buy hand over fist. It's also another brand-name company thatcan still make its shareholders a fortune.\nBuying into the Visa growth story is a simple numbers game. Visa grows its revenue and profits when consumers and businesses are spending more. This happens when the U.S. and global economy are expanding. Although contractions and recessions are an inevitable part of the economic cycle, they tend to be short-lived. Meanwhile, periods of economic expansion are almost always measured in years. Buying into Visa during these short-lived crashes or corrections should allow long-term investors to be handsomely rewarded by this numbers game.\nThe other interesting thing about Visa is thatit's shunned becoming a lender. You'd think that Visa could generate big bucks from interest income and fees by lending during these long-lived periods of expansion. But lending would also expose Visa to the credit delinquencies that arise during recessions. Operating solely as a payment processor means not having to set aside cash to cover delinquencies. It's why Visa rebounds so much faster than most financial stocks following a recession.\nAmazon\nLastly (andwho couldn't see this coming?), investors should take any discount they can get during a crash on e-commerce behemothAmazon(NASDAQ:AMZN).\nAmazon's online marketplace has proved virtually unstoppable for well over a decade. An April 2021 report from eMarketer pegged the company's share of U.S. online sales at 40.4%. That more than quintuples its next-closest competitor and effectively solidifies Amazon as the go-to source for online shopping in the U.S.\nWhat about those pesky low retail margins, you ask? Amazon has signed up more than 200 million people globally to a Prime membership. The fees collected from Prime members help to offset some of the company's retail-based margin weakness. Prime members are extremely loyal to the Amazon ecosystem and spend far more than non-members, too.\nBut it's Amazon's cloud infrastructure segmentthat's the superstar. Amazon Web Services (AWS) brings in around one-eighth of the company's total sales but accounts for well over half its operating income. Since cloud margins are superior to retail and advertising margins, AWS is the company's key to explosive cash flow growth this decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005335514,"gmtCreate":1642170915758,"gmtModify":1676533688781,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005335514","repostId":"2203805712","repostType":4,"repost":{"id":"2203805712","pubTimestamp":1642168440,"share":"https://ttm.financial/m/news/2203805712?lang=&edition=fundamental","pubTime":"2022-01-14 21:54","market":"us","language":"en","title":"1 Growth Stock Down 89% That Could Soar, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2203805712","media":"Motley Fool","summary":"A stock that plunges nearly 90% is inherently risky, but Wall Street is rapidly warming up to this small-cap company.","content":"<html><head></head><body><p>It&#39;s no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are observing the collapse in price of many technology stocks right now after a strong 2021.</p><p>But for action camera leader <b><a href=\"https://laohu8.com/S/GPRO\">GoPro</a></b> (NASDAQ:GPRO), the journey from top-of-the-world to rock bottom happened more slowly. After listing on the stock exchange in 2014, its stock hit an all-time closing high of $93.85 before a painful eight-year decline of 89% to $10.58 as of this writing. GoPro has become a rare case, though, because it&#39;s successfully turning things around.</p><p>Its recent strategies have been so promising that at least three top Wall Street firms have upgraded the stock since last November. A building consensus like that might be enough to get some investors off the sidelines and into the action.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/884d755da3119dda23b44f093ef5dd2d\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>Adapt and thrive</h2><p>Perhaps the heaviest criticism of GoPro since it went public was its <a href=\"https://laohu8.com/S/AONE.U\">one</a>-dimensional business. The company simply manufactured and sold action cameras, so while it has always led the market, competitors also improved over time, eroding GoPro&#39;s profit margins and stifling its revenue growth.</p><p>Less income meant less money to allocate to innovation, triggering an inevitable death spiral that crippled the company&#39;s share price. But over the last three years, that has changed. GoPro has leveraged its website to create a new direct-to-consumer sales channel which now accounts for 35% of the top line, replacing some of the large retail chains it previously relied on to sell its cameras and accessories. And selling directly from its website means it keeps a larger share of the profits.</p><p>GoPro has also introduced a subscription service for loyal customers to unlock exclusive benefits. These moves have increased the company&#39;s gross margin and delivered brand new revenue streams, which offer GoPro more flexibility with its business model.</p><p>The largest benefit of all is the renewed focus on innovation. In Sept. 2021, it released the new HERO10 Black action camera, which shoots video in 5.3K High Definition. It&#39;s priced at $499, and its closest competitor in terms of technical ability comes in at $3,500 -- in other words, it&#39;s blowing away the competition.</p><h2>Soaring subscriptions</h2><p>Building a subscriber base is a totally new concept for GoPro. It includes a shift from hardware to software and carries a gross margin as high as 80%, almost double that of its main business. That means more revenue flows to the bottom line, which investors love to see.</p><p>For $49.99 per year, subscribers get unlimited cloud storage for their videos, exclusive product discounts, and the ability to livestream directly from their GoPro camera. The response from customers has been overwhelmingly positive, and over the past year, in particular, subscriber growth has soared.</p><table><thead><tr><th><p>Metric</p></th><th><p>Q3 2020</p></th><th><p>Q3 2021</p></th><th><p>Growth</p></th></tr></thead><tbody><tr><td><p>GoPro.com Subscribers</p></td><td><p>501,000</p></td><td><p>1.34 million</p></td><td><p>168%</p></td></tr></tbody></table><p>Data source: GoPro.</p><p>The subscriber figure is expected to reach 1.7 million once GoPro officially reports its full-year 2021 results. And this year, the company estimates it will generate $90 million in recurring subscription revenue. Given the potential 80% margin mentioned earlier, GoPro&#39;s profitability should continue to rise.</p><h2>Impressing Wall Street</h2><p>After holding mostly negative views on GoPro during its difficult tenure as a public company, Wall Street firms recently began to recognize its newfound success with a tidal wave of upgrades between November and December 2021.</p><p>Investment bank <b><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a></b>, which had an underweight rating on GoPro stock, has upgraded it to neutral with an $11 price target. Investment firm <b>Wedbush Securities</b> maintained its outperform rating but added a $13.50 price target. And finally, investment bank <b>JP Morgan Chase</b> is the most bullish of the three, upgrading GoPro stock from neutral to overweight with a $15 price target, representing a 42% gain from its current price.</p><p>According to the consensus analyst estimate, GoPro is expected to generate $0.94 in earnings per share in 2022. With a stock price of $10.58, that means shares trade at a forward price-to-earnings multiple of just 11.3. By comparison, the technology-centric <b>Nasdaq 100</b> index trades at a forward multiple of just under 28, so GoPro stock would need to more than double to trade in line with the broader sector.</p><p>It&#39;s never easy to find hidden gems in the stock market, but Wall Street might have uncovered one in GoPro, and the company is backing it up with a truly incredible turnaround.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Growth Stock Down 89% That Could Soar, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Growth Stock Down 89% That Could Soar, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-14 21:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4078":"消费电子产品","BK4504":"桥水持仓","MS":"摩根士丹利","GPRO":"GoPro","BK4127":"投资银行业与经纪业"},"source_url":"https://www.fool.com/investing/2022/01/14/1-growth-stock-down-89-could-soar-says-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2203805712","content_text":"It's no secret that companies get things wrong sometimes. The corporate world is littered with stories of high-flying success met with abrupt descents back down to Earth. In fact, investors are observing the collapse in price of many technology stocks right now after a strong 2021.But for action camera leader GoPro (NASDAQ:GPRO), the journey from top-of-the-world to rock bottom happened more slowly. After listing on the stock exchange in 2014, its stock hit an all-time closing high of $93.85 before a painful eight-year decline of 89% to $10.58 as of this writing. GoPro has become a rare case, though, because it's successfully turning things around.Its recent strategies have been so promising that at least three top Wall Street firms have upgraded the stock since last November. A building consensus like that might be enough to get some investors off the sidelines and into the action.Image source: Getty Images.Adapt and thrivePerhaps the heaviest criticism of GoPro since it went public was its one-dimensional business. The company simply manufactured and sold action cameras, so while it has always led the market, competitors also improved over time, eroding GoPro's profit margins and stifling its revenue growth.Less income meant less money to allocate to innovation, triggering an inevitable death spiral that crippled the company's share price. But over the last three years, that has changed. GoPro has leveraged its website to create a new direct-to-consumer sales channel which now accounts for 35% of the top line, replacing some of the large retail chains it previously relied on to sell its cameras and accessories. And selling directly from its website means it keeps a larger share of the profits.GoPro has also introduced a subscription service for loyal customers to unlock exclusive benefits. These moves have increased the company's gross margin and delivered brand new revenue streams, which offer GoPro more flexibility with its business model.The largest benefit of all is the renewed focus on innovation. In Sept. 2021, it released the new HERO10 Black action camera, which shoots video in 5.3K High Definition. It's priced at $499, and its closest competitor in terms of technical ability comes in at $3,500 -- in other words, it's blowing away the competition.Soaring subscriptionsBuilding a subscriber base is a totally new concept for GoPro. It includes a shift from hardware to software and carries a gross margin as high as 80%, almost double that of its main business. That means more revenue flows to the bottom line, which investors love to see.For $49.99 per year, subscribers get unlimited cloud storage for their videos, exclusive product discounts, and the ability to livestream directly from their GoPro camera. The response from customers has been overwhelmingly positive, and over the past year, in particular, subscriber growth has soared.MetricQ3 2020Q3 2021GrowthGoPro.com Subscribers501,0001.34 million168%Data source: GoPro.The subscriber figure is expected to reach 1.7 million once GoPro officially reports its full-year 2021 results. And this year, the company estimates it will generate $90 million in recurring subscription revenue. Given the potential 80% margin mentioned earlier, GoPro's profitability should continue to rise.Impressing Wall StreetAfter holding mostly negative views on GoPro during its difficult tenure as a public company, Wall Street firms recently began to recognize its newfound success with a tidal wave of upgrades between November and December 2021.Investment bank Morgan Stanley, which had an underweight rating on GoPro stock, has upgraded it to neutral with an $11 price target. Investment firm Wedbush Securities maintained its outperform rating but added a $13.50 price target. And finally, investment bank JP Morgan Chase is the most bullish of the three, upgrading GoPro stock from neutral to overweight with a $15 price target, representing a 42% gain from its current price.According to the consensus analyst estimate, GoPro is expected to generate $0.94 in earnings per share in 2022. With a stock price of $10.58, that means shares trade at a forward price-to-earnings multiple of just 11.3. By comparison, the technology-centric Nasdaq 100 index trades at a forward multiple of just under 28, so GoPro stock would need to more than double to trade in line with the broader sector.It's never easy to find hidden gems in the stock market, but Wall Street might have uncovered one in GoPro, and the company is backing it up with a truly incredible turnaround.","news_type":1},"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002423377,"gmtCreate":1642075841811,"gmtModify":1676533678272,"author":{"id":"3574933488250733","authorId":"3574933488250733","name":"DoubleClick","avatar":"https://static.tigerbbs.com/91c1a51c4f84aa921e0b29d4e1b8f7e1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574933488250733","idStr":"3574933488250733"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002423377","repostId":"1119227901","repostType":4,"repost":{"id":"1119227901","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642066574,"share":"https://ttm.financial/m/news/1119227901?lang=&edition=fundamental","pubTime":"2022-01-13 17:36","market":"us","language":"en","title":"Vir Biotechnology shares rose over 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1119227901","media":"Tiger Newspress","summary":"Vir Biotechnology shares rose over 6% in premarket trading. Glaxo & Vir to supply more COVID antibod","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a> shares rose over 6% in premarket trading. Glaxo &amp; Vir to supply more COVID antibody doses in the US.</p><p><img src=\"https://static.tigerbbs.com/c86ab21aabe8a1f3f5d8adb3b045af6b\" tg-width=\"1033\" tg-height=\"645\" width=\"100%\" height=\"auto\"/></p><p><a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline </a> and partner <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology </a> announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.</p><p>The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.</p><p>The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.</p><p>Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.</p><p>The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology shares rose over 6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology shares rose over 6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-13 17:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology</a> shares rose over 6% in premarket trading. Glaxo &amp; Vir to supply more COVID antibody doses in the US.</p><p><img src=\"https://static.tigerbbs.com/c86ab21aabe8a1f3f5d8adb3b045af6b\" tg-width=\"1033\" tg-height=\"645\" width=\"100%\" height=\"auto\"/></p><p><a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline </a> and partner <a href=\"https://laohu8.com/S/VIR\">Vir Biotechnology </a> announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.</p><p>The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.</p><p>The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.</p><p>Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.</p><p>The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克","VIR":"Vir Biotechnology, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119227901","content_text":"Vir Biotechnology shares rose over 6% in premarket trading. Glaxo & Vir to supply more COVID antibody doses in the US.GlaxoSmithKline  and partner Vir Biotechnology  announced that they have signed an agreement with the U.S. government to supply an additional 600,000 doses of their monoclonal antibody, sotrovimab. These doses will be supplied throughout the first quarter of 2022.The agreement also allows the government to further procure additional doses of sotrovimab during second-quarter 2022. After taking into account this supply agreement with the U.S. government, both Glaxo and Vir have secured agreements with various entities across the world to supply nearly 1.7 million doses of sotrovimab.The press release indicates that Glaxo and Vir could produce 2 million doses of sotrovimab in first-half 2022. Both the companies also expect to produce additional doses of their antibody treatment in second-half 2022.Please note that this new supply agreement entered by Glaxo and Vir with the U.S. government is an amendment to a contract agreement signed between the same parties in November 2021 for the supply of sotrovimab doses for approximately $1 billion to the U.S. government by Dec 17, 2021.The signing of the supply agreement for sotrovimab is beneficial for both the companies, especially the small but growing pharma company, Vir Biotechnology, whose current revenue source is the supply of sotrovimab doses.","news_type":1},"isVote":1,"tweetType":1,"viewCount":737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}